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PHYSICAL ACTIVITY IN OVERWEIGHT AND OBESE ADULTS WITH 
SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS 
 
Carol Ann Janney, PhD 
University of Pittsburgh, 2012 
 
Objectives: Provide a comprehensive profile of physical activity in overweight and obese adults 
with schizophrenia or schizoaffective disorders (SZO/SA), and compare physical activity levels 
measured objectively with accelerometry in overweight and obese adults with SZO/SA with 
users of mental health services (NHANES 2003-2004). 
Design: Randomized clinical trial; Weight Assessment and Intervention in Schizophrenia 
Treatment (WAIST) Study: baseline data collected 2005-2008. 
Setting: University of Pittsburgh Medical Center, Pittsburgh, PA, USA 
Participants: Community-dwelling adults diagnosed with SZO/SA, experiencing mild 
psychiatric symptoms (PANSS<90), interested in losing weight, age 18-70 years, BMI>27 
kg/m2. 
Measurements: Self-reported physical activity questionnaire, objectively measured physical 
activity (accelerometry), and physical fitness.   
Results: Household activities were the primary source of activity (women 474, men 284 
mins/wk, p<0.001). Walking for transportation or leisure was reported by 64% (n=163) of 
participants. Occupational activities were limited due to low employment rate (~15%). Other 
than household activities, no differences in subjective physical activity were noted by gender, 
race, or age groups. On average, 81%, 17%, and 2% of the participant’s monitoring time was 
classified as sedentary, light, and moderate-vigorous activity, respectively, using accelerometry. 
Total (mins/day and counts/min) and light activity (mins/day) but not moderate-vigorous activity 
(mins/day) were significantly greater in users of mental health services than adults with SZO/SA 
(p<0.01).  Only 2 of 105 were classified as fit. No association was observed between objective 
and subjective physical activity and physical fitness. Subjective physical activity was associated 
with function and general health status but not psychiatric symptoms.   
Conclusion: Overweight and obese adults with SZO/SA were extremely sedentary; unfit; 
engaged in unstructured, intermittent, low-intensity physical activity; less active than users of 
 v 
 
mental health services. Physical activities were generally limited to walking for transportation or 
leisure, and household activities. 
Public Health Significance: These findings provide the first quantitative and comprehensive 
profile of physical activity in adults with SZO/SA. This extremely sedentary lifestyle is alarming, 
significantly lower than other inactive US populations, costly for the individual and community, 
and warrants immediate action. Interventions should focus on decreasing sedentary time in 
addition to promoting all aspects of physical activity in overweight and obese adults with 
SZO/SA. 
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1.0 OVERVIEW 
 
 
 
Schizophrenia and schizoaffective disorders are severe chronic mental illnesses that afflict 
approximately 1% of the US population (1).  Positive symptoms of schizophrenia represent an 
excess or distortion of normal function and include delusions, hallucinations, disorganized 
speech, and grossly disorganized or catatonic behavior(2).  Conversely, the negative symptoms 
of schizophrenia refer to a reduction or loss of normal function(2) manifested as affective 
flattening, alogia, or avolition (3).  In addition, the cognitive deficits of schizophrenia involve 
attention problems, poor executive functioning pertaining to planning and organizing, and 
impaired working memory(1).  These cognitive impairments often result in significant social and 
occupational dysfunction for individuals with schizophrenia(1, 3).  With schizoaffective 
disorders, individuals experience major depression, mania or a mixed episode (symptoms of 
depression and mania simultaneously) along with the positive, negative, and/or cognitive 
symptoms of schizophrenia(3).    
 Treatment of schizophrenia and schizoaffective disorder includes pharmacotherapy with 
antipsychotic medication and may be combined with psychosocial interventions(4).  However, 
adjunctive treatments or strategies are still needed to reduce the risk of relapse and the significant 
residual symptoms associated with schizophrenia(4).   
 It has been suggested that physical activity may improve the quality of life of adults with 
schizophrenia or schizoaffective disorder by providing physical and psychological benefits(4).  
Although limited, research on the psychiatric benefits of physical activity in adults with 
schizophrenia or schizoaffective disorder suggests that it may alleviate the negative symptoms of 
schizophrenia by reducing depression, decreasing social withdrawal and isolation, and increasing 
self-esteem(4). In addition, physical activity may provide an effective coping strategy for the 
positive symptoms of schizophrenia(4) that involve a loss of contact with reality such as 
hallucinations, delusions, and thought and movement disorders.   
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 In the general population, physical activity has been shown to reduce the risk of chronic 
diseases, including cardiovascular disease and diabetes, disabilities (5), and premature 
mortality(6-10).  Physical activity has also been shown to prevent weight gain, and is 
recommended as a component of weight loss and weight loss maintenance programs(11).  Since 
schizophrenia and schizoaffective disorders are associated with significant co-morbidities such 
as hypertension, diabetes, cardiovascular disease and obesity(4), unhealthy lifestyles(12), and 
increased morbidity and mortality(13-15), physical activity may be one avenue to reduce the risk 
of these co-morbidities in adults with schizophrenia or schizoaffective disorder. Since the degree 
of obesity and overweight among adults with schizophrenia or schizoaffective disorder equals or 
exceeds the epidemic levels observed in the general US population(16), physical activity may be 
especially beneficial for those adults with schizophrenia or schizoaffective disorders who are 
overweight or obese by reducing the risk of cardiovascular disease, diabetes, and premature 
mortality. 
 Although limited, previous studies using objective and subjective measures of physical 
activity suggest that individuals with schizophrenia or schizoaffective disorder have low levels of 
moderate to vigorous physical activity.  For the most part, these studies have been limited by the 
following: small sample sizes (17, 18), providing global rather comprehensive estimates of 
physical activity that primarily focused on high intensity physical activities(19, 20), the samples 
were either too homogenous such as patients with schizophrenia or schizoaffective disorder who 
had diabetes and were also overweight or obese(19), or heterogeneous such as patients with 
severe mental illness including schizophrenia, schizoaffective disorder, bipolar disorder, and 
major depression (20), and limited the assessment to subjective or objective measures of physical 
activity rather than measuring both to provide a comprehensive profile of physical activity that 
includes the quantity, intensity, pattern, and type of physical activity in adults with schizophrenia 
and/or schizoaffective disorders.  
 The Weight Assessment and Intervention in Schizophrenia Treatment Study (WAIST) 
provided the unique opportunity to profile physical activity levels in overweight and obese adults 
with schizophrenia or schizoaffective disorders enrolled in a clinical trial to investigate lifestyle 
interventions for weight reduction.  Briefly, overweight and obese adults with schizophrenia or 
schizoaffective disorders were randomized to one of three treatment groups: group-based 
behavioral treatment for weight reduction (BT), social skills training (SST) or usual care (UC). 
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At baseline, physical activity was measured objectively with accelerometry and subjectively with 
a modified version of an established physical activity questionnaire, the Modified Activity 
Questionnaire (MAQ), to provide a comprehensive profile of physical activity of overweight and 
obese adults with schizophrenia or schizoaffective disorder.     
 The first objective of the current investigation is to thoroughly describe physical activity 
levels of overweight and obese adults with schizophrenia and schizoaffective disorders by 
objective and subjective measures of physical activity. This comprehensive profile of physical 
activity will be a novel contribution to the schizophrenia and schizoaffective disorders literature.  
It is hypothesized that overweight and obese adults with schizophrenia and schizoaffective 
disorders will be relatively sedentary and primarily engage in unstructured and low-intensity 
physical activities such as walking and daily household activities.  Within overweight and obese 
adults with schizophrenia and schizoaffective disorder, physical activity levels are expected to 
have an inverse relationship with cognitive, social and occupational impairment or dysfunction 
i.e. as impairment increases physical activity decreases.   
 The second objective of this report is to compare physical activity levels measured 
objectively by accelerometry in overweight and obese adults with schizophrenia and 
schizoaffective disorder with the general US population based on data from the National Health 
and Nutrition Examination Survey (NHANES) 2003-2004.  It is hypothesized that the physical 
activity levels of overweight and obese adults with schizophrenia and schizoaffective disorder 
will be significantly less than overweight and obese adults in the general US population.  In 
addition, the NHANES sample will be stratified by whether or not they reported using mental 
health services during the preceding 12 months.  Physical activity levels of adults with 
schizophrenia or schizoaffective disorders will then be compared with adult users and non-users 
of mental health services. It is hypothesized that physical activity will be associated with the 
severity and the diagnosis of the mental health disorder.  In other words, adults with severe 
mental illness such as schizophrenia and schizoaffective disorder are expected to have 
significantly lower physical activity levels than users of mental health services who represent a 
broader spectrum of mental health disorders. 
 The findings from this study will provide a comprehensive profile of physical activity 
patterns and levels in overweight and obese adults with schizophrenia or schizoaffective 
disorder.  This population is at high risk for medical comorbidities and has not been thoroughly 
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studied before and would be expected to derive considerable benefit from physical activity 
interventions.  Furthermore, physical activity levels of overweight and obese adults with 
schizophrenia and schizoaffective disorder will be compared with a representative sample of the 
general US population who are overweight or obese to begin to investigate whether physical 
activity levels differ by psychiatric diagnoses and use of mental health services.   Collectively, 
this descriptive information will aid not only in the design and implementation of effective 
physical activity interventions for mental and physical health but also in the justification of 
physical activity research and promotion strategies among overweight and obese adults with 
schizophrenia or schizoaffective disorder.   
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2.0 INTRODUCTION 
 
 
 
2.1 SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER 
 
Both schizophrenia and schizoaffective disorders are considered serious mental illnesses.  
Schizophrenia is diagnosed when two or more of the following active symptoms occur for at 
least one month; 
          “(1) delusions 
 (2) hallucinations 
 (3) disorganized speech (e.g., frequent derailment or incoherence) 
 (4) grossly disorganized or catatonic behavior 
 (5) negative symptoms, i.e., affective flattening, alogia, or avolition”(3). 
These active symptoms must also be accompanied by social and/or occupational dysfunction that 
may involve work, interpersonal relations, or self-care. In addition, active, prodromal, or residual 
symptoms must persist for at least 6 months to meet the diagnostic criteria for schizophrenia(3).  
Usually the active symptoms are described as either positive or negative symptoms(2).  As the 
name implies, positive symptoms represent an excess or distortion of normal function such as 
delusions, hallucinations, disorganized speech, and grossly disorganized or catatonic 
behavior(2).  Negative symptoms refer to a loss of a normal function such as lack of emotion, 
low energy, low or no motivation, affective blunting, difficulty or inability to speak, social 
isolation and/or lack of social skills(2).  A schizoaffective disorder is defined by periods of 
overlapping psychotic symptoms and mood symptoms (depression, mania, or mixed episode) 
AND periods of psychotic symptoms in the absence of mood symptoms(3).   
 Treatment of these disorders includes pharmacotherapy with antipsychotic medication 
and may be combined with psychosocial interventions(4).  However, adjunctive treatments or 
strategies are still needed to reduce relapse and the residual symptoms associated with 
schizophrenia(4).  In addition, adults with schizophrenia or schizoaffective disorder often 
experience significant social and occupational dysfunction(3), and high rates of physical 
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comorbidities such as hypertension, diabetes, cardiovascular disease and obesity(4).  High rates 
of nicotine dependence is also observed with 80% to 90% of the individuals with schizophrenia 
smoking cigarettes(3). 
 Age of onset is typically early to mid-20s for men and late 20s for women(3).  Later onset 
of the first active symptoms of schizophrenia are associated with better outcome including fewer 
structural brain abnormalities, negative signs and symptoms, and cognitive impairments(3). 
Schizophrenia and schizoaffective disorders are chronic mental health conditions and complete 
remission seldom occurs(3).  However, the disease course is variable, and individuals may 
experience relatively stable symptoms, relapses and remissions of symptoms, or progressive 
worsening of symptoms(3).   Generally, the positive symptoms are more responsive to treatment 
than the negative symptoms(3). 
 
 
 
2.2 PHYSICAL ACTIVITY AND SCHIZOPHRENIA AND SCHIZOAFFECTIVE 
DISORDERS 
 
As outlined and reviewed by Taylor and Faulkner(4, 21), the role of physical activity on the 
physical and mental health of individuals with schizophrenia and schizoaffective disorders has 
not been extensively studied and is still emerging.  Published research on exercise as an adjunct 
treatment for schizophrenia has been limited to feasibility or pilot studies with methodological 
flaws such as small sample sizes, poor compliance, or failure to measure physical activity 
levels(4).  The evidence from these preliminary studies suggest that physical activity may 
alleviate some of the negative symptoms of schizophrenia and provide a useful coping 
mechanism for some of the positive symptoms of schizophrenia(4).  As for physical health, 
individuals with schizophrenia or schizoaffective disorder have a high rate of cardiovascular 
disease, diabetes, obesity, and premature mortality(4, 12-15). These comorbid conditions are 
strongly related to physical inactivity(5-10), and physical activity may be one avenue to reduce 
the risk of these comorbid conditions and improve the health and quality of life of individuals 
with schizophrenia and schizoaffective disorder. A detailed review of the literature regarding 
physical activity and schizophrenia and schizoaffective disorders is provided in the next section 
of this report (Review of the Literature).  
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3.0 REVIEW OF THE LITERATURE 
 
 
 
3.1 PHYSICAL ACTIVITY ASSESSMENT 
 
“Physical activity is defined as any bodily movement produced by skeletal muscles that results in 
energy expenditure”(22).  Physical activity may include occupational, household, sports, and 
leisure or recreational activities.  A variety of methods have been used to measure physical 
activity in free-living individuals.  The most frequently used subjective and objective measures 
of physical activity are physical activity questionnaires and accelerometers or pedometers, 
respectively, and are often used in unison to provide a comprehensive profile of physical activity 
in free-living individuals. 
 
3.1.1 Subjective Assessment of Physical Activity  
A variety of self-reported physical activity questionnaires have been developed to assess physical 
activity in free-living individuals.  The complexity of the self-reported physical activity 
assessment can vary from a single question(23, 24) to a very detailed report of the type, 
frequency, intensity and duration of physical activity(25-27).  Some surveys assess only sports or 
leisure physical activities(28-31) while other surveys measure daily physical activity including 
occupational, household, transportation and leisure physical activities(32-34).  Several published 
reviews have extensively discussed the strengths, limitations, validity and reliability of self-
reported physical activity assessments(25, 27, 35, 36).  Briefly, the advantages of self-reported 
physical activity include  
 minimal subject burden;  
 non-reactive assessment of physical activity;  
 inexpensive;  
 practical;  
 minimal time required for data collection and processing;  
 availability of a variety of self-reported surveys that have achieved acceptable levels of 
reliability and validity(25);  
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 availability of published articles on self-reported physical activity levels that permit 
comparisons across studies and populations;  
 ability to measure components of occupational, leisure, household and transportation-
related physical activities particularly those of moderate to vigorous intensity;  
 the ability to measure structured activities of moderate to vigorous intensity well; 
 the ability to tailor the survey to address specific activities of the target population;  
 the ability to translate the survey into other languages;  
 assessment of water activities, bicycling, weight lifting and other activities difficult to 
assess with accelerometry or pedometers;  
 relatively simple classification of individuals into activity categories;  
 assessment of physical activity over a variety of time frames (past 24 hours, past week, 
past year, childhood activity, historical activity, habitual activity); and  
 ability of the survey to be interviewer- or self-administered.   
However, self-reported physical activity surveys also have several limitations including  
 recall and social desirability bias with participants tending to overestimate the frequency, 
duration, and intensity of their physical activity;   
 inability of children or cognitively impaired individuals to report their physical activity;   
 inability to accurately or reliably assess low-intensity, intermittent, or unstructured 
physical activities; and  
 appropriate assessment of physical activity in diverse populations may require different 
questionnaires resulting in different measures of physical activity that are not 
comparable.  
 
3.1.2 Objective Assessments of Physical Activity 
 
The objective assessment of physical activity has been measured in a variety of ways including 
behavioral observation, occupational classification, heart rate monitoring, gait assessment, direct 
calorimetry, indirect calorimetry, doubly labeled water, and motion sensors(37).  Generally, 
motion sensors and heart rate monitoring are considered the only feasible objective assessments 
of physical activity in free-living individuals.  The other objective assessments of physical 
activity such as doubly labeled water, direct and indirect calorimetry, and behavioral observation 
are considered too expensive, impractical, and invasive and/or exceed acceptable levels of 
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subject burden for free-living individuals and epidemiological studies.  Occupational 
classification of physical activity would be inappropriate in adults with severe mental illness 
since the majority of adults with schizophrenia or schizoaffective disorder are unemployed or on 
disability. As discussed and reviewed by Freedson and Miller(38), heart rate monitoring is a 
physiological marker of physical activity.  However, heart rate monitoring may not be 
appropriate for measuring physical activity levels or intensities in free-living individuals since 
heart rate is influenced by high ambient temperatures, high humidity, emotional stress as well as 
exercise(38).   
Motion sensors (pedometers and accelerometers) are generally preferred for the objective 
assessment of physical activity in free-living individuals (38).  Pedometers count the number of 
steps taken daily by measuring vertical acceleration at the hip while walking.  Generally, 
pedometers are considered useful as a motivational tool in walking intervention studies and 
health promotion campaigns because participants can self-monitor their walking behavior(38, 
39). Although inexpensive, pedometers are considered less accurate than accelerometers, and 
generally not considered suitable for research in the assessment of habitual physical activity (38-
40).  For research, accelerometers are preferred for objectively measured free-living physical 
activity.  
As the name implies, accelerometers measure the body’s acceleration or change in speed 
with respect to time (m/s2)(40, 41).  Uniaxial accelerometers measure movement in a single 
plane (usually vertical) usually at the hip(26).  With accelerometry, the intensity, frequency, 
duration and pattern of physical activity can be measured and stored for extended periods of time 
(days or weeks) in free-living individuals.  In addition, the accelerometers measure low-intensity, 
intermittent, and unstructured physical activities such as running to catch a bus, walking to the 
mailbox, vacuuming, or climbing stairs that can be difficult for participant’s to estimate.  
Activity is quantified by counts or steps in user-specified epochs (usually one minute) (26, 40, 
41).     
Accelerometry addresses some of the limitations of self-reported physical activity. 
Specifically, accelerometry allows measurement of 1) low-intensity, intermittent, and 
unstructured physical activities such as walking that are difficult for participants to self-report 
(42), 2) physical activity over extended time periods (days or weeks) (38), and 3) objective 
physical activity avoiding overestimates of the time and intensity of physical activity that tends 
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to occur with subjective measures of physical activity. Accelerometry has been shown to be both 
reliable and valid (43-45), and is often used as the validity criterion for self-reported measures of 
physical activity (35, 46). Other advantages of accelerometers include  
 its small size;  
 lightweight;  
 wireless;  
 non-invasive;  
 non-intrusive with minimal subject burden for participants to wear over extended time 
periods;  
 tamper-proof and durable;  
 less susceptible to reactivity since data is stored but not displayed during the monitoring 
period;  
 published and replicated research on validity and reliability;  
 well-defined and established research methodology for data collection and processing for 
clinical and research applications;  
 extensive literature of accelerometers used in a variety of populations including children 
and the elderly; and  
 the ability to measure intermittent as well as continuous activity.    
However, accelerometers have several limitations including  
 the ability to only measure movement in certain planes (cycling, weight lifting, and 
upper-extremity activities are not accurately assessed when the accelerometer is attached 
to the hip) (39);   
 inability to measure water activities since the accelerometers are not water-proof;  
inability to estimate expenditure accurately (39);   
 inability to measure non-ambulatory activity such as seated or stationary activities (38);   
 unwillingness of participants to wear accelerometer at all occasions such as parties, 
weddings, sports competitions, and other events; and 
 dependency on the participant’s willingness and compliance in wearing the accelerometry 
over an extended period of time.  
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3.2 ASSESSMENT OF PHYSICAL ACTIVITY IN PATIENTS WITH SCHIZOPHRENIA 
OR SCHIZOAFFECTIVE DISORDER 
 
Although limited, previous studies have used subjective and objective measures of physical 
activity in individuals with schizophrenia and schizoaffective disorder.  These published studies 
suggest that the assessment of physical activity is challenging in adults with schizophrenia and 
schizoaffective disorder since the majority are relatively sedentary, primarily engage in 
unstructured and low-intensity physical activities that are likely difficult to recall, and may have 
cognitive impairments.  The findings from these earlier studies that reported subjective and/or 
objective assessments of physical activity in individuals with schizophrenia or schizoaffective 
disorder are summarized and reviewed in the sections below and Tables 3.1-3.4.     
 
3.2.1 Subjective Assessment of Physical Activity in Patients with Schizophrenia and 
Schizoaffective Disorder 
 
The reliability and validity of subjective assessments of physical activity in adults with 
schizophrenia or schizoaffective disorder have only been published for the Yale Physical 
Activity Scale (YPAS)(18) and the Short-Form of the International Physical Activity 
Questionnaire (IPAQ)(47).  The IPAQ primarily measures moderate to vigorous intensity 
physical activities while the YPAS assesses the full spectrum of physical activities from light to 
vigorous intensity that may occur at work, home or during leisure time activities. Faulkner and 
associates found one-week test-retest reliability for the IPAQ in adults with schizophrenia (n=35) 
to be comparable to values reported in the general population (Spearman correlation coefficients 
= 0.70 for total MET mins/wk -1, 0.68 for total minutes of PA per week, 0.69 for vigorous PA, 
0.50 for moderate PA, and 0.68 for walking per week, p<0.01 for all).  In contrast, one week test-
retest reliability of YPAS in adults with schizophrenia (n=19), aged 40 and older, were lower 
than normal comparisons (n=10) for seven out of eight activity summary measures [activity time 
(h/wk) (r=0.62 versus r=0.90), energy (kcal/wk) (r=0.60 versus r=0.91), vigorous activity index 
(r=0.40 versus r=0.69), leisurely walking index (r=0.04 versus r=0.95), moving index (r=0.10 
versus r=0.60), standing index (r=0.34 versus r=0.58), and total activity index (r=0.36 versus 
r=0.64) but not sitting index (r=0.36 versus r=0.29)] in a study conducted by Lindamer and 
associates(18).  Only modest correlations (r=0.40 to 0.62, p<0.01) were reported for YPAS 
activity time (h/week), total energy expenditure (kcal/week), and vigorous activity index in 
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adults with schizophrenia or schizoaffective disorder(18).  The Pearson correlation coefficients 
for test-retest reliability for the YPAS leisurely walking (r=0.04) and moving (r=0.10) indices 
were low compared to adults without schizophrenia (r=0.95 for leisurely walking index and 0.60 
for moving index) and suggest that adults with schizophrenia or schizoaffective disorder may not 
reliably estimate recent walking and moving activity(18).   It should also be noted that neither 
study (Faulkner(47) or Lindamer(18) assessed or reported the severity of schizophrenia or 
schizoaffective disorders in the study samples, and the sample sizes were small. 
 Similar to test-retest reliability, concurrent validity using accelerometry as the criterion 
measure was only acceptable for the IPAQ (ρ=0.37, p<0.05)(47) and not the YPAS  in adults 
with schizophrenia or schizoaffective disorder (Pearson correlations not reported, p>0.05, 
n=16)(18) or normal controls except for the moving index and average daily minutes of light 
activity (r=0.93, p<0.01, n=6)(18).  It is unfortunate that the investigators did not report 
correlations between YPAS and accelerometry.  Feasibly, the magnitude of correlations may 
have been comparable but statistical significance was not achieved due to the smaller sample size 
in the study using the YPAS versus the IPAQ. 
 With the IPAQ, 75% and >40% of the patients with schizophrenia reported no vigorous 
activity and no moderate physical activity, respectively(47).  Also, 74% of the patients with 
schizophrenia did not met the current minimal public health guidelines of 150 min/wk of 
moderate-intensity physical activity(47). It is interesting to note that the YPAS physical activity 
measures that were considered reliable (activity time (h/week), total energy expenditure 
(kcal/week), and vigorous activity index) were consistently and statistically (p<0.01) lower for 
patients with schizophrenia compared to the community dwelling controls(18).  Furthermore, 
YPAS estimated lower total energy expenditure for physical activity for diabetic (approximately 
2600 kcal/week)(19) than non-diabetic (3174 kcal/week)(18) patients with schizophrenia, aged 
40 or older. 
 Studies by Osborn(48) and Brown(49) assessed physical activity by the Godin Leisure-
Time Exercise Questionnaire, a brief self-administered questionnaire that assesses usual leisure-
time physical activity over a 7-day period(25, 28).  Participants self-report how many times per 
week they engage in strenuous (running, basketball, vigorous swimming, vigorous bicycling, 
soccer), moderate (fast walking, tennis, easy bicycling, dancing), or mild (golf, bowling, easy 
walking) exercise for more than 15 minutes. Few participants with schizophrenia or 
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schizoaffective disorder reported strenuous physical activity (8% (48) and 0% (49)).  The vast 
majority of participants (55% (48)) reported either mild (45%) or no exercise (36%) (49).   
 Physical activity patterns during the preceding week were compared in Australians with 
schizophrenia from mental health services in New South Wales, Victoria, and Queensland 
(n=125) and the general Australian population (n=3841) using the Active Australia 
Survey(AAS)(50).  The AAS measured the following 4 dimensions of physical activity; 1) types, 
2) duration (minutes), 3) intensity (walking, moderate and vigorous), and 4) number of sessions 
of physical activity over the past 7 days(50).  Total activity time per week was calculated by 
adding time spent walking, time spent in moderate activity, and twice the time spent in vigorous 
activity.  Sufficient physical activity was defined as achieving 150 minutes or more of total 
activity time during the past week.   
Overall, a smaller percentage of Australians with schizophrenia (49%) achieved 
sufficient physical activity than the general Australian population (57%) (50).  Interestingly, the 
pattern of physical activity also differed between the two populations; a greater proportion of 
Australians with schizophrenia walked (82.5% versus 72.2%) while a greater proportion of the 
general Australian population reported moderate (43% versus 29%) or vigorous (38% versus 
34%) activity (50).  Only time spent in vigorous activity was significantly greater in the general 
Australian population compared to the Australians with schizophrenia (142 versus 66 mins/wk, 
respectively) (50). While no difference was noted for minutes walked per week (~115 minutes), 
the Australians with schizophrenia reported a greater number of walking sessions for shorter 
time intervals than the general Australian population (50).   
Among the Australians with schizophrenia, no statistically significant differences were 
noted for gender and BMI (p=0.09), total activity time (p=0.33) or total number of activity 
sessions (p=0.85), age and total activity time (p=0.92) or total number of activity sessions 
(p=0.63), and those who did and did not exercise for at least 150 minutes during the past week 
and BMI (p=0.28), number of weeks since their last hospitalization, duration of their last 
hospitalization, and psychological distress level (p-values not reported)(50). However, 
significantly fewer hospitalizations during the past three years and severe social problems were 
noted for those who exercised at least 150 minutes during the past week compared to the 
participants with schizophrenia who do not (p<0.05)(50). 
 14 
 
 Frequency of leisure physical activity per month was used as one of five health indices to 
compare adults (aged 18-65) with serious mental illness (n=200) including 50 adults for each of 
following chart diagnoses; schizophrenia excluding schizoaffective disorder, schizoaffective 
disorder, major depression, and bipolar disorder) in community-based psychiatric treatment with 
age, gender, and race-matched respondents from the US general population that participated in 
NHANES III or NHIS studies(51).  If respondents indicated leisure physical activities at least 20 
times per month then respondents were classified as meeting recommended levels of exercise as 
defined by the Healthy People 2010 program of the Centers for Disease Control(51).  The 
prevalence of recommended levels of exercise was 39% in both adults with serious mental illness 
and the general population comparison group(51).  Within the psychiatric sample, adults with 
schizophrenia or schizoaffective disorder (9 of 100) were less likely to exercise at recommended 
levels and be nonsmokers than adults with mood disorders (22 of 100, p=0.02)(51). Even though 
physical activity was one of five components of the primary health indicators, the authors 
provide no information on how leisure physical activity was defined or assessed.  Given the 
sample sizes (n=100 or 50 per group), it is unfortunate that little information is provided on 
recommended exercise levels within psychiatric diagnosis. These oversights severely limit the 
comparison of these results with other studies or providing additional information on the 
physical activity levels of adults with schizophrenia and/or schizoaffective disorder. 
 Leisure-time physical activities and participation in routine activities based on items in 
the Canada’s Health Promotion Survey were used to obtain lifestyle profiles of adult psychiatric 
outpatients attending mental health clinics in Calgary, Canada(52).  The study recruited 
outpatients in the following 3 diagnostic categories; schizophrenia (n=61), bipolar disorder 
(n=60), and anxiety and/or depression (n=61)(52).  The study did not recruit outpatients with no 
diagnosed mental health disorder. Overall, there was no difference in the frequency of daily 
participation in vigorous exercise reported between the diagnostic groups (24%, p=0.16)(52).  
Only 5-8% of each diagnostic group reported engaging in active leisure activity and the vast 
majority (67-77%) only engaged in sedentary routine activities(52).  The primary limitations of 
this study are that the items selected to assess physical activity from Canada’s Health Promotion 
Survey are not provided and have been field-tested but not formally validated(52).    
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 A cohort of healthy male adolescents between the ages of 16 and 17 was studied based on 
the compulsory Israeli Draft Board tests.  Using the cohort, cases and controls were identified at 
follow-up, approximately 9 years later.  Cases were defined as males diagnosed with 
schizophrenia and schizoaffective disorder after age 17, and controls were defined as males 
experiencing no psychiatric symptoms after age 17.  To assess recall bias, physical activity self-
reported at age 17 was compared to recall of physical activity for age 17 at follow-up 
(approximate mean age 26 years) for the cases and controls.  Trained interviewers score the 
adolescent’s involvement in structured physical activity and interest in physical activity from 1 
(lowest) to 5 (highest) at age 17 and at recall for age 17.   Although not statistically significant, 
the cases compared to the controls had slightly lower physical activity scores self-reported at age 
17 (2.9+3.1 vs. 3.0+1.0, respectively) and at recall for age 17 (3.1+1.1 vs. 3.4+1.0, 
respectively)(53).  Generally, participants had identical physical activity scores at age 17 and 
recall for age 17 (59% of the cases with schizophrenia or schizoaffective disorder, and 41% of 
the controls, p>0.05)(53). When scores differed for self-reported physical activity at age 17 and 
at recall for age 17, males tended to slightly overestimate their recall of physical activity for age 
17 (27% of the cases and 41% of the controls, p>0.05)(53).  Differences in physical activity 
assessments at age 17 and recall for age 17 were significantly correlated with IQ, immediate 
memory, and delayed memory(53).  
 The investigators concluded that memory deficits associated with schizophrenia did not 
negatively affect the retrospective recall of premorbid adolescence behaviors (social functioning, 
individual autonomy, organizational ability, physical activity and functioning in structured 
environments); males with schizophrenia and schizoaffective disorder were as reliable as the 
healthy controls in self-reporting behaviors for age 17(53).  Unfortunately, this conclusion 
probably should be tempered for physical activity since the recall of physical activity was less 
robust and more susceptible to recall bias than the other adolescent behaviors based on the 
published findings and study limitations outlined by the authors.  Specifically, the consistency in 
recalling physical activity for age 17 was associated with IQ and memory impairments, as noted 
above.  In addition, all the patients diagnosed with schizophrenia and schizoaffective disorders 
were in remission with few positive symptoms.  Hence, it is feasible that patients with 
schizophrenia and schizoaffective disorders with active symptoms, low IQ, and/or memory 
impairments may not provide reliable self-reported estimates of past physical activity.   
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 The Israeli Draft Board test was also used in a prospective study to compare interest in 
physical activity at age 17 among males later hospitalized for schizophrenia at least one year 
later than the draft board test date and healthy controls who were eligible for military service and 
matched by age and attendance at the same high school as the cases(54).  To be eligible for the 
study, the adolescent males at age 17 had to be apparently healthy with no obvious signs of 
disease, to have no detectable signs or symptoms of any mental illness or mental retardation, no 
prior history of psychiatric hospitalization, and no psychiatric hospitalization within 1 year of the 
draft board test(54). Follow-up from the draft board test date ranged from 4 to 10 years. Interest 
in physical activity at age 17 was significantly lower for males later hospitalized for 
schizophrenia than healthy male controls (p=0.0001)(54).  However, interest in physical activity 
was not a significant predictor of schizophrenia in the multivariate conditional logistic regression 
model(54).   Poor social functioning, poor organizational ability, and low intellectual functioning 
were the significant predictors of schizophrenia in the final multivariate conditional logistic 
regression model(54).  The primary limitation of this study is that interest in physical activity at 
age 17 is not an assessment of physical activity levels, and the investigators did not analyze 
engagement in structured physical activities at age 17.  Despite this limitation, the findings 
suggest that the low physical activity levels of patients with schizophrenia may not be due to the 
mental health disorder, per se.  Overall, the findings from the two studies based on the Israeli 
Draft Board tests suggested that prior to diagnosis and symptoms of schizophrenia, male 
adolescents at age 17 were less active and less interested in physical activity than healthy 
controls. 
 Several studies subjectively measured physical activity of adults with schizophrenia 
although it was not the primary objective of the study(15, 55, 56).  In a study to investigate 
whether the disorder or the antipsychotic medications explain high mortality rates of adults with 
schizophrenia, Joukamaa and associates report the physical activity levels of 99 Finish adults 
with schizophrenia in a representative population sample of 7217 Finns aged > 30 years(15).  
Only 7 adults with schizophrenia [2 (4%) women and 5 (11%) men] report regular or high levels 
of physical activity(15).  Similar to previous studies, the majority of adults with schizophrenia 
report none [33 (62%) women and 19 (42%) men], or occasional or low levels of exercise [18 
(34%) women and 21 (47%) men](15).  An inverse association between exercise and the 
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prevalence of schizophrenia was observed for both men and women but was only statistically 
significant for women(15).  
 In a descriptive study of the cardiovascular risk and lifestyle of adults with schizophrenia, 
McCreadie and associates used the Scottish Physical Activity Questionnaire (SPAQ) to measure 
physical activity levels(55).  SPAQ measures the stage of exercise behavior change, and seven 
day recall of leisure and occupational physical activity of moderate intensity and above(57).  In 
contrast to other studies, the majority of the men (n=41, 57%) and women (n=18, 60%) with 
schizophrenia considered themselves physically active(55).  In a feasibility and efficacy study 
for weight control of adults with schizophrenia (n=20) or schizoaffective disorder (n=11) using 
atypical antipsychotic medications and BMI > 26 kg/m2, participants self-reported exercising 53 
mins/wk at baseline(56).   Unfortunately, neither the McCreadie nor the Menza study(55, 56) 
defined physically active or exercise making comparisons with other studies difficult.  
 Collectively, these studies suggest that self-reported physical activity among participants 
with schizophrenia or schizoaffective disorder is low and significantly less than participants 
without mental health disorders.  The consistency of the findings is noteworthy.  Simple as well 
as complex self-reported measures of physical activity concur with clinical impressions that 
patients with schizophrenia or schizoaffective disorder are relatively sedentary.  While the 
subjective assessment of physical activity has been shown to be reliable and valid for the 
assessment of moderate and strenuous physical activity, self-reports are not recommended for 
assessment of unstructured and low-intensity physical activity in the general adult populations 
(36, 48, 58).  The findings reported by Lindamer and associates also suggested that self-reports 
of physical activity may not be recommended for adults with schizophrenia(18).  Reliability was 
only acceptable for moderate to vigorous physical activities but not acceptable for walking and 
low-intensity physical activities in adults with schizophrenia(18).  Hence, objective monitoring 
may be necessary to accurately assess and quantify this unstructured and low intensity physical 
activity of relatively sedentary adults with schizophrenia or schizoaffective disorder.  The 
evidence from the above studies justifies the additional subject burden, time and expense of 
objective versus subjective monitoring of physical activity in adults with schizophrenia and 
schizoaffective disorder.  
 Objective monitoring of physical activity may also be warranted due to the cognitive 
symptoms that adults with schizophrenia or schizoaffective disorder often experience.  Cognitive 
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deficits including reality distortions may impair the participant’s ability to accurately self-report 
or recall their physical activity.  Cognitive impairment may explain why the reliability and 
validity of self-reported physical activity using the YPAS was acceptable but lower in adults 
with schizophrenia than adults without psychiatric disorders(18).  With cognitive impairments, 
adults with schizophrenia and schizoaffective disorder may only be able to accurately and 
reliably complete simple but not complex physical activity assessments.  For instance, a simple 
assessment may only assess whether or not the patient participated in vigorous physical activity 
such as swimming, bicycling, or running?  A complex assessment may also assess the frequency, 
duration and intensity of each vigorous physical activity.  The simple assessments of physical 
activity are useful as crude measures of physical activity (e.g. sedentary, insufficiently active, 
and active) especially for pilot studies or exploratory analyses.  However, the complex 
assessments of physical activity are generally necessary to examine dose-response relationships, 
change in physical activity especially walking, light- or moderate-intensity physical activity, 
physical activity patterns, and mechanisms of action, and to generate and test hypotheses.    
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Table 3-1 Summary of patient characteristics for studies reporting subjective assessment of 
physical activity in individuals with schizophrenia (SZ) or schizoaffective (SA) disorders. 
 
 
 
Author, year 
 
N (Men, Women) 
N by disorder 
PANSS 
(positive, negative, general 
psycho-pathology, total) 
Age (years) 
Mean + STD 
Range 
 
 
BMI (kg/m2) 
Brill, 2007 (53) 121 (121,0) 
70 SZ or SA 
51 Controls 
SZ/SA: 11 + 5, 18 + 9, NR, 
60 + 20 
Controls: NR 
SZ/SA: 26 + 4 
Controls: 26 + 3 
NR 
Davidson, 1999 (54) 9724 (9724,0) 
509 SZ 
9215 Controls 
NR 16 and 17 year olds NR 
Faulkner, 2006 (47) 35 (22, 13) 
28 SZ,1 SF, 6 SA 
outpatients 
NR 40 + 11 31+7 
Dickerson, 2006 (51) 200 (95, 105) 
50 SZ 
50 SA 
50 Bipolar 
50 Major Depression 
(MD)  
 
Matched to general 
population from 
NHANES3 (n=2890), 
NHIS (n=3052) by 
gender, age (+3 yrs), 
and race 
NR 44+9  
18-65  
 
SZ/SA: 42 + 9 
Bipolar/MD: 46 + 8 
 
54% (92/169) with BMI 
< 30 
Brown, 1999 (49) 102 (54, 48) 
102 SZ 
 
NR 53 
Middle-aged 
BMI: Men n (%), 
Women n (%) 
<20: 2 (4), 3 (6) 
21-25:17(35),  
          11 (23) 
26-30:21(42),  
          22 (47) 
>30: 9(18), 11(23) 
Chuang, 2008 (52) 182 (94,88) 
61 SZ 
60 BP 
61MDD/Anxiety 
 
NR 43.0 30.2 SZ 
29.2 BP 
28.1 MDD/Anxiety 
 
BMI>25, n=50 (82%), 
SZ 
BMI>30, n=29 (47.5%), 
SZ 
Joukamaa, 2006 (15) 7217 (3322,3895) 
99 SZ (45,53) 
7118 Non-SZ 
(3277,3842) 
NR n=2716; 30-44 yrs 
n=1609; 45-54 yrs 
n=1348; 55-64 yrs 
n=1078; 65-74 yrs 
n=466; >75 yrs 
n=359, <20 
n=2946, 20-24.9 
n=2815, 25-29.9 
n=909, 30-34.9 
n=188, >35 
Lindamer, 2008 (18) 81 (48,33);  
54 SZ/SA  
27 Normal Comparison 
(no known psychiatric 
diagnosis) 
SZ/SA: 13 + 6, 14 + 5, 27 + 
7, NR 
Normals: NR 
50.7+6.4 SZ 
52.2+8.6 Normals 
Range: 40 years or 
older 
30.5+7.1 SZ 
27.8+4.4 Normals  
(p=0.13) 
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Table 3-1 (continued)  Summary of patient characteristics for studies reporting subjective 
assessment of physical activity in individuals with schizophrenia (SZ) or schizoaffective (SA) 
disorders. 
 
 
 
 
 
 
 
 
 
 
Author, year 
 
N (Men, Women) 
N by disorder 
PANSS 
(positive, negative, general 
psycho-pathology, total) 
Age (years) 
Mean + STD 
Range 
 
 
BMI (kg/m2) 
McCreadie, 2003 (55)  102 (72,30) 
102 SZ 
14 + 5  
19 + 6 
32 + 7 
65 + 15 
45+13 73% overweight or 
obese 
n=4, <18.5 
n=22, 18.5-24.9 
n=44, 25-29.9 
n=29, 30-39.9 
n=2, >40 
McKibbin, 2006 (19) 
 
64 (37, 20) diabetic 
48 SZ 
9 SA 
 
DART (n=28) 
13.1 + 4.6 
5.2 + 0.8 
3.6 + 0.6 
UCI (n=29) 
15.1 + 5.1 
5.6 + 0.7 
4.0 + 0.7 
53.1 + 10.4 DART 
54.8 + 8.2 UCI 
 
33.6 + 6.8 DART 
32.9 + 6.2 UCI 
 
McLeod, 2009 
(50) 
125 (81,44) 
125 SZ 
NA 40.3 + 12.4 
 
Note: recruited > 18 
yrs 
28.9 + 6.6 
 
0%, <18.5 
30%, 18.5-24.9 
36%, 25-29.9 
34%, >30 
Menza, 2004 (56) 51 (29,22) 
20 SZ 
11 SA 
20 historical controls 
NA 42.6 SZ/SA 
47.2 Controls 
Study inclusion BMI > 
26 
 
34.3 + 6.3 SZ/SA 
32.2 + NR Controls 
Osborn, 2007 (48) 225  
75 SMI (66 SZ, 6 SA, 2 
persistent delusional 
disorder) 
150 no SMI 
Manchester scale median 6, 
IQR 3-10 
47.2 SMI 
46.6 non-SMI 
 
Note: recruited 30-
75 year olds 
No information 
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Table 3-2 Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) or 
schizoaffective (SA) disorders. 
 
Author, year Study Design Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
Findings 
Brill,  
2007 (53) 
Case-Control Study 
 
Israeli Draft Board 
Behavioral Assessment 
1 to 5 point scale of 
extent of involvement in 
PA.  Presumably, 1=low 
interest in PA, 
5=high interest in PA 
Contemporary (age 17) 
and retro-spective (~26 
yrs) recall of physical 
activity 
 NS difference in PA at age 17 
and recall of PA at age 17 between 
cases and controls.   
 Recall PA at age 17 > PA 
reported at age 17 for all. 
 NS association between PA 
and PANSS 
Davidson, 
1999 (54) 
Matched (age, gender, 
school attended) case-
control study 
Case: hospitalized with 
SZ diagnosis 
Control: nonpatient by 
National Psychiatric 
Hospitalization Case 
Registry 
Israeli Draft Board 
Behavioral Assessment 
1 to 5 point scale of 
extent of involvement in 
extracurricular PA.    
1=low interest in PA, 
5=high interest in PA 
PA at age 17 
Follow-up 4-10 years 
 SZ < Controls for interest in 
PA at age 17 (p< 0.0001) 
 PA at age 17 not a predictor 
of future SZ in multivariate 
conditional logistic regression 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
Faulkner, 
2006 (47) 
Cross-sectional study  Short-form 
International Physical 
Activity Questionnaire 
(IPAQ) 
Minutes/wk and 
METS/wk for walking, 
moderate (breathe 
somewhat harder than 
normal, take moderate 
physical effort such as 
carrying light loads, 
bicycling at regular pace, 
or easy swimming), and 
vigorous (breathe much 
harder than normal, take 
hard physical effort such 
as heavy lifting, digging, 
aerobics, or fast 
bicycling) PA. 
7 day recall 
 
Objective measure-
ment of PA by 
accelerometry (7 day 
period) for reliability 
and validity 
 Walking most common PA 
 26% exercised 150 min/week 
at moderate intensity 
 75% no vigorous PA 
 40% no moderate PA 
 Test-Retest reliability for 
METS/wk (0.70), min/wk 
(0.68), vigorous (0.69), 
moderate (0.50), and walking 
(0.68) PA. 
 Validity for min/wk (ρ=0.37, 
p<0.05), METS/wk (ρ=0.33, 
p>0.05) 
Dickerson, 
2006 (51) 
Case-control study: 
1:15 matched (age + 3 
yrs, gender, and race) 
 
  
NHIS and NHANES III # of  leisure-time PA 
during previous month 
Previous 30 days. 
Frequency of leisure 
PA dichotomized as  
1) exceeds exercise 
recommendations (>20 
days/month) 2) less 
than exercise 
recommendations (<20 
days/min) 
 39% of cases and controls 
exceeded exercise 
recommendations (NS) 
 SZ/SA(9%) < mood disorders 
(22%) exceeds exercise 
recommendations and 
nonsmoker (p=0.02) 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
 
Author, year 
 
 
Study Design 
 
Physical activity (PA) 
questionnaire 
 
Physical activity (PA) 
definition 
Physical activity 
(PA) assessment 
period 
 
 
Findings 
Brown, 1999 
(49) 
Cross-sectional Godin Leisure-Time 
Exercise Questionnaire 
Light PA: gentle walking 
Moderate PA: brisk 
walking 
Strenuous PA: running, 
most sports 
 
Previous 7days SZO Men: 36% no PA,  
45% only light PA, 
19% > 1 moderate PA, 
0% strenuous PA.  
SZO Women: 32% no PA,  
57% only light PA, 
15% > 1 moderate PA, 
0% strenuous PA.  
Chuang, 2008 
(52) 
Cross-sectional Selected items from 
Canada’s Health 
Promotion Survey 
Leisure-time physical 
activity (LPTA) 
 
 
 
NR   No difference in LPTA between 3 
diagnoses 
 26% report getting as much 
exercise as needed 
 14% never engaged in vigorous PA 
 24% daily engagement in vigorous 
PA 
 5-8% engaged in active leisure 
activities 
 67-77% only engaged in sedentary 
routine activities 
Joukamaa, 
2006 (15) 
Prospective cohort  Mini-Finland Health 
Survey 
3 categories (None, Low 
level or occasional, High 
level and regular) 
NR  SZ RR lower for higher rates of pa 
in men (1.0, 0.72,0.47, trend, NS), 
women (1.0,0.42,0.16 sig) 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
Lindamer, 
2008 (18) 
Cross-sectional; 
2:1 SZ:Normals 
Matched on gender and 
age (+10 years) 
Yale Physical Activity 
Scale (YPAS) 
1. Total time spent per 
week (h/wk) in all 
physical activities 
2. Total energy 
expenditure (kcal/wk) 
3. Vigorous activity index  
4. Leisurely walking 
index  
5. Moving index 
6. Standing index  
7. Sitting index  
8. Total activity 
dimension index 
Typical week during 
the past month 
 All activity measures SZ < 
normals (p<0.01 except for 
leisurely walking p=0.24)  
 SZ ~ normals for sitting index 
(p=0.26) 
 Test-retest reliability (n=19) 
was poor (0.04 for leisurely 
walking and 0.10 moving 
index, p>0.60) to modest 
(0.40 to 0.62 for total time, 
energy, and vigorous activity, 
p<0.01).  
 No significant association 
between YPAS measures and 
accelerometry 
McCreadie, 
2003 (55)  
Cross-sectional Scottish Physical 
Activity Questionnaire 
(SPAQ) 
Not defined in publication 
or cited reference 
7 day recall  57% M, 60% F reported being 
physically active. 
 5.8 M, 6.4 F hrs/week PA, NS 
difference between gender 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
McKibbin, 
2006 (19) 
Randomized Clinical 
Trial; randomized to 
either Diabetes 
Awareness and 
Training (DART, n=32) 
or Usual Care plus 
Information (USI, 
n=32)  
Yale Physical Activity 
Scale (YPAS) 
YPAS: Total activity 
summary index (ASI) 
YPAS: Total energy 
expenditure  
(TEE) (kcal/week) 
7 days recall YPAS Pre-test 
 ASI 35+20 UCI and 
29+22 DART,  
 TEE 2707+3302 UCI and 
2186 + 2451 DART 
YPAS Post-test 
 ASI 24+17 UCI and 
29+35 DART,  
 TEE 1739+1714 UCI and 
2510 + 2151 DART 
Pre- vs Post-test comparison 
 DART increased ASI, 
UCI decreased ASI over 
intervention (p=0.02 
adjusting for PANSS negative 
and HAM-D scores) 
 Trend for group 
differences for TEE over time 
(p=0.04) 
McLeod, 
2009 
(50) 
Cross-sectional Active Australia 
Survey (AAS) 
1.Ttypes of physical 
activity 
2. Duration of activity 
episodes (total activity 
time= walking time + 
moderate activity time + 2 
x vigorous activity time if 
> 10 minutes per episode) 
3. Intensity of the 
exercise 
4. Number of sessions of 
activity over the previous 
7 days 
Preceding week  49% reported 150 min 
per week of physical activity 
 34% engaged in at least 
one episode of vigorous 
activity 
 83% engaged in walking 
 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
McLeod, 
2009 
(50) 
(continued) 
     SZ spent less time in vigorous 
activity (66 vs 142 min) and 
walked significantly more sessions 
(p=0.03) than normative data for 
Australian adults (n=3841).  No 
difference in amount of time in 
moderate activity (185 vs 168) and 
walking (119 vs 114 min) for SZO 
and normative data for Australian 
adults (p>0.05)(n=3841).   
 No difference in BMI 
between SZ who did and did not 
participate in 150 min of physical 
activity per week (p=0.28) 
 Fewer mental health 
hospitalizations in last 3 years for 
SZ who did vs. did not participate 
in 15 min of physical activity per 
week (p=<0.05) 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
McLeod, 
2009 
(50) 
(continued) 
     No significant differences in 
number of weeks since last 
hospitalization, duration of their 
last hospitalization, or in levels of 
psychological distress between SZ 
who did and did not participate in 
150 min of physical activity per 
week 
 No differences in anxiety or  
depression/distress between SZ 
who did and did not participate in 
150 min of physical activity per 
week 
 No age (p>0.63) or gender 
(p>0.33) differences in SZ activity 
levels 
 Only overactive, aggressive, 
and disruptive impairment items 
were associated with sufficient 
physical activity levels (p=0.04) 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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Table 3-2 (continued) Summary of studies reporting subjective assessment of physical activity in individuals with schizophrenia (SZ) 
or schizoaffective (SA) disorders. 
 
 
Author, year 
 
Study Design 
Physical activity (PA) 
questionnaire 
Physical activity (PA) 
definition 
Physical activity (PA) 
assessment period 
 
Findings 
Menza, 2004 
(56) 
Intervention study: 12 
month weight control 
No information Exercise self-reported 
total minutes 
exercise/week for SZ/SA 
only 
One week  SZ/SA  
Baseline: 53 min/wk 
Endpoint: 124 min/wk (p=0.003) 
 Controls: Not assessed 
Osborn, 2007 
(48) 
Cross-sectional Godin Leisure-Time 
Exercise Questionnaire 
Frequency of mild (easy 
walking), moderate (fast 
walking or easy 
swimming), and 
strenuous (fast swimming 
or running) leisure 
exercise undertaken for 
more than 15 min at a 
time, per week 
Total Godin Score 
dichotomized 
 0: <=25; 1: >25  
 Any Strenuous 
 Any strenuous or 
moderate exercise 
One week  SMI less likely to take 
strenuous (8 vs 33%, 
p=0.001) or strenuous and 
moderate exercise (45 vs 
63%, p=0.01) than non-SMI 
 Godin median scores (21 SMI 
vs 27 non-SMI, p<0.001)  
 High Godin score (>25) 35% 
SMI vs 78% non-SMI, 
p=0.01 
 Adjusting for SES, PA still 
predictive of SMI.  
 Only Manchester mental state 
predicted high Godin score  
o 0-3   60% 
o 4-6   29% 
o 7-10 33% 
o 10+  18% 
o p=0.045 
SZ = Schizophrenia; SA= Schizoaffective Disorder; SF= Schizophreniform; MD= Major mood disorder; SMI= severe or serious mental illness; PA= physical 
activity; NS= nonsignificant, p>0.05; NR= not reported; NI= no information 
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3.2.2 Objective Assessment of Physical Activity in Patients with Schizophrenia and 
Schizoaffective Disorder 
 
Six published studies have used accelerometry to measure physical activity in patients with 
schizophrenia or schizoaffective disorder. Collectively, these studies have monitored 
approximately 220 patients with schizophrenia or schizoaffective disorder as summarized in 
Table 3.3.    
 Even though physical activity was measured with accelerometry, Faulkner and associates 
report few details about objectively measured physical activity levels or patterns among 35 
patients diagnosed with schizophrenia, schizophreniform, or schizoaffective disorder (47).   It is 
interesting to note that the authors reported only modest Spearman correlations between the 
objectively and subjectively measured physical activity [total minutes (ρ=0.37; 95% CI: 0.04-
0.63) and MET min week-1 (ρ=0.33; 95% CI: 0.00-0.60)] as measured by the RT3 accelerometer 
and the Short-Form of the International Physical Activity Questionnaire (IPAQ), respectively, in  
patients diagnosed with schizophrenia, schizophreniform, or schizoaffective disorder (47).  
Feasibly, these modest correlations may reflect either true measurement differences in subjective 
and objective measures of physical activity, recall bias for self-reported physical activity, or 
measurement error in objective and/or subjective measurement of physical activity in adults with 
schizophrenia or schizoaffective disorder. 
 In a pilot study of 8 males with paranoid schizophrenia, Sharpe and associates found that 
accelerometry was not a valid measure of energy expenditure (59).  Although the pilot study had 
limited power due to the small sample size, the findings support results reported in other 
published studies (60-62).  Unfortunately, the physical activity levels by accelerometry in this 
pilot study are not reported hence preventing comparisons with previously published reports or 
the current study. 
 Only one study investigated physical activity among inpatients.  Specifically, male 
adolescents treated with olanzapine and diagnosed with schizophrenia(17) were studied.  This 
pilot study found that 9 out of the 10 participants engaged in moderate activity for less than 10 
continuous minutes per day.  However, this short report provides little additional information on 
the low habitual physical profile or levels of the male adolescent in patients treated with 
olanzapine.  For instance, the investigators report the daily percentage of time engaged in 
moderate to very vigorous physical activity as measured by accelerometry rather than standard 
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accelerometry measurements such as activity counts, steps, or minutes per day engaged in 
physical activity.  This atypical reporting makes comparisons with other studies, populations, 
and public health guidelines difficult.  Also, percentage of time engaged in physical activity may 
be biased or misleading as an outcome.  For instance, 2 participants may both engage in 1 hour 
of physical activity but the percentage of time engaged in physical activity may differ between 
the two participants if one participant wears the accelerometry for only 2 hours and the other 
participant wears the accelerometry for 12 hours.  Although the actual time engaged in physical 
activity is the same for the 2 participants, the percentage of time engaged in physical activity will 
differ.  Another shortcoming of the pilot study is that physical activity was monitored for only 2 
days.  Standard conventions for objective monitoring of physical activity suggests at least 4 days 
of monitoring with at least one weekend day.  Also, the authors do not mention if the participants 
were compliant with activity monitoring.  Typically, these measurements are only considered 
valid if the participant wears the accelerometer for at least 10 hours per day. 
 Similar to the present study, McKibbin and associates investigated a lifestyle intervention 
for older (age > 40 years) ambulatory patients with diabetes mellitus and schizophrenia or 
schizoaffective disorder (19).  The physical activity monitoring, data processing and analysis of 
the accelerometry data was well-designed and conducted according to conventional research 
practices; 7 days of monitoring with at least 3 valid days of data (> 10 hrs/day).  Unfortunately, 
the cut points for moderate and vigorous physical activities were not defined making 
comparisons with other studies difficult.  Also, accelerometry data was not obtained from 21% 
(12 out of 57 patients) of the sample due to malfunctions in the accelerometers.  Prior to the 
lifestyle intervention, patients with schizophrenia and schizoaffective disorder averaged between 
23 and 25 minutes of moderate and vigorous activity per day.  No additional details on the 
physical activity profile or pattern of middle-aged and older patients with 
schizophrenia/schizoaffective disorder and diabetes mellitus are provided since the purpose of 
the paper was to report the feasibility and health changes of a lifestyle intervention in study 
participants. 
 Lindamer and associates reported the first detailed physical activity profile based on 
subjective and objective measures of physical activity in a small sample of middle-aged and 
older patients with schizophrenia (n=16) compared to age and gender-matched controls with no 
psychiatric diagnosis (n=6) (18).  Based on accelerometry, average daily minutes of moderate 
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and vigorous activity, average of sedentary hours, or mean activity counts did not differ between 
the groups.  However, these results should be cautiously interpreted due to the small sample size.  
Patients with schizophrenia averaged lower light activity hours per day than the controls (4.0 vs. 
5.4 hrs/day, p=0.01).  
 In a larger sample (n=55) of overweight and obese adults with severe mental illness 
[schizophrenia or schizoaffective disorder (n=38), bipolar disorder (n=15, and major depression 
(n=12)], average mins/wk of moderate to vigorous physical activity measured by accelerometry 
were greater in male than female (157 vs. 85 min/wk) and younger than older (149 vs. 88 
min/wk) participants (20).  Initially, compliance with objective monitoring of physical activity 
was low with only 38% of participants (n=25) wearing the accelerometer for at least 4 days with 
at least 10 hours of accelerometer data per day (20).  Participants who did not initially provide 
valid accelerometry data were asked to wear the accelerometer again. Overall, valid 
accelerometry data was obtained from 82% of the sample (20) and approximated activity levels 
reported in previously reported studies (18, 19).  Moderate to vigorous physical activity levels 
were not correlated with self-reported severity of psychological symptoms, depressive symptoms 
or cognitive function using the Symptom Checklist-90 (SCL-90), Center for Epidemiologic 
Studies Depression Scale (CES-D) and the Repeatable Battery for the Assessment of 
Neuropsychological Status (RBANS), respectively (20).  Unfortunately, no comparisons or 
information is provided regarding the physical activity levels of participants by psychiatric 
diagnosis. 
 Collectively, these studies suggest that it is possible to objectively measure physical 
activity in patients with schizophrenia and schizoaffective disorders but that compliance may be 
lower than in other populations.  In addition, these studies provide some preliminary evidence 
that patients with schizophrenia and schizoaffective disorder have low levels of moderate to 
vigorous physical activity.  It should be emphasized that physical activity was objectively 
measured but not the primary focus for five out of six reported studies.  One study (59)only 
attempted to validate estimates of energy expenditure by accelerometry with doubly labeled 
water.  Two of the studies (18, 47) used accelerometry to validate self-reported physical activity 
surveys in patients with schizophrenia and schizoaffective disorders.  In the other two studies 
(17, 19), physical activity was assessed pre- and post-treatment as one of several health 
characteristics of patients with schizophrenia and schizoaffective disorder.  Hence, it is not 
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surprising that these reports would only provide limited or no information on objectively 
measured physical activity profiles of patients with schizophrenia or schizoaffective disorder.  In 
the remaining study, the physical activity profile of patients with schizophrenia or 
schizoaffective disorder was not reported(20).  Instead, the physical activity profile of patients 
with severe mental illness was reported and included patients with schizophrenia and 
schizoaffective disorder as well as patients with bipolar disorder and major depression (20). 
Hence, none of these studies provided a comprehensive profile of objectively measured physical 
activity in patients with schizophrenia and schizoaffective disorder.  In addition, these studies 
have been limited by the following research methodologies; 1) small sample sizes (17, 18), 2) 
only reported moderate to vigorous physical activity but not overall activity levels, light physical 
activity or sedentary minutes (19, 20)  and 3) the samples were either too homogenous such as 
patients with schizophrenia or schizoaffective disorder who are diabetic as well as overweight or 
obese (19), or heterogeneous such as patients with severe mental illness including schizophrenia, 
schizoaffective disorder, bipolar disorder, and major depression(20).  Furthermore, these studies 
did not examine the association between physical activity and symptoms of schizophrenia or 
schizoaffective disorder. 
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Table 3-3  Demographic review of studies reporting objective assessment of physical activity 
with accelerometry in individuals with schizophrenia or schizoaffective disorders. 
 
 
 
Author, yr 
 
N (Men, Women) 
N by disorder 
PANSS 
(positive, negative, general 
psycho-pathology, total) 
Age (years) 
Mean + STD 
Range 
BMI (kg/m2) 
Mean + STD 
Range 
Faulkner, 
2006(47) 
35 (22, 13) 
28 SZ,1 SF, 6 SA 
outpatients 
NR 40 + 11 31+7 
Gothelf, 
2002 (17) 
20 (20,0) 
20 SZ  
 10 olanzapine 
treated (OT) 
 10 halopriodol 
treated (HT) 
NA 17.0 + 1.6 OT 
24.5 + 5.9 HT 
24.5 + 5.9 
Jerome, 
2009 (20) 
66 (32,34) 
~ 38 SZ/SA  
~ 15 Bipolar   
~ 12 MDD 
55 (27,28) with 
accelerometry 
NA 44 
Range 20-67 years 
Restricted to > 25 
 
14 Overweight 
41 Obese 
Lindamer, 
2008 (18) 
81 (48,33);  
54 SZ/SA  
27 Normal Comparison 
(no known psychiatric 
diagnosis) 
SZ/SA: 13 + 6, 14 + 5, 27 + 
7, NR 
Normals: NR 
50.7+6.4 SZ 
52.2+8.6 Normals 
Range: 40 years or 
older 
30.5+7.1 SZ 
27.8+4.4 Normals  
(p=0.13) 
McKibbin, 
2006 (19) 
 
64 (37, 20) diabetic 
48 SZ 
9 SA 
 
DART (n=28) 
13.1 + 4.6 
5.2 + 0.8 
3.6 + 0.6 
UCI (n=29) 
15.1 + 5.1 
5.6 + 0.7 
4.0 + 0.7 
53.1 + 10.4 DART 
54.8 + 8.2 UCI 
 
Note: recruited > 40 
years 
 
33.6 + 6.8 DART 
32.9 + 6.2 UCI 
 
Sharpe, 
2006(59) 
8 (8, 0) 
8 paranoid SZ treated 
with Clozapine (450 
mg/day) 
NA 28 29.8  
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Table 3-4  Physical activity  review of studies reporting objective assessment of physical activity with accelerometry in individuals 
with schizophrenia or schizoaffective disorders. 
 
 
Author, yr 
 
Study Design 
 
Accelerometer 
Accelerometry 
definitions of PA 
Physical activity (PA) 
assessment period 
 
Findings 
Faulkner, 
2006(47) 
Cross-sectional study RT3 triaxial 
accelerometer 
(Stayhealthy, Inc) 
Total mins/wk of 
physical activity (>3.3 
MET min-1, the 
estimated level for 
walking) 
 
Total METS per week 
estimated from the total 
mins/wk of physical 
activity 
7 days; at least 600 min 
of registered time per day 
for at least 5 days with at 
least one weekend day 
 Used as criterion measure 
for IPAQ 
 ρ=0.37; p=0.05, [95% CI 
0.04-0.63] for IPAQ and total 
min wk-1 of physical activity 
 ρ=0.33; p>0.05, [95% CI 
0.0-0.60] for IPAQ and METS 
min wk-1 of physical activity 
Gothelf, 2002 
(17) 
Longitudinal CSA (Computer 
Science&Application), 
Shalimar, FLA 
 
1. Light 
2. Moderate 
3. Vigorous 
4. Very vigorous 
5. % of time in moderate 
to very vigorous activity 
Note: Cutpoints not 
provided 
2 days at baseline and 4 
weeks later after starting 
olanzapine treatment; 
right hip 
OT 
 4.4% (baseline) and 2.9% (4 
wk) of time in moderate to very 
vigorous activity (p=0.13) 
 90% < 10 min per day of 
MVPA 
 Low physical activity before 
and after treatment 
alater renamed CSA AM7164 or Actigraph Accelerometer (model 7164) 
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Table 3-4 (continued) Physical activity  review of studies reporting objective assessment of physical activity with accelerometry in 
individuals with schizophrenia or schizoaffective disorders. 
 
 
Author, yr 
 
Study Design 
 
Accelerometer 
Accelerometry 
definitions of PA 
Physical activity (PA) 
assessment period 
 
Findings 
Jerome, 2009 
(20) 
Cross-sectional study RT3 (Stayhealthy, Inc) 
triaxial accelerometer 
1. Minutes of MVPA (> 
1316 counts/min) per 
day 
2. Minutes of MVPA  
in bouts of >10 minutes 
per day  
3. Estimated average 
mins/wk of MVPA 
4 days including one 
weekend day, at least 10 
h of wear time for 4 days, 
worn on right hip 
 Only n=25 (38%) compliant 
wearing accelerometry initially; 
Final compliance n=55 (83%) 
 120 + 13 min/wk  MVPA 
 25 + 6 min/wk MVPA in 
>10 min bouts 
 35% meet physical activity 
guidelines (>150 min/wk) 
 4% meet physical activity 
guidelines (>150 min/wk in >10 
min bouts) 
 men>women (p<0.05) 
 overweight>obese (p>0.40) 
 younger>older for min/wk 
but not min/wk in bouts for 
MVPA  
 no MVPA difference by 
CES-D or psychological distress 
Lindamer, 2008 
(18) 
Cross-sectional; 
2:1 SZ:Normals 
Matched on gender 
and age (+10 years) 
Actigraph 
Accelerometer  
(model 7164) 
 
0-100 counts/hr 
sedentary 
101-1951 counts/hr light 
activity 
1952-5724 counts/hr 
moderate 
>5725 counts/hr 
vigorous 
7 days; considered valid 
data if at least 3 days with 
10 hours of monitoring; 
invalid hour if 0 counts > 
30 min  
 data from 17 (31%) 
participants excluded because of 
monitor malfunctions or too few 
days; 15 (28%) excluded, not 
able to match for gender and age 
 16 SZ, 6 Normals 
 SZ/SA (4.0 h/day) <controls 
(5.4 h/day) for light activity 
(p>0.01) 
 No difference for moderate 
(32.0 vs 31.6 min/day), vigorous 
(4.1 vs 5.4 min/day) or sedentary 
(8.9 vs 8.2 h/day) minutes, or 
mean activity counts (337.7 vs 
365.3) (SZ vs Normals)(p>0.71) 
alater renamed CSA AM7164 or Actigraph Accelerometer (model 7164) 
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Table 3-4  (continued) Physical activity  review of studies reporting objective assessment of physical activity with accelerometry in 
individuals with schizophrenia or schizoaffective disorders 
 
 
 
Author, yr 
 
Study Design 
 
Accelerometer 
Accelerometry 
definitions of PA 
Physical activity (PA) 
assessment period 
 
Findings 
McKibbin, 2006 
(19) 
Randomized Clinical 
Trial; 
randomized to either 
Diabetes Awareness 
and Training (DART, 
n=32) or Usual Care 
plus Information 
(USI, n=32) 
Actigraph 
Accelerometer  
(model 7164) 
 
Average minutes of 
moderate and vigorous 
activity per day 
 
7 days; valid data >= 3 
days, 10 h per day, (lost 
data for 12 patients due to 
downloading error) 
 Pre vs Post-Intervention 
 
23+20 vs 14+15  UCI 
25+24 vs 23+17  DART  
NS, presumably p>0.05 
Sharpe, 2006(59) Cross-sectional study RT3 triaxial 
accelerometer 
Estimate of energy 
expenditure for each 
recorded activity minute 
4 consecutive days; 12 h 
per day 
 Over-predicted energy 
expended on physical activity 
compared to doubly labeled 
water (148 + 413 kcal/day) with 
RT3 
 r= -0.83 (p=0.001) for 
inactivity and activity energy 
expenditure with RT3 
 NS correlation between 
accelerometry output and activity 
energy expenditure 
alater renamed CSA AM7164 or Actigraph Accelerometer (model 7164) 
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3.2.3   Subjective versus Objective Measures of Physical Assessment in Patients with 
Schizophrenia or Schizoaffective Disorders 
 
As discussed above, neither subjective nor objective assessment of physical activity is ideal for 
adults with schizophrenia or schizoaffective disorder.  Briefly, subjective measures of physical 
activity poorly assess unstructured, intermittent, and low-intensity activity such as walking 
which is the primary activity for adults with schizophrenia and schizoaffective disorder as well 
as the general population.  Even though unstructured, intermittent, and low-intensity physical 
activity are measured well with objective assessments of physical activity, only subjective 
assessments of physical activity can identify the actual physical activity (running, bicycling, 
walking), the type of physical activity (occupation, household, leisure), and quantify activities 
such as swimming, cycling, or weight lifting that are poorly measured by accelerometers.  Also, 
lower compliance with wearing the accelerometer was noted in the pilot studies in adults with 
schizophrenia or schizoaffective disorder(18, 20) compared to the general population.  This 
lower compliance rate for accelerometry may jeopardize the feasibility of objective monitoring 
of physical activity in adults with schizophrenia and schizoaffective disorder for research studies 
as well as limit the generalizability of any research findings.  
 The weak to modest correlations between subjective and objective measures of physical 
activity reported by Lindamer et.al.(18) and Faulkner et al.(47) suggest that objective measures 
of physical activity may differ from subjective measures of physical activity among patients with 
schizophrenia or schizoaffective disorder.  This finding may not be limited to adults with 
schizophrenia or schizoaffective disorder.  In a recent commentary, Troiano indicated that 
objective measures of physical activity may substantially differ from subjective measures of 
physical activity in the general population (63).  For example, accelerometry was found to have 
significantly lower estimates of physical activity levels and different patterns of physical activity 
than self-reported physical activity in an adult Swedish population (n=1114)(64).  Additional 
research is necessary to confirm these preliminary findings, and to accurately describe and define 
objectively measured physical activity in various populations. The present study will address this 
gap in the research literature by quantifying and comparing objective and subjective measures of 
physical activity levels and patterns among overweight and obese adults with schizophrenia and 
schizoaffective disorders in a relatively large sample (n=250).  
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 As others have suggested(36, 58),(37) both objective and subjective assessment of 
physical activity may be necessary to obtain a comprehensive profile of physical activity in free-
living adults.  For this reason, the proposed study assessed physical activity subjectively using a 
highly Modified Activity Questionnaire (MAQ) (Appendix 9.1.1) and objectively by 
accelerometry (Actiwatch) to obtain a comprehensive profile of physical activity in overweight 
and obese adults with schizophrenia or schizoaffective disorder.  As summarized in Table 3.5, 
the strengths and limitations of the two assessments selected in this study complement each other 
and should provide the most comprehensive profile of physical activity in overweight and obese 
adults with schizophrenia and schizoaffective disorder to date.  
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Table 3-5  Strengths and limitations of physical activity measured objectively by accelerometry 
(Actiwatch) and subjectively by questionnaire [Modified Activity Questionnaire (MAQ)] in free-
living individuals. 
 
Variable Accelerometry Questionnaire 
Type of assessment Objective Subjective 
Device Actiwatch 7164 MAQ 
Data collection Prospective Recall 
Data collection time 7 Days 15-30 Minutes 
Recall bias No Yes 
Reactivity Yes No 
Subject burden Moderate Minimal 
Reliability Yes Yes 
Validity Yes Yes 
Cost Expensive Inexpensive 
Activity time period 7 Days 7 Days 
Measures intensity/duration/ frequency of activities Yes Yes 
Measures leisure time activities Primarily Activity 
Related To Hip 
Movement Only 
Selected Activities 
Measures occupational activities Primarily Activity 
Related To Hip 
Movement Only 
Selected Activities 
Measures unstructured or low intensity activities Primarily Activity 
Related To Hip 
Movement Only 
Poor 
Measures housework/household activities Primarily Activity 
Related To Hip 
Movement Only 
Selected Activities 
Ability to measure  swimming and water activities No Yes 
Ability to measure weight lifting and cycling Poor Good 
Use in special populations 
   Children 
   Cognitively impaired 
   Restricted to Wheelchair 
 
Yes 
Possibly 
No 
 
No 
Yes 
Yes 
Data entry requirements Low Moderate 
Data processing High Low 
 
 
 
 
3.3 CONCLUSION 
 
Although limited, published studies using objective and subjective measures of physical activity 
suggest that individuals with schizophrenia or schizoaffective disorder have low levels of 
moderate to vigorous physical activity.  For the most part, these studies have been limited by the 
following research methodologies; 1) small sample sizes (17, 18), 2) moderate to vigorous 
physical activity reported but not activity counts, light physical activity or sedentary minutes (19, 
20), 3) the samples were either too homogenous such as patients with schizophrenia or 
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schizoaffective disorder who are diabetic and overweight or obese (19), or heterogeneous such as 
patients with severe mental illness including schizophrenia, schizoaffective disorder, bipolar 
disorder, and major depression (20), 4) only measured objective or subjective physical activity 
hence the studies were not able to provide a comprehensive profile of physical activity that 
includes the quantity, intensity, pattern, and type of physical activity in adults with schizophrenia 
and/or schizoaffective disorder, and 5) lack of control for confounding factors such as BMI.   
 This investigation will address these shortcomings by 1) measuring physical activity in a 
significantly larger sample of adults with schizophrenia or schizoaffective disorders (n~250), 2) 
measuring physical activity both subjectively and objectively, 3) reporting the full spectrum of 
intensity (light to moderate/vigorous activity) and types (leisure, occupational, household) of 
physical activity, 4) quantifying physical activity or inactivity using total activity counts, 
mins/wk of physical activity or inactivity, or energy expenditure, 5) studying only adults with 
schizophrenia and schizoaffective disorders rather than adults with severe mental illness, and 6) 
control for BMI, a possible confounder in previously reported studies.  In addition, the project 
will also examine the association between physical activity and the symptoms and impairments 
associated with schizophrenia and schizoaffective disorders that previous studies have not 
examined.  
 Finally, physical activity levels of adults with schizophrenia and schizoaffective disorder 
will be compared with a representative sample of adult users of mental health services in the US.  
This analysis will begin to investigate whether physical activity levels differ by diagnoses and 
severity of symptoms within mental health populations.  Ultimately, this investigation will make 
significant contributions to the existing literature by providing a comprehensive profile of 
physical activity in adults with schizophrenia and schizoaffective disorders and by providing an 
initial framework for determining whether physical activity levels or patterns differ by diagnosis 
or severity of the mental illness. 
 
 
 
3.4 STUDY OBJECTIVES 
 
The first objective of this study is to provide a comprehensive physical activity profile of 
overweight and obese adults with schizophrenia and schizoaffective disorder.  The 
comprehensive profile will be based on physical activity measured subjectively by questionnaire 
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and objectively by accelerometry.  It is hypothesized that overweight and obese adults with 
schizophrenia and schizoaffective disorders will be relatively sedentary and primarily engage in 
unstructured, intermittent, and low-intensity physical activities such as walking and daily 
household activities.  This descriptive profile of physical activity in overweight and obese adults 
with schizophrenia or schizoaffective disorder will also examine the association between 
physical activity levels and 1) symptoms of schizophrenia, 2) psychiatric medications, 3) 
demographics, and 4) quality of life.  An inverse relationship is expected between physical 
activity levels and cognitive, social and occupational impairments or dysfunction in overweight 
and obese adults with schizophrenia and schizoaffective disorder.   
 The second objective of this study is to compare physical activity levels measured 
objectively by accelerometry in adults with schizophrenia and schizoaffective disorder with 
adults who used mental health services in the general US population. Using accelerometry data 
from the National Health and Nutrition Examination Survey (NHANES 2003-2004), men and 
women who used mental health services were relatively sedentary(65). Men who used mental 
health services were significantly less active than men who did not use mental health 
services(65).  Women, regardless of mental health service use, were significantly less active than 
men who used mental health services(65).  This study will extend these findings by determining 
if the physical activity levels of adults with schizophrenia or schizoaffective disorder differ from 
adults who use and do not use mental health services.  Feasibly, physical activity levels of adults 
with mental illness may differ depending on the diagnosis and the severity of the symptoms.  In 
other words, lower physical activity levels may be observed in adults with severe mental illness 
(schizophrenia and bipolar disorder) and higher physical activity may be expected in adults with 
less severe mental illness such as anxiety and adjustment disorder.   
 By objectively measuring physical activity levels, this report will provide not only a 
comparison of physical activity among adults with schizophrenia and schizoaffective disorder 
and users and non-users of mental health services but also determine whether physical activity 
differs by symptoms or function among adults with schizophrenia and schizoaffective disorder.  
These findings may justify and guide in the development of effective physical activity programs 
tailored to provide physical and psychologically benefit to overweight and obese adults with 
schizophrenia and schizoaffective disorder.  
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4.0 METHODS 
 
 
 
4.1. BRIEF OVERVIEW 
 
This report is based on baseline data from the Weight Assessment and Intervention in 
Schizophrenia Treatment (WAIST) study and the National Health and Nutrition Examination 
Survey 2003-2004.  A brief overview of the two study designs are provided below. 
 
4.1.1 Weight Assessment and Intervention in Schizophrenia Treatment (WAIST) Study 
 
The WAIST study is a randomized, parallel group, clinical trial designed to assess the efficacy of 
a group-based behavioral treatment for weight reduction (BT) compared to social skills training 
(SST) or usual care (UC) in overweight or obese (BMI>27 kg/m2) but clinically stable patients 
with a diagnosis of DSM-IV-TR schizophrenia or schizoaffective disorder.  Eligibility criteria 
for enrollment in the study included: age 18-70 years, DSM-IV-TR schizophrenia or 
schizoaffective disorder, BMI>27 kg/m2 at the time of enrollment, ability to provide informed 
consent, and spontaneously expressed a desire to lose weight. Subjects were accepted if treated 
with novel or conventional antipsychotics or if not treated with any antipsychotic medication, 
Positive and Negative Symptom Scale (PANSS) score < 90, no psychiatric hospitalization in the 
30 days prior to enrollment, and no medical contraindication to participation in weight 
reduction/exercise program. Female subjects, of child-bearing potential, were enrolled if they 
said they were using a medically accepted means of contraception.  Study exclusion criteria 
included: inability to give informed consent, moderate mental retardation, currently enrolled in 
another weight management program, currently being treated with medication to reduce weight, 
unstable medical illnesses that may have affected body weight, history of myocardial infarction 
or coronary heart failure, end-stage renal disease, unstable thyroid disease, and prominent 
cardiovascular risks that may have jeopardized patient’s safety in a weight reduction program 
that included some exercising.  Participants were recruited from the outpatient clinics and partial 
hospital programs at Western Psychiatric Institute and Clinic, University of Pittsburgh Medical 
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Center, Pittsburgh, PA, from WPIC satellite clinics at Beaver Valley and McKeesport, and from 
the Safe Harbor Behavioral Health Clinic in Erie, Pennsylvania.  Potential participants were 
informed about the study by a member of their medical team (psychiatrist, therapist, or case 
manager). 
 During Phase I, BT and SST groups attended 20 sessions over a 14-week period where 
the patients were taught 7 topics or techniques relevant to their group assignment. After the 
conclusion of Phase I, only patients in BT who had lost at least 3% of initial body weight entered 
Phase II, a 24-month follow-up period with brief ‘booster’ sessions at two week intervals. At the 
end of Phase I, SST and UC patients were given the opportunity to participate in a weight 
reduction group if they so desired. 
Physical activity was measured objectively by accelerometry and subjectively by an interview-
administered survey at screening prior to randomization and at the end of phase I.  Physical 
fitness was measured by graded exercise stress testing.  This report is restricted to the screening 
assessments that occurred prior to randomization at baseline. 
All participants in the WAIST Study were eligible for the subjective measurement of 
physical activity and physical fitness testing. Only a subsample of the WAIST Study participants 
were offered actigraphy monitoring.  Based on the staff’s perception of the participant’s 
compliance to complete the research intervention, the WAIST Study staff evaluated participants 
at baseline on a subjective rating scale, Observer Related Compliance Rating (ORCR).  ORCR 
scores ranged from 1 to 7.  Participants rated 5, 6, or 7 were considered eligible for actigraphy 
monitoring.  Due to initially low compliance with actigraphy monitoring by the participants, the 
eligibility criteria for actigraphy monitoring was modified.  Only participants whom had a rating 
of 5 or greater on the ORCR and the staff considered psychiatrically compliant with 
appointments to the outpatient clinic and under “regular” care with a psychiatrists/therapist 
(being seen more often than once every 3 months) were considered eligible for actigraphy 
monitoring. 
 
4.1.2 National Health and Nutrition Examination Survey (NHANES) 2003 – 2004 
 
NHANES 2003 – 2004 is designed to assess the health and nutritional status of adults and 
children in the United States by means of interviews and physical examinations. The NHANES 
interview is composed of demographic, socioeconomic, dietary, and health-related questions.  
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Medical, dental, and physiological measurements and laboratory tests are administered by highly 
trained medical personnel during the physical examinations.  The National Center for Health 
Statistics of the Centers for Disease Control conducted NHANES as a cross-sectional 
observational study using a stratified, multistage probability design to obtain a nationally 
representative sample of the civilian, non-institutionalized US population(66).  From January 
2003 through December 2004, NHANES participants that agreed to a medical examination were 
recruited for physical activity monitoring by accelerometry(67).  Only 16% (n=880) of the adult 
population (n=5620, age 18 years or older) did not participate in the physical activity monitoring 
for the following reasons: declined the medical examination, declined physical activity 
monitoring, or had physical impairments limiting walking or wearing the accelerometry and 
were not eligible to receive an activity monitor (67).  Overall, 4740 adults participated in the 
physical activity monitoring (n=2282 for men and n= 2458 for women).  For this report, the 
NHANES actigraphy sample was restricted by the age eligibility criteria used in the WAIST 
Study (18-70 years). The NHANES actigraphy sample consisted of 758 men and 832 women 
between the ages of 18 and 70 years.   Another subset of the NHANES actigraphy sample was 
created based on the BMI (> 27 kg/m2) and age (18-70 years) eligibility criteria used in the 
WAIST Study. The NHANES actigraphy subsample consisted of 49 men and 68 women 
between the ages of 18 and 70 years with BMI >27 kg/m2.    
This report only used a subset of the NHANES 2003-2004 data as outlined in Table 4-1.  
The methodology associated with this data subset is described in the following sections of this 
report (Table 4-1). 
 
 
Table 4-1. Sections describing NHANES 2003-2004’s methodology. 
Dissertation Sections NHANES Variable 
4.2.2 Objectively measured physical activity (actigraphy) 
4.3.4 Users of mental health services 
4.4.2 General health status (SF12) 
4.6.2 Demographics (age, race, gender) 
4.7 Height, Weight, BMI 
4.8.2 Smoking Status 
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4.2. PHYSICAL ACTIVITY MEASURES 
 
4.2.1 Subjectively measured physical activity in the WAIST Study 
 
In the WAIST study, physical activity was subjectively assessed using a very modified, past 
week version of the Modifiable Activity Questionnaire (MAQ), an interviewer administered 
questionnaire (33, 46) (Appendix A1).  Participants reported the number of minutes they engage 
in specified occupational, housework, gardening/yard work, caretaking, transportation, and 
leisure physical activities for ten minutes or longer during the past week.  Estimated metabolic 
cost of the physical activities (METS/wk) were calculated by multiplying the mins/wk engaged 
in the specified physical activity by the estimated MET value of the activity published in the 
compendium of physical activities (68) (Appendix A1).  For occupational activity, the METS 
values were estimated as 0 for category A, 4.0 for category B, and 7.0 for category C activities.  
The six types of physical activities (occupational, housework, gardening/yard work, caretaking, 
transportation, and leisure) were summed to obtain total physical activity in mins/wk and 
MET/wk for the past week.  In addition, total physical activity excluding occupational activities 
and total physical activity excluding household activities were created. 
Finally, the physical activities were individually classified by intensity as sedentary, light, 
moderate or vigorous.  Minutes per week and MET-minutes per week were calculated for light, 
moderate, and vigorous activities.  For comparison with the accelerometry data, moderate and 
vigorous estimates were combined and reported as moderate-vigorous mins/wk and MET-
mins/wk.   
 
4.2.2 Objectively measured physical activity in WAIST Study and NHANES 2003-2004 
 
Both WAIST and NHANES 2003-2004 studies used the ActiGraph AM-7164 monitoring device 
(ActiGraph, Ft. Walton Beach, FL)(67) to objectively measure physical activity. The ActiGraph 
is considered the gold standard of accelerometer measurement and it has been used in over 215 
published studies (http://www.theactigraph.com and select research databases). The ActiGraph 
has been validated with indirect calorimetry, and as expected, higher correlations were observed 
for treadmill activities (r  = .76 to .85) than simulated lifestyle activities (r = .48)(43). High 
interinstrument reliability was observed in free-living adults (intraclass correlations > 0.97). The 
ActiGraphs were set to measure the duration and intensity of uniaxial movement within one-
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minute epochs. Participants wore the accelerometer on an elasticized belt over the right hip for 
seven consecutive days(67). If there were no activity counts for > 60 minutes, the accelerometer 
was considered not worn for that interval of time. For this report, analyses were restricted to 
those respondents with valid and reliable accelerometry data according to standard NHANES 
protocol and who wore the accelerometers for at least 10 hours a day for three or more days. 
Each minute epoch was assigned an activity level based on the number of counts per minute; 
sedentary (< 100 counts), light (101 - 1951 counts), or moderate/vigorous (> 1952 counts). For 
the most part, strenuous physical activities such as running, cycling, brisk walking and other 
aerobic activities were included in this definition of moderate/vigorous activity. Daily totals of 
sedentary, light, and moderate-vigorous minutes as well as total activity counts were averaged.  
The average of total counts per minute was calculated.  In addition, percentage of monitoring 
time for sedentary, light, and moderate-vigorous activities was calculated by dividing the 
minutes engaged in each category by the total monitoring minutes for each participant.     
 
4.2.3 Fitness measures in the WAIST Study 
 
Graded exercise stress testing (GXT) was optional for participants in the WAIST Study.  
Volunteers were excluded from GXT if medical clearance was not provided by their primary 
care physician.   
The modified Bruce protocol was used to ascertain cardiosrepiratory fitness and physical 
function capacity as previously described and summarized by Strassnig and associates (69).  
Briefly, GXT was performed on a stationary cycle ergometer except for 2 participants who 
completed the GXT on a treadmill since their weight exceeded 400 pounds, the upper weight 
limit for safety on a cycle ergometer.  Speed remained constant throughout the GXT while 
resistance was increased at 2 minute intervals.  Heart rate, blood pressure, and ratings of 
perceived exertion (RPE) were measured at defined periods during the GXT.  GXT was 
terminated at voluntary exhaustion or if the participant reported signs or symptoms of exercise 
intolerance such as muscular fatigue, significant ST depression and ischemia, or complex 
arrhythmias. GXT outcome measures were 1) cardiorespiratory fitness defined as maximal 
oxygen uptake (mL/min/kg), 2) peak exercise time in minutes, 3) peak exercise capacity 
estimated in metabolic equivalents (METs), and 3) maximal RPE during GXT test.   
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4.3 PSYCHIATRIC AND MENTAL HEALTH ASSESSMENTS 
 
4.3.1 Diagnosis of schizophrenia and schizoaffective disorder in WAIST Study 
Diagnosis of schizophrenia and schizoaffective disorder of the study participants was verified by 
at least 2 out of 3 study psychiatrists using data from a modified Structured Clinical Interview for 
DSM-IV (SCID)(70), medical charts, and corroborating information from reliable informants.  
 
4.3.2 Positive and Negative Syndrome Scale (PANSS) in WAIST Study 
 
The PANSS (71) was used to assess psychopathology in the study participants for the previous 
week. The PANSS is administered as a clinician interview or semi-structured interview by a 
trained rater and takes approximately 30 to 40 minutes to complete.  Based on a 7-point scale 
(1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 7=extreme), the clinician rates 
the patient on 30 items; 7 positive symptoms (delusions, conceptual disorganization, 
hallucinatory behavior, excitement, grandiosity, suspiciousness/persecution, and hostility), 7 
negative symptoms (blunted affect, emotional withdrawal, poor rapport, passive/apathetic social 
withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of conversation, and 
stereotyped thinking), and 16 general psychopathology (somatic concern, anxiety, guilt feelings, 
tensions, mannerisms and posturing, depression, motor retardation, uncooperativeness, unusual 
thought content, disorientation, poor attention, lack of judgment and insight, disturbance of 
volition, poor impulse control, preoccupation, and active social avoidance)(Appendix A2.1).  
The scores from the 30 items are summed to obtain the PANSS score that can range from 30 to 
210.  Although there are different conventions for clinical cut points for the PANSS, the severity 
of the illness has been categorized as mild, moderate and severe for scores <60, 60-129, and 
>129, respectively, in this study. Participants were only eligible for this study if their PANSS 
scores were less than 90 at enrollment. 
 
4.3.3 Clinical Global Impression of Severity (CGI-S) in WAIST Study 
 
With the CGI-S (72, 73), clinicians subjectively rate the severity of the patient’s mental illness 
(1=not ill, 2=very mild, 3=mild, 4=moderate, 5=severe, 7=extremely severe) at the time of the 
assessment compared to the clinician’s experience with previous patients with the same 
diagnosis (Appendix A2.2).    
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4.3.4  Use of Mental Health Services in NHANES 2003-2004 
 
During the household interview, the use of mental health services was assessed by asking: 
“During the past 12 months, that is since (date), have you seen or talked to a mental health 
professional such as a psychologist, psychiatrist, psychiatric nurse, or clinical social worker 
about your health?” and participants responded yes or no. 
 
 
 
4.4 ASSESSMENT OF FUNCTION AND HEALTH STATUS 
 
4.4.1 Global Assessment of Functioning (GAF) Scale in WAIST study 
With GAF, the clinician rated the adult patient on a predefined hypothetical continuum of mental 
health-illness based on the patient’s psychological, social and occupational functioning 
(Appendix A3.1) (3).  Functional impairments due to physical or environmental limitations are 
not considered.  The GAF scale ranges from 0-100 and the 11 categories are briefly defined as 
superior functioning (91-100), absent or minimal symptoms (81-90), transient symptoms (71-
80), mild symptoms (61-70), moderate symptoms (51-60), serious symptoms (41-50), 
impairment in reality testing or communication (31-40), serious impairment in communication 
and judgment (21-30), some danger of hurting self or others (11-20), persistent danger of hurting 
self or others (1-10), and inadequate information (0).  
 
4.4.2 General Health Status (SF12) in WAIST Study and NHANES 2003-2004 
 
In both studies, participants self-reported their general health as excellent (1), very good (2), 
good (3), fair (4), or poor (5) in an interview administered by a trained rater (Appendix A.3.2) 
(74).   For the analyses, general health status was dichotomized as 1= poor and fair, or 0= good, 
very good, and excellent (reference group).  
 
 
 
4.5 ASSESSMENT OF MEDICATIONS IN WAIST STUDY 
 
Subjects needed to have been on a stable dose of medications for at least 30 days prior to 
enrollment. Study participants were not allowed to be on any weight reduction treatment 
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including prescription or over-the-counter drugs.  Information on medications was obtained from 
reviewing the subjects’ medical records and by subject report.  
 Study participants were classified as taking a single antipsychotic (Aripiprazole, 
Clozapine, Olanzapine, Quetiapine, Risperidone, Haloperidol and Ziprasidone) or polypharmacy 
(more than one antipsychotic medication). Participants taking a single antipsychotic medication 
were also classified by the medication’s weight gaining properties [high (Clozapine and 
Olanzapine), moderate (Quetiapine, Risperidone, and Haloperidol), low/none (Aripiprazole and 
Ziprasidone)] as reported in the literature(75, 76). Participants with polypharmacy antipsychotic 
medications were excluded from all analyses involving weight gaining properties. 
 
 
 
4.6 ASSESSMENT OF DEMOGRAPHICS 
4.6.1 WAIST Study 
At baseline, WAIST participants self-reported their date of birth, gender, race/ethnicity 
(White/Caucasian; Black or African American; American Indian/Alaska Native; more than one 
race; other; or unknown/not reported), marital status (married and living with spouse; married 
but not living with spouse; never married; separated, divorced, widowed; don’t know/refused), 
primary employment (unemployed; occupational/vocational therapy; administrative or clerical 
support; precision production, craft or repair; transportation or material moving; technician and 
related support; don’t know/refused; volunteer; handlers, equipment cleaners, helpers; sales; 
professional specialty; other services), education [elementary school (grade 6 or less); some 
secondary school (grade 7 to 11); vocational training; GED/high school equivalent; graduated 
high school; graduated 2-year college; some college; some graduate/professional school; 
graduated 4-year college; completed graduate/professional school; don’t know/refused], and 
residence [hospital; 24-hour skilled nursing facility; intermediate care facility; supervised group 
living; transitional group home (halfway or quarterway house); family foster care; supervised 
cooperative apartment; unsupervised cooperative apartment; board and care home; boarding 
house (includes meals, no program or supervision); rooming or boarding house or hotel; private 
house or apartment; shelter; jail; no current residence; other; no other information] (Appendix 
A.3.3) (77).   
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4.6.2. NHANES 2003-2004 
Date of birth was used to calculate age at interview. To reduce the risk of disclosures, older 
adults age 85 years or older were given an age value of 85(78).   Highest grade or level of 
education was coded as less than 9th grade, 9-11th grade education (including 12th grade and no 
diploma), high school education/GED, some college or associates (AA), and college graduate or 
higher(78). Respondents self-identified their race as White, Black/African American, Indian 
(American), Alaska Native, Native Hawaiian, Guamanian, Samoan, Other Pacific Islander, Asian 
Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, Other Asian, Some other race 
(specify), don’t know, or refused(79).  Also respondents were asked if they considered 
themselves Hispanic and/or Latino and could answer yes, no, don’t know or refused(79). Based 
on these two questions, respondents were classified as white, black, Hispanic, or other. 
 
 
 
4.7 ASSESSMENT OF HEIGHT, WEIGHT, AND BMI IN NHANES AND WAIST 
STUDY 
 
Height and weight were measured using hospital quality weight and height scales for the WAIST 
Study.  In NHANES, weight was measured with a Toledo digital scale that was daily calibrated 
with 50-lb. calibrated weights by a trained technician (80).  During the weighing, the adult 
participants wore underpants, disposable gowns and foam slippers(80). Weight was measured in 
pounds and converted in kilograms by an automated computer program(80). If the participant 
weighed more than 440 lbs. then weight was measured using 2 Seca digital scales with the 
participant standing with one foot on each scale(80).  Height was measured in centimeters with a 
fixed stadiometer with vertical backboard and moveable headboard(80).  The stadiometer was 
calibrated weekly by a trained technician(80).  For both studies, BMI (kg/m2) was calculated as 
weight (kg) divided by height squared. 
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4.8 ASSESSMENT OF SMOKING STATUS 
4.8.1 WAIST Study 
Participants’ self-reported the number of cigarettes per day smoked as part of an interview 
administered questionnaire. This information was used to classify participants as current smokers 
(> 1 cigarette per day) or non-smokers (< 1 cigarette per day). 
 
4.8.2 NHANES 2003-2004 
 
As a metabolite of nicotine, serum cotinine levels were used to assess respondents exposure to 
tobacco smoke including active and passive smoking(81).  Participants were classified as current 
smokers if cotinine levels were equal to or greater than 10 ng/dl and as non-smokers if cotinine 
levels were less than 10 ng/dl. 
 
 
 
4.9 CODING FOR ANALYSES 
 
For descriptive summaries, race was summarized in 3 categories; White/Caucasian, 
Black/African American, and Other (Other, Native American, More Than One Race, 
Unknown/Not Reported).  Due to the small sample size of the other category (n=6) in the 
WAIST study, analyses were only performed on the White/Caucasian and Black/African 
American categories.  Marital status was recoded into 5 categories; married (living or not living 
with spouse), never married, separated/divorced, widowed, and don’t know/refused.  Highest 
grade or level of education was categorized as less than high school graduate [elementary school 
(grade 6 or less); some secondary school (grade 7 to 11)], high school graduate [vocational 
training; GED/high school equivalent; graduated high school], college educated [graduated 2-
year college; some college; some graduate/professional school; graduated 4-year college; 
completed graduate/professional school], or don’t know/refused.  Employment was categorized 
as unemployed, employed (occupational/vocational therapy; administrative or clerical support; 
precision production, craft or repair; transportation or material moving; technician and related 
support; volunteer; handlers, equipment cleaners, helpers; sales; professional specialty; other 
services), or don’t know/refused.  Residence was categorized as private residence (unsupervised 
cooperative apartment; board only; rooming house; private house or apartment; family foster 
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care; shelter), group home/supervised care (hospital; 24-hour nursing facility; intermediate care 
facility; supervised group living; transitional group home; supervised cooperative apartment; 
board and care home; jail), or no information.  Using categories defined by the National Heart, 
Lung, and Blood Institute, BMI was categorized as overweight (25.0-29.9 kg/m2), obesity (30.0-
39.9 kg/m2), and extreme obesity (>40 kg/m2) (p.179(82)).  Age was categorized into the 
following 3 groups; 18-39 years, 40-49 years, and 50-65 years. 
 With the MAQ, several participants reported extreme values for selected activities.  For 
these participants, the mins/wk for these selected activities were truncated to the second highest 
reported value in the sample.  Specifically, shopping was recoded 480 mins/wk instead of 4320 
mins/wk for participant 001WAI-000028, and light housework was recoded 1680 mins/wk 
instead of 4200 mins/wk for participant 001WAI-000402.  For participant 001WAI-000433, 
childcare was recoded 0 mins/wk instead of 7200 mins/wk since these childcare activities 
seemed to be reported under household activities as well.   Under caretaking, participant 
001WAI-000121 indicated ‘take mother for a walk’ under the other category.  The METS value 
assigned was 3.5 for ‘take mother for a walk’ to correspond to the METS value assigned to 
walking for transportation and leisure.  
GXT participants were classified as fit and unfit based on their maximal oxygen fitness 
and ratings of perceived exertion (RPE).  Participants with VO2max below the twentieth 
percentile for normative values for VO2max (mL/kg/min) by age and sex were considered unfit, 
and participants with VO2max above or equal to the twentieth percentile for normative values for 
VO2max (mL/kg/min) by age and sex were considered fit (83).  Ratings of Perceived Exertion 
were dichotomized as fit (12-20) and unfit (6-11). 
Categories were created for the psychiatric and mental health status variables for the 
summary tables and logistic regression.  The Positive and Negative Syndrome Scale for severity 
of illness was coded as none or mild (0) and moderate (1).  The Clinical Global Impression of 
Severity was coded as mild (0=not ill, very mild, or mild illness) (reference group) or severe 
(1=moderate, severe, and extremely severe illness).  General health status was dichotomized as 
good (0= good, very good, or excellent) 9reference group) or poor (1=poor or fair). Global 
assessment of functioning was recoded as mild (0=scores greater than or equal to 61) (reference 
group) or severe (1=scores between 0 and 60). 
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4.10 DATA ANALYSIS 
Descriptive summaries and statistical analyses were performed using Stata (release 9, StataCorp, 
College Station, TX) and SAS (version 9.2, SAS Institute, Triangle Park, NC).  In general, 
Kruskal-Wallis analyses of variance were performed for the continuous variables.  For the 
categorical variables, Chi-square tests were performed if the cell sizes were adequate.  If the cell 
sizes were small, Fischer’s exact tests were performed. 
 
4.10.1 Activity Populations 
 
Definitions for the various populations from the WAIST Study and NHANES used in this report 
are provided below.  The WAIST Study consists of the MAQ, GXT, and Actigraph cohorts.  The 
MAQ cohort is defined as all participants whom were administered the MAQ.  The GXT cohort 
is defined as all participants who volunteered for the graded exercise stress testing, were 
medically cleared for GXT by their primary care physician, and had complete fitness data.  The 
actigraph cohort is defined as all participants with at least 3 days of valid actigraph data.  For 
NHANES, users of mental health services was defined as adults who reported using a mental 
health service during the past year, age between 18-70 years, BMI greater than 27 kg/m2, and 
had at least 3 days of valid actigraph data. 
 
4.10.2 Analyses for MAQ cohort 
Descriptive summaries and statistical analyses are presented separately for 1) men and women, 
2) whites and blacks, and 3) age groups.  Since the MAQ variables were continuous, Kruskal-
Wallis analyses of variance were performed to detect differences in the MAQ cohort between 1) 
men and women, 2) whites and blacks, and 3) age groups. Due to the small cell counts, Fisher’s 
Exact Test were used to compare participants who were (n=252) and were not (n=6) 
administered the MAQ for the various categorical variables related to demographic and health 
information. Kruskal-Wallis nonparametric tests were used to compare participants who were 
(n=252) and were not (n=6) administered the MAQ for the following continuous variables; age, 
BMI, PANSS, and GAF score.    
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4.10.3 Analyses for Actigraph cohort 
 
Descriptive summaries and statistical analyses are presented separately for 1) men and women, 
2) whites and blacks, and 3) age groups.  Since the actigraph variables were continuous, Kruskal-
Wallis analyses of variance were performed to detect differences in the actigraphy variables 
between 1) men and women, 2) whites and blacks, and 3) age groups in the actigraph cohort. 
Due to the small cell counts, Fisher’s Exact Test were used to compare participants with valid 
(n=46) and not valid (n=9) actigraphy data for the various categorical variables related to 
demographic and health information. Kruskal-Wallis nonparametric tests were used to compare 
participants with valid (n=46) and not valid (n=9) actigraphy data for the following continuous 
variables; age, BMI, PANSS, and GAF score. 
 
4.10.4 Analyses for GXT cohort 
 
Descriptive summaries and statistical analyses are presented separately for 1) men and women, 
2) whites and blacks, and 3) age groups.  For the continuous variables (VO2max, minutes on the 
treadmill, resting GXT heart rate, peak GXT heart rate, and ratings of perceived exertion), 
Kruskal-Wallis analyses of variance were performed to detect differences between 1) men and 
women, 2) whites and blacks, and 3) age groups in the GXT cohort. Chi Square Tests were used 
to compare 1) categorical variables for ratings of perceived exertion and GXT by gender, race, 
and age groups, and 2) participants with (n=115) and without (n=143) GXT data for the various 
categorical variables related to demographic and health information. Kruskal-Wallis 
nonparametric tests were used to compare participants with (n=115) and without (n=143) GXT 
data for the following continuous variables; age, BMI, PANSS, and GAF score. 
 
4.10.5 Correlations between subjective and objective physical activity measures and 
physical fitness 
 
Spearman correlations were calculated to examine the associations between the objective and 
subjective measures of physical activity and fitness.  Spearman correlations were also calculated 
to examine the associations between the objective and subjective measures of physical activity 
and fitness and 1) psychiatric symptoms (PANSS), 2) severity of symptoms (CGIS), 3) function 
(GAF), 4) self-reported health status (SF12), 5) age and 6) BMI. 
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4.10.6 NHANES 2003-2004 
Descriptive statistics were calculated accounting for the weighting and clustering of the complex 
sampling design of NHANES (84).   The NHANES sample with valid and reliable actigraphy 
data were restricted to age 18-70 years to correspond to the age eligibility criteria for the WAIST 
Study.   Subsequent analyses also restricted the NHANES sample to adults with BMI greater 
than 27 kg/m2 to correspond to the BMI eligibility criteria for the WAIST Study.  The objective 
measures of physical activity and sedentary minutes of the users of mental health services from 
NHANES were compared to adults with schizophrenia or schizoaffective disorder from the 
WAIST study by means of a t-test for the comparison of two independent samples. 
 
4.10.7 Linear regression modeling 
 
Multivariate linear regression analyses were employed to identify the determinants of psychiatric 
symptoms (PANSS) and function (GAF) in adults with schizophrenia or schizoaffective disorder.  
Candidates for the multivariate models were objective measures of physical activity, subjective 
measures of physical activity, fitness, age, BMI, smoking status, gender, race, and medications. 
The first step in the model building process involved developing univariate linear regression 
models for each candidate.  Variables were considered candidates for the backwards step-wise 
selection of the multivariate linear regression model if the p-value was 0.20 or less in the 
univariate linear regression model. Next, all candidates were entered into a multivariate linear 
regression model.  Variables were removed from the model sequentially based on the p-values.  
The stepwise approach retained candidates in the multivariate model with p-values less than or 
equal to 0.10, and removed candidates with p-values greater than 0.10.  A p-value of 0.10 was 
selected to include potential predictors and confounders of each outcome (psychiatric symptom 
and function).  Next, biologically, plausible interactions were added to the main effects model.  
Interactions were only retained in the multivariate models if the p-value was < 0.05.   
 
4.10.8 Logistic regression modeling 
Multivariate logistic regression analyses were employed to identify the determinants of general 
health status (SF12) and symptom severity (CGIS) in adults with schizophrenia or 
schizoaffective disorder.  Candidates for the multivariate models were objective measures of 
physical activity, subjective measures of physical activity, age, BMI, smoking status, gender, 
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race, and medications. The first step in the model building process involved developing 
univariate logistic regression models for each candidate.  Variables were considered candidates 
for the backwards step-wise selection of the multivariate logistic regression model if the p-value 
was 0.20 or less in the univariate logistic regression model.  Next, all candidates were entered 
into a multivariate logistic regression model.  Variables were removed from the model 
sequentially based on the p-values.  The stepwise approach retained candidates in the 
multivariate model with p-values less than or equal to 0.10, and removed candidates with p-
values greater than 0.10.  A p-value of 0.10 was selected to include potential predictors and 
confounders of each outcome (symptom severity and general health status).  Next, biologically, 
plausible interactions were added to the main effects model.  Interactions were only retained in 
the multivariate models if the p-value was < 0.05.  Odds ratios and 95% confidence intervals 
were computed based on the Wald methods.  
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5.0 RESULTS 
 
 
 
5.1 PARTICIPATION RATES 
 
Two hundred and sixty overweight or obese adults with schizophrenia or schizoaffective 
disorders were recruited to participate in the WAIST Study.  After study entry, two participants 
withdrew their consent during the study and requested their data not be used.  Hence, the 
analytical sample for the WAIST Study consisted of 258 study participants.   Four participants 
only had baseline data and no assessments of physical activity (MAQ and actigraphy) or fitness 
(GXT).  Overall, 254 (98%) study participants had at least one physical activity or fitness 
assessment at baseline. The MAQ was administered to 252 (98%) participants to assess 
subjective physical activity levels.  One hundred and fifteen (45%) participants volunteered for 
fitness testing and 55 (21%) participants consented to wear actigraphs.  Figure 5-1 provides a 
summary of the number of participants with completed data for the subjective and objective 
physical activity measures and physical fitness.  The MAQ cohort consisted of 252 participants. 
The GXT cohort consisted of 109 participants, and the actigraphy cohort consisted of 46 
participants.  Only 10% (n=27) of the WAIST Study participants had completed data for all 
measures of physical activity and fitness. 
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Figure 5-1  Venn diagram for the number of participants with completed data for modified 
MAQ, GXT and Actigraphy in the WAIST Study. 
 
 
WAIST Study Participants N=254 Percentage 
Modified MAQ only           126 49.6 
Modified MAQ and GXT           80 31.5 
Modified MAQ and Actigraph           19 7.5 
Modified MAQ, GXT, and Actigraph           27 10.6 
GXT only           2 0.8 
GXT and Actigraph           0 0 
Actigraph only           0 0 
Number of participants 
with modified MAQ 
completed Data (n=252) 
 
126 
2 0 
80 
0 
27 
19 
Number of participants 
with Actigraph 
completed Data 
(n=46) 
Number of 
participants with 
GXT completed 
Data (n=109) 
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5.2 DEMOGRAPHICS AND HEALTH STATUS OF WAIST STUDY PARTICIPANTS 
The majority of the WAIST Study participants were middle-aged between 40 to 65 years of age 
(Appendix Tables A-1 and A-2).  Approximately, two-thirds of the sample was comprised of 
women.  White/Caucasians (50%) and Black/African Americans (48%) were equally 
representative in the study.  Partially due to study eligibility criteria (BMI > 27.0 kg/m2), the 
majority of participants were classified as obese (57%) or extremely obese (31%).  Almost half 
of the participants (114 out of 258 or 44%) reported smoking cigarettes. Few participants were 
married (8%) or employed (17%).  Study participants were generally low functioning adults with 
limited education (high school education or general education diploma).  Approximately, ninety 
percent of the study participants lived in group or community housing in the Pittsburgh area, 
specifically the east end. Generally, study participants were unemployed of low socioeconomic 
status with their primary source of income being social security disability. 
 Due to study eligibility criteria, study participation was restricted to adults with mild or 
moderate mental illness as determined by the PANSS.  Approximately, two-thirds of the study 
participants were classified as experiencing mild mental illness at baseline (PANSS <60).  
Likewise, the majority of participants were rated as experiencing moderate to mild symptoms 
based on the clinician’s evaluation of psychological, social and occupational function using the 
GAF (83%) and clinical global impression of mental health severity using the CGI-S (80%) 
(Appendix Table A-2).  Similar to the clinician-rated measures of mental health, the majority of 
the participants considered their general health status to be good (33%) or fair (32%) (Appendix 
Table A-2).  All of the participants were prescribed medications for schizophrenia or 
schizoaffective disorder.  Due to the study eligibility criteria, polypharmacy medications were 
limited to 2 antipsychotic medications.  However, the majority of the study participants (82%) 
were prescribed a single atypical antipsychotic medication (Appendix Table A-2). The weight 
gaining properties of these antipsychotic medications were evenly distributed among the 
participants taking a single anti-psychotic medication (Appendix Table A-2). 
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5.3 SUBJECTIVE MEASURE OF PHYSICAL ACTIVITY (MAQ) IN THE WAIST 
STUDY 
 
5.3.1 Comparison of MAQ cohort and participants not administered the MAQ 
 
The modified MAQ was administered at baseline to 98% (252 of 258) of the WAIST Study 
participants. Those participants administered the modified MAQ are referred to as the MAQ 
cohort (n=252) in the remainder of this paper.  Descriptive tables for those participants who were 
and were not administered the modified MAQ are provided in the appendix (Appendix Tables A-
1 and A-2) for demographics, psychiatric symptoms, function, and health status. 
 
5.3.2 MAQ Cohort  
 
5.3.2.1 Gender As summarized in Table 5-1, housework is the primary source of physical 
activity in overweight and obese adults with schizophrenia or schizoaffective disorders and 
accounted for 68% of the total mins/wk of physical activity.  On average, the female participants 
reported significantly (p<0.01) greater mins/wk of housework (474 min/week) than the male 
participants (284 min/week).  Based on the medians, the women reported approximately twice 
the minutes of housework per week than the men (305 versus 150 mins/wk, respectively).  The 
amount of time spent gardening/yardwork, caretaking, and transportation was not statistically 
different between men and women (p>0.10). Although not statistically significant, male 
participants reported approximately 30 minutes less of leisure physical activity per week than the 
female participants.   
 On average, men reported approximately twice the number of minutes of occupational 
physical activity than women (75 versus 39 minutes, respectively) (Table 5-1).  However, only 
15% (39 out of 252) of the MAQ cohort reported being employed.  Among those employed, 
occupational physical activity averaged 364+555 mins/wk (n=35).  Among employed 
participants, there was no statistically significant differences (p=0.36 based on Kruskal-Wallis 
test) between men (413+525 mins/wk, n=16) and women (324+589 mins/wk, n=19) in 
occupational physical activity.  
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Table 5-1 Subjective physical activity [modified MAQ (mins/wk)] for overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) by gender (n=252) 
 
 
 
modified MAQ (mins/wk) 
MAQ 
Cohort 
(n=252) 
 
Female 
(n=162) 
 
Male  
(n=90) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
52.0 + 243.3 
0 
0, 1800 
0, 0 
245 (13) 
 
39.2 + 226.5 
0 
0, 1800.0 
0, 0 
157 (5) 
 
75.0 + 270.5 
0 
0, 1500.0 
0, 0 
88 (2) 
0.09 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
406.1 + 502.5 
242.5 
0, 2940 
105.5, 507.5 
252 (6) 
 
473.9 + 552.5 
305.0 
0, 2940.0 
147.0, 585.0 
162 (0) 
 
284.1 + 369.6 
150.0 
0, 2430.0 
80.0, 300.0 
90 (0) 
0.0005 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
9.9 + 59.3 
0 
0, 840 
0, 0 
252 (6) 
 
8.9 + 68.1 
0 
0, 840.0 
0, 0 
162 (0) 
 
11.7 + 39.3 
0 
0, 240.0 
0, 0 
90 (0) 
0.10 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
21.6 + 124.8 
0 
0, 1260.0 
0, 0 
252 (6) 
 
22.9 + 131.2 
0 
0, 1260.0 
0, 0 
162 (0) 
 
19.3 + 113.0 
0 
0, 840.0 
0, 0 
90 (0) 
0.30 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
43.2 + 84.3 
0 
0, 840.0 
0, 60 
252 (6) 
 
42.3 + 90.7 
0 
0, 840.0 
0, 60.0 
162 (0) 
 
45.0 + 71.8 
20.0 
0, 360.0 
0, 60.0 
90 (0) 
0.13 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
81.5 + 144.8 
15.0 
0, 875.0 
0, 100 
250 (8) 
 
92.3 + 163.0 
10.0 
0, 875.0 
0, 120.0 
162 (0) 
 
62.2 + 102.9 
20.0 
0, 540.0 
0, 90.0 
90 (0) 
0.87 
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Table 5-1 (continued)  Subjective physical activity [modified MAQ (mins/wk)] for overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) by gender 
(n=252) 
  
 
 
modified MAQ (mins/wk) 
MAQ 
Cohort 
(n=252) 
 
Female 
(n=162) 
 
Male  
(n=90) 
p-value for 
Kruskal-
Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
605.2 + 679.0 
375.0 
0, 3900.0 
170.0, 830.0 
243 (15) 
 
669.2 + 759.5 
440.0 
0, 3900.0 
170.0, 885.0 
155 (7) 
 
492.5 + 491.1 
295.0 
0, 2535.0 
160.0, 800.0 
88 (2) 
0.15 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
558.6 + 689.3 
629.5 
0, 3900.0 
160.0,750.0 
250 (8) 
 
635.3 + 703.6 
432.5 
0, 3900.0 
170.0, 840.0 
160 (2) 
 
422.3 + 441.4 
273.5 
0, 2535.0 
146.0, 565.0 
90 (0) 
0.02 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
174.6 + 293.5 
80.0 
0, 2130.0 
10.0, 210.0 
243 (15) 
 
170.5 + 295.3 
75.0 
0, 2130.0 
0, 210.0 
155 (7) 
 
181.7 + 292.0 
85.0 
0, 1520.0 
25.0, 195.0 
88 (2) 
0.42 
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As described in section 4.2.1 of this report, estimated metabolic cost of the physical 
activities (METS/wk) were calculated by multiplying the mins/wk engaged in the specified 
physical activity by the estimated MET value of the activity published in the compendium of 
physical activities (68).  Similar physical activity patterns (Appendix Table A-8) were observed 
for subjective physical activity measured in METS per week as minutes per week for the 
modified MAQ. 
 
5.3.2.2  Race  No statistically or clinically significant differences for the subjective physical 
activity measures (mins/wk or METS/wk) were observed between black and white participants 
as summarized in Table 5-2 and Appendix Table A-4.   On average, white participants reported 
approximately twice the number of minutes of occupational activity than blacks (72 versus 35 
minutes, respectively) (p=0.09) (Table 5-2).  However, a greater percentage of the employed 
participants were white (59%) than black (26%) or other races (15%), and this may account for 
the observed average differences in occupational activity between blacks and whites in the MAQ 
cohort.  When the MAQ cohort is restricted to employed participants only, there was no 
statistically significant differences in occupational physical activity between white (369+523 
minutes, n=23) and black participants (426+678 minutes, n=10) (p=0.98 based on Kruskal-
Wallis test).   
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Table 5-2 Subjective physical activity [modified MAQ (mins/wk)] for overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) by race (n=246)a. 
 
 
 
Modified MAQ (mins/wk) 
 
White 
(n=124) 
 
Black  
(n=122)  
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
71.9 + 270.2 
0 
0, 1800.0 
0, 0 
118 (10) 
 
35.2 + 219.9 
0 
0, 1800.0 
0, 0 
121 (1) 
0.09 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
376.7 + 485.5 
220.0 
0, 2940.0 
105.5, 442.5 
124 (4) 
 
436.4 + 527.4 
247.5 
0, 2700.0 
115.0, 580.0 
122 (0) 
0.39 
Gardening/Yard work 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
14.6 + 81.5 
0 
0, 840.0 
0, 0 
124 (4) 
 
4.3 + 18.1 
0 
0, 120.0 
0, 0 
122 (0) 
0.52 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
18.1 + 104.8 
0 
0, 840.0 
0, 0 
124 (4) 
 
26.3 + 145.1 
0 
0, 1260.0 
0, 0 
122 (0) 
0.75 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
49.3 + 101.7 
0 
0, 840.0 
0, 60.0 
124 (4) 
 
36.2 + 56.8 
5.0 
0, 360.0 
0, 60.0 
122 (0) 
0.94 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
74.3 + 128.7 
17.5 
0, 840.0 
0, 90.0 
124 (4) 
 
90.2 + 162.3 
5.0 
0, 875.0 
0, 107.5 
120 (2) 
0.95 
a n=1 for other race; size of other race category considered insufficient to include in analyses 
or summary tables . 
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Table 5-2 (continued)  Subjective physical activity [modified MAQ (mins/wk)] for overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) by race 
(n=246)a. 
 
 
 
Modified MAQ (mins/wk) 
 
White 
(n=124) 
 
Black  
(n=122)  
p-value for 
Kruskal-
Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
588.7 + 644.9 
382.5 
0, 3900.0 
170.0, 790.0 
118 (10) 
 
624.8 + 723.1 
360.0 
0, 3635.0 
170.0, 895.0 
119 (3) 
0.98 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
533.0 + 598.6 
357.5 
0, 3900.0 
165.0, 700.0 
124 (4) 
 
586.1 + 669.5 
342.5 
0, 3635.0 
165.0, 857.5 
120 (2) 
0.85 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
188.4 + 295.4 
87.5 
0, 1800.0 
20.0, 225.0 
118 (10) 
 
163.8 + 298.2 
60.0 
0, 2130.0 
0, 180.0 
119 (3) 
0.32 
a n=1 for other race; size of other race category considered insufficient to include in analyses 
or summary tables . 
 
 
5.3.2.3 Age groups  Generally, self-reported physical activity reported on the modified MAQ 
(minutes or METS per week) did not significantly differ by age groups (Table 5-3 and Appendix 
Table A-5).  The proportion employed in each age group averaged 12% to 18%.  Among the 
employed, 40-49 years old reported approximately half the number of minutes of occupational 
physical activity than 18-39 or 50-65 years old (240 versus 462 and 382 mins/wk, respectively) 
(p=0.45 for Kruskal-Wallis test).  
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Table 5-3 Subjective physical activity [modified MAQ (mins/wk)] by age groups for overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) (n=252) 
 
 
  
Modified MAQ (mins/wk) 
 
18-39 yrs 
(n=70) 
 
40-49 yrs 
(n=85) 
 
50-65 yrs 
(n=97) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th  percentile 
   N (missing) 
 
67.9 + 277.6 
0 
0, 1800.0 
0, 0 
68 (2) 
 
28.9 + 191.0 
0 
0, 1500.0 
0, 0 
83 (2) 
 
61.0 + 258.6 
0 
0, 1800.0 
0, 0 
94 (3) 
0.29 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
343.0 + 450.3 
195.0 
0, 2700.0 
75.0, 475.0 
70 (0) 
 
404.0 + 494.5 
255.0 
0, 2940.0 
90.0, 580.0 
85 (0) 
 
453.6 + 543.6 
250.0 
0, 2940.0 
130.0, 510.0 
97 (0) 
0.22 
Gardening/Yard work 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
6.9 + 28.4 
0 
0, 210.0 
0, 0 
70 (0) 
 
14.2 + 92.6 
0 
0, 840.0 
0, 0 
85 (0) 
 
8.2 + 33.1 
0 
0, 240.0 
0, 0 
97 (0) 
0.69 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
34.0 + 184.1 
0 
0, 1260.0 
0, 0 
70 (0) 
 
17.8 + 98.7 
0 
0, 840.0 
0, 0 
85 (0) 
 
16.1 + 87.6 
0 
0, 660.0 
0, 0 
97 (0) 
0.96 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
43.0 + 69.3 
5.0 
0, 360.0 
0, 60.0 
70 (0) 
 
45.2 + 111.9 
0 
0, 840.0 
0, 60.0 
85 (0) 
 
41.7 + 64.5 
10.0 
0, 300.0 
0, 60.0 
97 (0) 
0.37 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
82.2 + 139.9 
20.0 
0, 780.0 
0, 110.0 
69 (1) 
 
77.9 + 138.5 
0 
0, 840.0 
0, 105.0 
85 (0) 
 
84.0 + 154.7 
17.5 
0, 875.0 
0, 90.0 
96 (1) 
0.89 
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Table 5-3 (continued)  Subjective physical activity [modified MAQ (mins/wk)] by age groups 
for overweight and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) 
(n=252) 
 
 
 
 
5.3.2.4 Description of physical activities  As summarized in Table 5-4, housework was the 
primary activity for overweight and obese adults with schizophrenia and schizoaffective 
disorders.  Walking for transportation or exercise was reported by 64% of the overweight and 
obese adults with schizophrenia and schizoaffective disorders. Other leisure physical activities 
were reported by less than 10% of the WAIST Study participants. 
 
  
 
 
Modified MAQ (mins/wk) 
 
18-39 yrs 
(n=70) 
 
40-49 yrs 
(n=85) 
 
50-65 yrs 
(n=97) 
p-value for 
Kruskal-
Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
568.4 + 701.7 
328.0 
0, 3635.0 
140.0, 790.0 
67, (3) 
 
568.7 + 630.0 
355.0 
0, 3900.0 
147.0, 815.0 
83 (2) 
 
664.2 + 707.0 
430.0 
0, 3390.0 
210.0, 895.0 
93 (4) 
0.41 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
501.3 + 649.2 
315.0 
0, 3635.0 
140.0, 615.0 
69 (1) 
 
559.1 + 626.4 
330.0 
0, 3900.0 
147.0, 815.0 
85 (0) 
 
599.4 + 621.3 
410.0 
0, 3270 
187.5, 835.0 
96 (1) 
0.33 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
198.5 + 299.3 
100.0 
0, 1800.0 
20.0, 230.0 
67 (3) 
 
139.8 + 231.2 
60.0 
0, 1520.0 
0, 180.0 
83 (2) 
 
188.3 + 336.2 
85.0 
0, 2130.0  
20.0, 185.0 
93 (4) 
0.23 
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Table 5-4. Frequencies of subjective physical activities for overweight and obese adults with 
schizophrenia and schizoaffective disorders in the MAQ Cohort (n=252). 
 
Physical Activity N (%) Physical Activity N (%) 
Shopping 
Housework 
 Light 
 Heavy 
Laundry 
177 (70.2) 
 
186 (73.8) 
128 (50.8) 
174 (69.1) 
Walking 
 Transportation only 
 Exercise only 
 Transportation and   
 exercise 
161 (63.9) 
        69 (27.4) 
        44 (17.5) 
        48 (19.1) 
Home repair 
 Light 
 Heavy 
 
16 (6.4) 
6 (2.4) 
Bicycling 
 Transportation only 
 Leisure only 
 Transportation and leisure 
18 (7.1) 
        4 (1.6) 
        14 (5.6) 
         0 (0) 
Food preparation 123 (48.8) Jogging 5 (2.0) 
Food Service 57 (22.6) Swimming 3 (1.2) 
Dish washing 171 (67.9) Softball/Baseball 2 (0.8) 
Gardening 
Lawn Mowing 
Cleaning Walks/ 
 Driveway 
16 (6.3) 
6 (2.4) 
10 (4.0) 
Bowling 
Basketball 
Calisthenics/Toning Exercises 
Wood Chopping 
2 (0.8) 
5 (2.0) 
26 (10.3) 
1 (0.4) 
Caretaking 
 Older or disabled 
 Child 
 
8 (3.2) 
10 (4.0) 
Aerobic Dance/Step Aerobics 
Strength/Weight Training 
Jumping Rope 
17 (6.8)a 
17 (6.8) 
1 (0.4)b 
  Yoga 
Pilates 
11 (4.4)b 
2 (0.8) 
a n=250; b n=251 
 
 
 
5.3.3 Summary 
 
Assessment of subjective physical activity was feasible for the majority of adults with 
schizophrenia and schizoaffective disorder.  Female participants reported significantly more time 
in household physical activities than the male participants. Otherwise, there was no difference 
between male and female participants in total physical activity per week or the various 
subcategories of physical activity.  In addition, there were no clinical or statistically significant 
differences between race or age groups for any of the subjective measures of physical activity 
among adults with schizophrenia or schizoaffective disorders. 
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5.4 OBJECTIVE MEASURE OF PHYSICAL ACTIVITY (ACTIGRAPHY) 
 
5.4.1 WAIST Study 
 
5.4.1.1 Participation rates  Initially, the WAIST Study planned to objectively monitor physical 
activity in all WAIST study participants.  However, several problems were experienced in the 
field. One participant left the Actigraph in the bathroom of a retail store and another participant 
reported that the Actigraph clip broke and discarded the Actigraph in the garbage.  Other 
participants either lost or misplaced the Actigraph or did not wear the device. Based on these 
experiences, confidence in the appropriate handling and return of an expensive activity monitor 
by adults with schizophrenia or schizoaffective disorders was low among the research team.  
Hence, the study protocol was modified. Study personnel only provided accelerometers to those 
study participants who were considered relatively stable and not experiencing severe symptoms 
or significant impairments due to their schizophrenia or schizoaffective disorders.     
Fifty-five participants (21.3 %) were consented to wear accelerometers at baseline 
(Figure 5-2).  One participant (id= 39) refused to wear the accelerometer, and one participant lost 
the Actigraph during the monitoring period (id=227). Three participants (id=2, 21, 437) did not 
provide any useable data for the monitoring period.  Due to technical problems attributed to the 
battery, no data was retrieved from the accelerometer worn by two participants (id=25, 27). 
 
5.4.1.2 Comparison of participants with valid (> 3 days) and non-valid (0-2 days) 
actigraphy data  The majority of the participants (84%) provided at least 3 days of valid 
accelerometry data (Appendix Table A-6) (Figure 5-2).  No statistically or clinically significant 
differences were noted for BMI, demographics, self-reported health status, or clinician rated 
function and psychiatric symptoms between participants with and without 3 days of valid 
actigraphy monitoring.  Participants who had at least 3 days of valid actigraphy data are referred 
to as the actigraphy cohort (n=46) for the remainder of this report.  
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Figure 5-2  Final dispositions for participants consented to actigraphy monitoring in the WAIST 
Study (n=55). 
 
 
5.4.1.3 Comparison between Actigraphy cohort and Actigraphy non-participants in the 
WAIST Study  A comparison of demographic information and health scores for adults with 
schizophrenia or schizoaffective disorder with and without actigraphy monitoring is summarized 
in Table 5-5.  Briefly, no statistically or clinically significant differences were noted between 
those who did and did not participate in actigraphy monitoring.   
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Table 5-5 Demographics and mental health scores for overweight and obese adults with 
schizophrenia or schizoaffective disorder by actigraphy monitoring (WAIST Study) (n=249a). 
 
 Actigraphy 
cohort   
(n=46) 
Non-actigraphy 
cohort  
(n=203) 
 
 
p-value 
Age (yrs) 45.6 (9.8) 44.9 (10.7) 0.75 
BMI (kg/m2) 37.9 (8.1) 37.9 (8.0) 0.94 
Male [N (%)] 17 (37.0) 71 (35.0) 0.80b 
Current Smoker [N (%)] 16 (34.8) 94 (46.3) 0.16b 
Race [N (%)] 
   White 
   Black 
   Other 
 
19 (41.3) 
26 (56.5) 
1 (2.2) 
 
106 (52.2) 
92 (45.3) 
5 (2.5) 
0.17b,c 
Positive and Negative Syndrome Scale (PANSS) 58.8 (15.9) 54.9 (10.6) 0.26 
Global Assessment of Functioning Scale (GAF) Scores 58.5 (8.2)c 59.7 (7.4)d 0.50 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; or mild mental illness 
   Moderate or severe mental illness     
   Not assessed 
 
20 (43.5) 
4 (52.2) 
2 (4.4) 
 
79 (38.9) 
97 (47.8) 
27 (13.3) 
0.95 b 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
23 (50.0) 
21 (45.7) 
2 (4.4) 
 
101 (49.8) 
93 (45.8) 
9 (4.4) 
0.98 b 
a  n=9 for consented participants with 0-2 valid actigraphy monitoring days; size of category considered 
insufficient to include in analyses or summary table. 
b Chi-square test 
c Other race (n=1) excluded from the Chi-square test due to insufficient sample size 
 
 
In addition, subjective physical activity measures were not statistically different between 
those adults who did and did not participate in actigraphy monitoring (p>0.05) (Table 5-6).  
However, there were several interesting non-significant trends worth noting.  On average, adults 
who participated in actigraphy monitoring tended to report more time engaged in leisure 
activities than those who did not participate in actigraphy monitoring  (116 versus 76 minutes, 
respectively, p=0.28).  Among those employed, occupational activity averaged 150 and 360 
minutes per day (p=0.62) for those in the actigraphy cohort (n=3) versus the non-actigraphy 
cohort (n=30), respectively (data not shown). 
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Table 5-6  Subjective physical activity [modified MAQ (mins or METS/wk)] for overweight and 
obese adults with schizophrenia or schizoaffective disorder by actigraphy monitoring (WAIST 
Study) (n=249a). 
 
 
Modified MAQ Categories 
Actigraph   
(n=46) 
No Actigraph 
(n=197) 
 
p-valueb 
Minutes per/wk 
   Occupational 
   Housework 
   Gardening/Yardwork 
   Caretaking 
   Transportation 
   Leisure 
   Total  
   Total  w/o occupational  activities 
   Total w/o household activities 
 
10.0 + 67.1 
408.7 + 438.4 
10.8 + 37.0 
4.6 + 31.0 
29.9 + 62.0 
115.5 + 171.9 
576.4 + 555.0 
559.1 + 528.3 
159.6 + 204.7 
 
36.8 + 214.0 
381.0 + 417.5 
10.3 + 34.9 
3.9 + 28.6 
76.0 + 140.1 
76.0 + 140.1 
612.6 + 709.9 
564.8 + 657.0 
175.9 + 300.6 
 
0.27 
0.97 
0.40 
0.18 
0.06 
0.28 
0.83 
0.65 
0.97 
METS per/wk 
   Occupational 
   Housework 
   Gardening/Yardwork 
   Caretaking 
   Transportation 
   Leisure 
   Total  
   Total w/o occupational activities 
   Total w/o household activities 
 
40.0 + 268.3 
1011.7 + 1093.2 
47.1 + 168.2 
18.3 + 123.9 
106.4 + 217.7 
474.1 + 704.1 
1698.8 + 1623.5 
1633.4 + 1528.1 
637.0 + 815.5 
 
233.7 + 1024.9 
1014.2 + 1325.7 
37.2 + 234.9 
89.3 + 509.2 
166.2 + 314.7 
317.5 + 633.9 
1822.5 + 2192.7 
1619.9 + 1928.8 
701.3 + 1250.1 
 
0.27 
0.90 
0.40 
0.18 
0.07 
0.30 
0.71 
0.51 
0.98 
a   n=9 for consented participants with 0-2 valid actigraphy monitoring days; size of category 
considered insufficient to include in analyses or summary table. 
b Kruskal-Wallis Test 
 
 
 
5.4.2 Actigraphy cohort in the WAIST Study 
 
5.4.2.1 Objective physical activity  On average, the actigraphy cohort wore the actigraphs over 
15 hours per day, 7 days per week (Table 5-7).  Actigraphy counts averaged 151,000 per day or 
163/min. The majority of the monitoring time was spent in sedentary activities (approximately 
13 hours per day or 81% of the monitoring time). On average, moderate/vigorous and light 
physical activity accounted only for 2% and 17% of the monitoring time per day, respectively.   
Adults with schizophrenia or schizoaffective disorder averaged 19 and 157 minutes per day of 
moderate/vigorous and light physical activity, respectively, as measured by accelerometry. 
.  
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Table 5-7 Objective physical activity assessment by actigraphy in overweight and obese adults 
with schizophrenia and schizoaffective disorders in the actigraphy cohort (n=46). 
 
 
Actigraphy measurements 
Actual actigraphy 
wear timea 
Percentage of actigraphy 
wear time (%)a 
Sedentary (mins/day)  
    Mean + STD 
   Median  
   Range 
   25th and 75th percentile 
 
756 + 140 
709 
491, 1125 
658, 831 
 
81 + 6 
82 
62, 91 
77, 85 
Physical Activity (mins/day)    
   Total   
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
176 + 54 
160 
89, 299 
134, 211 
 
19 + 6 
18 
9, 38 
15, 23 
   Moderate/Vigorous 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
19 + 12 
18 
2, 53 
10, 23 
 
2 + 1 
2 
0.2, 6 
1, 3 
   Light 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
157 + 48 
154 
78, 280 
120, 179 
 
17 + 5 
16 
8, 35 
13, 20 
Activity    
   Counts/day 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile   
 
151036 + 60998 
138420 
51852, 313684 
105533, 198801 
 
N/A 
Counts/min 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
163 + 64 
157 
62, 328 
113, 205 
 
N/A 
Monitoring period   
   Days 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
7.4 + 2.8 
7.0 
3.0, 13.0 
5.0, 9.0 
 
N/A 
Mins/day 
      Mean + STD 
      Median  
      Range 
      25th and 75th percentile     
 
933 + 149 
923 
721, 1286 
817, 1011 
 
N/A 
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5.4.2.1.1 Gender  Demographically, the racial composition was significantly different between 
men and women who participated in actigraphy monitoring (p=0.01) (Appendix Table A-7).  The 
majority with valid actigraphy data were black (72%) among the female participants and white 
(65%) among the male participants (Appendix Table A-7).  In addition, BMI tended to be greater 
(p=0.17) in women compared to men among those with valid accelerometry data (Appendix 
Table A-7).  Otherwise, there were no statistically or clinically significant differences between 
males and females with valid actigraphy data for age, smoking status, psychiatric symptoms, 
functioning, and general health status (p>0.15). 
Overall, no statistically or clinically significant differences were noted between men and 
women with respect to activity counts, minutes per day or percentage of monitoring time for total 
physical activity or the various subcategories of physical activities (p > 0.39) (Appendix Table 
A-7).   
 
5.4.2.1.2 Race  Statistically significant demographic differences were noted for race; black 
actigraphy participants were younger, heavier, and a greater percentage female and smokers than 
the white actigraphy participants (p<0.05) (Appendix Table A-8).   Also, the majority of black 
actigraphy cohort (58%) tended to report fair or poor general health compared to the white 
actigraphy cohort (32%, p=0.08).  There were no statistically or clinically significant differences 
between whites and blacks with valid actigraphy data for psychiatric symptoms or functioning 
(p>0.14).  As summarized in Appendix Table A-8, there were no statistically or clinically 
significant differences between black and white adults for the objective measures of physical 
activity (p>0.29).   
 
5.4.2.1.3 Age groups  Statistically significant age differences were noted for BMI (p<0.01) with 
younger participants having greater BMIs than older actigraphy cohort participants (Appendix 
Table A-9).   In addition, the older age group was comprised of fewer blacks (35%) than the 
younger age groups (73%) (p=0.05) (Appendix Table A-9).  There were no statistically or 
clinically significant differences between age groups with respect to  psychiatric symptoms, 
general health status, or functioning (p>0.48).  Finally, there were no statistically or clinically 
significant differences between age groups for the objective measures of physical activity 
(Appendix Table A-9).   
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5.4.2.2 Subjective physical activity  Subjective assessment of physical activity (modified 
MAQ) indicated that household activities were the primary source of physical activity for those 
with valid accelerometry data (Table 5-8 and Appendix Table A-10).  On average, adults with 
schizophrenia and schizoaffective disorder that provided valid accelerometry data self-reported 
150 min/week of physical activity (Table 5-8).  Among the actigraphy cohort, there were no 
statistically significant differences in modified MAQ scores (minutes or METS/day) for (Table 
5-8 and Appendix Table A-10), race (Appendix Tables A-11 and A12), or age groups (Appendix 
Tables A-13 and A-14). 
 
Table 5-8  Subjective physical activity [modified MAQ (mins/wk)] at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy 
cohort by gender (n=46). 
 
 
 
Modified MAQ (mins/wk)  
Actigraphy 
Cohort 
(n=46) 
 
Female 
(n=29) 
 
Male  
(n=17) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th per   centile 
   N (missing) 
 
10.0 + 67.1 
0 
0, 450.0 
0, 0 
45 (1) 
 
16.1 + 85.0 
0 
0, 450.0 
0, 0 
28 (1) 
 
0 + 0 
0 
0, 0 
0, 0 
17 (0) 
0.44 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
408.7 + 438.4 
213.0 
0, 1725.0 
99.0, 580.0 
46 (0) 
 
456.7 + 482.4 
245.0 
0, 1725.0 
130.0, 735.0 
29 (0) 
 
326.8 + 349.4 
180.0 
0, 1100.0 
99.0, 420.0 
17 (0) 
0.41 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
10.8 + 37.0 
0 
0, 210.0 
0, 0 
46 (0) 
 
5.2 + 22.8 
0 
0, 120.0 
0, 0 
29 (0) 
 
20.3 + 52.8 
0 
0, 210.0 
0, 0 
17 (0) 
0.11 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
4.6 + 31.0 
0 
0, 210.0 
0, 0 
46 (0) 
 
7.2 + 39.0 
0 
0, 210.0 
0, 0 
29 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
17 (0) 
0.44 
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Table 5-8  (continued) Subjective physical activity [modified MAQ (mins/wk)] at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the 
actigraphy cohort by gender (n=46). 
 
 
 
Modified MAQ (mins/wk)  
Actigraphy 
Cohort 
(n=46) 
 
Female 
(n=29) 
 
Male  
(n=17) 
p-value for 
Kruskal-
Wallis Test 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
29.9 + 62.0 
0 
0, 300.0 
0, 30.0 
46 (0) 
 
26.2 + 64.3 
0 
0, 300.0 
0, 20.0 
29 (0) 
 
36.2 + 59.1 
0 
0, 200.0 
0, 60.0 
17 (0) 
0.41 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
115.5 + 171.9 
20.0 
0, 840.0 
0, 180.0 
45 (1) 
 
119.3 + 188.5 
0 
0, 840.0 
0, 230.0 
28 (1) 
 
109.2 + 145.8 
45.0 
0, 450.0 
0, 135.0 
17 (0) 
0.55 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
576.4 + 555.0 
372.5 
0, 2160.0 
239.0, 920.0 
44 (2) 
 
629.3 + 632.8 
400.0 
0, 2160.0 
210.0, 1005.0 
27 (2) 
 
492.5 + 406.0 
328.0 
0, 1280.0 
239.0, 920.0 
17 (0) 
0.69 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
559.1 + 528.3 
345.0 
0, 2160.0 
90.0, 225.0 
45 (1) 
 
599.5 + 593.9 
372.5 
0, 2160.0 
227.5, 890.0 
28 (1) 
 
492.5 + 406.0 
328.0 
0, 1280.0 
239.0, 920.0 
17 (0) 
0.76 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
159.6 + 204.7 
90.0 
0, 840.0 
0, 255.0 
44 (2) 
 
168.5 + 228.1 
60.0 
0, 840.0 
0, 270.0 
27 (2) 
 
145.4 + 166.5 
90.0 
0, 510.0 
20.0, 165.0 
17 (0) 
0.66 
 
5.4.3  Actigraphy comparison between WAIST Study and NHANES 2003-2004 
 
Users of mental health services in NHANES were less obese (p<0.001) than adults with 
schizophrenia or schizoaffective disorder with valid accelerometry data (Table 5-9) despite using 
the same BMI eligibility criteria as the WAIST Study (BMI > 27 kg/m2). In addition, users of 
mental health services in NHANES self-reported better general health status (p<0.01) than adults 
with schizophrenia or schizoaffective disorder with valid accelerometry data (Table 5-9).  No 
statistically significant difference in age was observed among users of mental health services and 
the adults with schizophrenia or schizoaffective disorders.   
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Actigraphs were worn by the adults with schizophrenia or schizoaffective disorder 
approximately 1 day more than the users of mental health services.  However, there was no 
statistical or clinical difference in the average number of monitoring minutes per day between the 
two groups. On average, the actigraphs were worn almost 16 hours per day.   
Light physical activity (minutes/day or percentage of wear time), total physical activity 
(minutes/day or percentage of wear time), and total activity counts (per day or per minute) were 
statistically greater in users of mental health services than adults with schizophrenia or 
schizoaffective disorder (p<0.001).  Light activity and total activity (minutes/day or percentage 
of wear time) of adults with schizophrenia or schizoaffective disorders was approximately one-
half the monitoring time of the users of mental health services (approximately 2.5 versus 5 hours 
for light activity, and 3 versus 6 hours for total activity, respectively). However, there was no 
clinically or statistically significant difference in moderate/vigorous activity (minutes/day or 
percentage of wear time) between users of mental health services and adults with schizophrenia 
and schizoaffective disorders (p>0.32).  Sedentary time (minutes/day or percentage of wear time) 
was significantly greater in adults with schizophrenia and schizoaffective disorders than the users 
of mental health services (p<0.001). 
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Table 5-9  Comparison of adults who used mental health services in NHANES 2003-2004 with 
overweight and obese adults with schizophrenia or schizoaffective disorder in WAIST study.  
Age restricted to 18-70 years and BMI>27 kg/m2. 
 
 
 
 
Variable 
NHANES  
Users of mental 
health services 
(n=117) 
WAIST Study 
Adults with schizophrenia 
or schizoaffective disorder 
 (n=46) 
 
 
 
p-value 
Age (yrs) [Mean + STD] 45.2 + 0.8 45.6 +  9.8 1.00 
BMI (kg/m2) [Mean + STD] 34.6 + 0.8 37.9 + 8.1 0.001 
Men [N (%)]  49 (44.8) 17 (37.0) 0.56 
Current Smoker [N (%)] 35 (30.3) 16 (34.8) 0.67 
Race [N (%)] 
   White  
   Black  
   Other 
 
64 (74.7) 
30 (13.5) 
23 (11.8) 
 
19 (41.3) 
26 (56.5) 
1 (2.2) 
0.002 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
73 (62.4) 
38 (32.5) 
6 (5.1) 
 
23 (50.0) 
21 (45.7) 
2 (4.4) 
0.12 
Monitoring [Mean + STD] 
   Days 
   Min/day 
 
6.2 + 0.1 
963 + 10 
 
7.4 + 2.8 
933 + 149 
 
0.02 
0.64 
Sedentary [Mean + STD] 
   (min/day) 
   % of wear time 
 
643 + 18 
66 + 0.01 
 
756 + 140 
81 + 6 
 
<0.0001 
<0.0001 
Light Activity [Mean + STD] 
   (min/day) 
   % of wear time 
 
300 + 6 
32 + 0.01 
 
157 + 48 
17 + 5 
 
<0.0001 
<0.0001 
Moderate/Vigorous Activity 
 [Mean + STD] 
   (min/day) 
   % of wear time 
 
 
20 + 2 
2 + 0.002 
 
 
19 + 12 
2 + 1 
 
 
0.49 
0.32 
Total Activity [Mean + STD] 
   (min/day) 
   % of wear time 
 
320 + 7 
34 + 0.01 
 
176 + 54 
19 + 6 
 
<0.0001 
<0.0001 
Activity [Mean + STD] 
   counts/day 
   counts/min 
 
227116 + 11105 
239 + 17 
 
151036 + 60998  
163 + 64 
 
<0.0001 
<0.0001 
 
 
 
5.4.4 Summary 
 
In the WAIST Study, 55 participants were asked to participate in the actigraphy study, and 84% 
(46 of 55 participants) provided at least three days of valid actigraphy data.  No clinical or 
statistically significant differences were noted between the actigraphy cohort (n=46) and non-
participants in the actigraphy monitoring (n=203) with respect to demographics, health status, or 
subjective measures of physical activity.  
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The majority of the objective monitoring time was spent in sedentary activities 
(approximately 13 hours per day or 81% of the monitoring time). Adults with schizophrenia or 
schizoaffective disorder averaged 19 and 157 minutes per day of moderate/vigorous and light 
physical activity, respectively, as measured by accelerometry.  On average, moderate/vigorous 
and light physical activity accounted for 2% and 17% of the monitoring period per day, 
respectively.  No clinical or statistically significant differences were noted between males and 
females, whites and blacks, or the age groups for any of the objective measures of physical 
activity.  Finally, light physical activity time (minutes/day or percentage of wear time), total 
physical activity time (minutes/day or percentage of wear time), and total activity counts (per 
day or per minute) were statistically greater in users of mental health services than adults 
diagnosed with schizophrenia or schizoaffective disorder.   
 
 
 
5.5 PHYSICAL FITNESS (V02 MAX) IN THE WAIST STUDY 
 
5.5.1 Comparison of GXT Cohort and non-participants for GXT Testing 
 
5.5.1.1 Demographics and health status  Overall, 45% (115 of 258) of WAIST Study 
participants volunteered and their primary care physician provided medical clearance for the 
graded exercise stress testing.  The GXT participants were less likely to smoke than the non-
GXT participants (37% versus 50%, respectively; p=0.05) (Table 5-10).  Otherwise, no 
statistically or clinically significant differences were noted for age, gender, and severity of 
schizophrenic symptoms or function as measured by the PANSS, GAF, CGI-S, and SF-12 
between those who did and did not participate in the GXT testing (Table 5-10) (p>0.12)   
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Table 5-10  Demographics and mental health scores for overweight and obese adults with 
schizophrenia or schizoaffective disorder by GXT testing (WAIST Study) (n=252a). 
 
 
 
Variable 
 
GXT  Cohort 
(n=109a) 
 
No GXT  
(n=143) 
p-value for 
Kruskal-
Wallis Test 
Age (years) 
[Mean + std] 
 
45.8 + 10.0 
 
44.6 + 10.7 
0.59 
BMI (kg/m2)  
[Mean + std] 
 
37.0 + 6.4 
 
38.7 + 9.0 
0.27 
Male [N (%)] 45 (41.3) 45 (31.5) 0.12b 
Race [N (%)] 
   White 
   Black 
   Other 
 
50 (45.9) 
58 (53.2) 
1 (0.9) 
 
74 (51.8) 
64 (44.8) 
5 (3.5) 
0.25 bc 
0.32 bd 
 
Current Smoker [N (%)] 43 (39.5) 71 (49.7) 0.05b 
Positive and Negative Syndrome Scale (PANSS) [Mean + std] 55.9 + 12.1 55.3 + 11.5 0.59 
Global Assessment of Functioning Scale (GAF) Scores [Mean + std] 59.4 + 12.1 59.5 + 7.7 0.99 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill 
   Very mild mental illness 
   Mild mental illness 
   Moderate mental illness 
   Severe mental illness 
   Extremely severe mental illness 
   Not assessed 
 
1 (0.9) 
8 (7.3) 
36 (33.1) 
53 (48.6) 
1 (0.9) 
0 (0) 
10 (9.2) 
 
5 (3.5) 
5 (3.5) 
44 (30.8) 
67 (46.9) 
3 (2.1) 
0 (0) 
19 (13.3) 
0.43e 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
45 (41.3) 
54 (49.5) 
10 (9.2) 
 
54 (37.8) 
70 (49.0) 
19 (13.3)  
0.74 b 
General Health Status [N (%)] 
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
   Missing 
 
6 (5.5) 
15 (13.8) 
41 (37.6) 
31 (28.4) 
12 (11.0) 
4 (3.7) 
 
6 (4.2) 
17 (11.9) 
42 (29.4) 
49 (34.3) 
22 (15.4) 
7 (4.9) 
0.60b 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
62 (56.9) 
43 (39.4) 
4 (3.7) 
 
65 (45.5) 
71 (49.7) 
7 (4.9)  
0.12 
a volunteers for GXT Study with incomplete GXT data (n=6); numbers are insufficient to include in summary table. 
b Chi-square test; c Including Other category; d Excluding Other category ; e Fischer’s Exact test 
  
 
5.5.1.2 Subjective physical activity (MAQ)  Appendix Table A-15 provides a summary of the 
subjective measures of physical activity (modified MAQ scores for mins/wk or METS per week) 
for GXT cohort and non-participants for GXT testing.  Briefly, none of the subjective measures 
of physical activity (modified MAQ scores for mins/wk or METS per week) differed 
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significantly between those who did and did not participate for the GXT testing (p>0.14) 
(Appendix Table A-15).    
 
5.5.1.3 Objective physical activity (Actigraphy) Objective physical activity patterns for the 
GXT cohort compared to the non-participants for GXT testing are summarized in Appendix 
Table A-16.   Moderate/vigorous physical activity averaged approximately 19 minutes per day or 
2.0% of monitoring time in both groups and was not clinically or statistically different between 
those who did and did not participate in the GXT testing (Appendix Table A-16) (p>0.58).  In 
addition, the percentage of monitoring time for sedentary (~80%), light activities (~17%), and 
total activities (~19%) and activity counts per minute (~160) were not statistically or clinically 
significant different between the GXT cohort and those who did not participate in GXT testing 
(Appendix Table A-16) (p>0.41). However, the GXT cohort wore the actigraphs approximately 
2 hours less per day than those who did not participate in GXT testing (p=0.01) (Appendix Table 
A-16).  Hence, the GXT cohort engaged in less cumulative time per day in sedentary 
(approximately 80 minutes), light (approximately 40 minutes), and total (approximately 40 
minutes) physical activities and activity counts per day (~30,000) than participants who did not 
participate in the GXT testing (Appendix Table A-16) (p<0.06). However, the percentage of 
wear time for sedentary, light and total physical activities, and activity counts per day was not 
clinically or statistically different between the GXT cohort and non-participants for GXT testing 
(p>0.41). 
 
5.5.2 GXT Cohort in the WAIST Study 
 
5.5.2.1 Fitness testing results 
5.5.2.1.1 Gender  Less than 2% (2 of 109) of the participants in the GXT cohort were classified 
as fit based on their maximal oxygen fitness (Table 5-11).   Male compared to female 
participants had significantly greater VO2Max levels (18 versus 13 mL/kg/min, respectively) as 
well as minutes on the treadmill (8.9 versus 6.6 minutes, respectively) for the graded exercise 
testing (p<0.001).  No clinically or statistically difference was noted for resting or peak GXT 
Heart Rate or RPE between males and females (p>0.20).  Due to the observed fitness differences 
in male and female participants, separate analyses and summary tables by gender were created to 
examine racial and age group differences in the fitness measures for the GXT cohort. 
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Table 5-11 Summary of graded exercise test results for overweight and obese adults with 
schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by gender (n=109a). 
 
 
 
 
 
Variable 
 
Graded 
Exercise 
Test 
(n=109) 
 
 
 
Female 
(n=64) 
 
 
 
Male  
(n=45) 
p-value 
for 
Kruskal-
Wallis 
Test 
VO2 Max (mL/kg/min) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
15.2 + 6.0 
14.1 
4.5, 38.4 
11.3, 18.1 
 
12.8 + 4.1 
12.2 
4.5, 21.2 
10.3, 14.8 
 
18.4 + 6.6 
17.5 
4.5, 38.4 
14.3, 20.5 
<0.001 
Minutes on Treadmill 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
7.6 + 3.4 
8.0 
2.0, 19.0 
6.0, 8.0 
 
6.6 + 2.4 
6.0 
2.0, 12.0 
5.0, 8.0 
 
8.9 + 4.2 
8.0 
2.0, 19.0 
6.0, 10.0 
0.003 
Resting GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
88.3 + 13.8 
88.0 
60.0, 126.0 
78.0, 97.0 
 
87.8 + 13.7 
87.5 
61.0, 126.0  
77.0, 98.0 
 
89.0 + 13.9 
88.0 
60.0, 120.0 
79.0, 97.0 
0.79 
Peak GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
142.1 + 21.0 
142.0 
72.0, 192.0 
128.0, 155.0 
 
139.2 + 21.2 
142.0 
72.0, 187.0 
122.5, 152.0 
 
144.7 + 20.4 
144.0 
112.0,  192.0 
131.0, 159.0 
0.51 
Ratings of Perceived Exertion (RPE) N (%) 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
 
2 (1.9) 
0 (0) 
3 (2.9) 
1 (1.0) 
28 (26.7) 
7 (6.7) 
30 (28.6) 
9 (8.6) 
19 (18.1) 
3 (2.9) 
2 (1.9) 
1 (1.0) 
 
1 (1.7) 
0 (0) 
3 (5.0) 
1 (1.7) 
18 (30.0) 
6 (10.0) 
17 (28.3) 
3 (5.0) 
9 (15.0) 
1 (1.7) 
0 (0) 
1 (1.7) 
 
1 (2.2) 
0 (0) 
0 (0) 
0 (0) 
10 (22.2) 
1 (2.2) 
13 (28.9) 
6 (13.3) 
10 (22.2) 
2 (4.4) 
2 (4.4) 
0 (0) 
0.20 
 
Ratings of Perceived Exertion (RPE) Categories N (%) 
   6-12 
   13-20 
 
5 (4.8) 
100 (95.2) 
 
4 (6.7) 
60 (93.3) 
 
1 (2.2) 
44 (97.8) 
0.39b 
GXT Categories N (%) 
   Unfit 
   Fit 
 
107 (98.2) 
2 (1.8) 
 
64 (100.8) 
0 (0) 
 
43 (95.6) 
2 (4.4) 
0.17b 
a participants in WAIST Study with incomplete GXT data (n=6); numbers are insufficient to include in summary table. 
bFischer’s Exact Test 
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5.5.2.1.2 GXT results by race for male participants  Only 2 white males and no black males 
were classified as fit.  Otherwise, no clinically or statistically significant differences were noted 
for fitness levels, time on the treadmill, resting or peak GXT heart rate or RPE between white 
and black male participants (p>0.18) (Appendix Table A-17).   
 
5.5.2.1.3 GXT results by race for female participants  None of the females were classified as 
fit.  On average, fitness levels tended to be higher in white (14.4 mL/kg/min) compared to black 
(12.2 mL/kg/min) female participants (p=0.11). Otherwise, no clinically or statistically 
significant differences were noted for time on the treadmill, resting or peak GXT heart rate or 
RPE between white and black female participants (p>0.45) (Appendix Table A-18).   
 
5.5.2.1.4 GXT results by age groups for male participants  Age trends for male fitness levels 
are summarized in Appendix Table A-19.  One male in the 40-49 age group and one male in the 
50-65 age group were classified as fit based on their maximal oxygen fitness.  Although not 
statistically significant, fitness level (p=0.60) and time on the treadmill (0.17) tended to be less 
for males in the 50-65 age group compared to the younger age groups (18-39 and 40-49 years).  
In contrast, peak GXT heart rate tended to be greater in the 18-39 age group compared to the 
older age groups (40-49 and 50-65 years)(p=0.11). 
 
5.5.2.1.5 GXT results by age groups for female participants  Age trends for female fitness 
levels are summarized in Appendix Table A-20.  No females were classified as fit based on their 
maximal oxygen fitness.  Statistically significant age declines were observed for time on the 
treadmill (p<0.01) and peak GXT heart rate (p=0.06. In addition, fitness levels of the females 
tended to decline with age, although not statistically significantly (p=0.11).  
 
5.5.2.2 Subjective physical activity (modified MAQ) for GXT cohort 
5.5.2.2.1 Gender  Subjective physical activity patterns for the GXT cohort are summarized in 
Table 5-12 and Appendix Table A-21.  Briefly, female participants reported significantly 
(p<0.01) greater mins/wk of housework (488 min/week) than the male participants (273 
min/week).  The amount of time spent on occupational, gardening/yard work, caretaking, leisure 
activities, and transportation was not statistically different between men and women (p>0.10).  
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Differences in total physical activity between male and female participants (500 versus 770 
mins/wk, respectively) approached statistically significance (p=0.07) primarily due to the 
statistically significant gender differences in housework activities. 
 
 
Table 5-12  Subjective physical activity [modified MAQ (mins/wk)] of overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by gender 
(n=109). 
 
 
 
Variable 
 
GXT Cohort 
(n=109) 
 
Male 
(n=45) 
 
Female  
(n=64) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
82.0 + 300.4 
0 
0, 1800.0 
0, 0 
105 (4) 
 
99.1 + 333.3 
0 
0, 1500.0 
0, 0 
43 (2) 
 
70.2 + 277.5 
0 
0, 1800.0 
0, 0 
62 (2) 
0.77 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
399.3 + 425.4 
250.0 
0, 2490.0 
127.0, 570.0 
107 (2) 
 
272.5 + 291.6 
160.0 
0, 1320.0 
105.5, 307.5 
44 (1) 
 
487.9 + 480.6 
340.0 
0, 2490.0 
150.0, 735.0 
63 (1) 
0.005 
Gardening/Yard work 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
5.6 + 27.2 
0 
0, 240.0 
0, 0 
107 (2) 
 
9.5 + 38.1 
0 
0, 240.0 
0, 0 
44 (1) 
 
2.9 + 15.6 
0 
0, 120.0 
0, 0 
63 (1) 
0.29 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
28.6 + 132.9 
0 
0, 900.0 
0, 0 
107 (2) 
 
19.1 + 126.6 
0 
0, 840.0 
0, 0 
44 (1) 
 
35.2 + 137.7 
0 
0, 900.0 
0, 0 
63 (1) 
0.10 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
41.6 + 68.2 
0 
0, 350.0 
0, 60.0 
107 (2) 
 
41.6 + 76.0 
0 
0, 350.0 
0, 45.0 
44 (1) 
 
41.6 + 62.7 
0 
0, 300.0 
0, 60.0 
63 (1) 
0.68 
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Table 5-12 (continued)  Subjective physical activity [modified MAQ (mins/wk)] of overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort 
by gender (n=109) 
 
 
 
Variable 
 
GXT Cohort 
(n=109) 
 
Male 
(n=45) 
 
Female  
(n=64) 
p-value for 
Kruskal-
Wallis Test 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
97.4 + 185.6 
0 
0, 875.0 
0, 90.0 
105 (4) 
 
50.3 + 101.0 
5.0 
0, 540.0 
0, 60.0 
44 (1) 
 
131.3 + 222.7 
0 
0, 875.0 
0, 210.0 
61 (4) 
0.26 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
654.4 + 647.9 
400.0 
0, 3390.0 
180.0, 975.0 
103 (6) 
 
497.6 + 473.4 
285.0 
0, 1580.0 
170.0, 690.0 
43 (2) 
 
766.7 + 731.7 
585.0 
0, 3390.0 
230.0, 1047.5 
60 (5) 
0.07 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
563.6 + 554.0 
340.0 
0, 2630.0 
170.0, 815.0 
105 (4) 
 
393.1 + 380.2 
260.0 
0, 1580.0 
165.0, 556.5 
44 (1) 
 
686.6 + 625.8 
520.0 
0,  2630.0 
230.0, 998.0 
61 (4) 
0.02 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
225.0 + 370.3 
90.0 
0, 2130.0 
0, 270.0 
103 (6) 
 
192.4 + 353.9 
60.0 
0, 1520.0 
0, 150.0 
43 (2) 
 
248.4 + 382.8 
112.5 
0, 2130.0 
0, 330.0 
60 (5) 
0.11 
 
 
 
5.5.2.2.2 Race  No statistically significant differences (p>0.05) for minutes or METS per week 
of total physical activity or sub-categories of physical activity were observed between black and 
white participants in the GXT cohort as summarized in Appendix Tables A-22 and A-23.  
However, gardening (p=0.07 for mins/wk and p=0.06 for METS per week), leisure (p=0.07 for 
mins/wk and METS per week) and housework (p=0.13 for mins/wk and p=0.15 for METS per 
week) physical activities approached statistical significance and may be clinically relevant.  On 
average, white participants engaged more time in gardening (11 versus 1 minutes) and less time 
in leisure activities (61 versus 132 minutes) and housework (320 versus 467 minutes) than black 
participants.   
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5.5.2.2.3 Age groups  Subjective physical activity measures for the GXT cohort by age groups 
are summarized in Appendix Table A-24 for mins/wk and Appendix Table A-25 for METS per 
week.  No statistically significant differences (p>0.15) for minutes or METS of total physical 
activity or sub-categories of physical activity were observed between age groups in the GXT 
cohort as summarized in Appendix Tables A-24 and A-25.   
Due to the small number of employed participants, occupational mins/wk and METS per 
week by age group were examined among employed participants of the GXT cohort only.  A 
different pattern of occupational physical activity by age was observed among employed 
participants of the GXT cohort versus the entire GXT cohort.  Among the employed participants, 
occupational minutes of physical activity averaged 720 min/week (n=1), 343 min/week (n=7), 
and 686 min/week (n=8) for age groups 18-39, 40-49, and 50-65, respectively, (p=0.37).   
Among the employed participants, occupational METS of physical activity averaged 2880 
METS/week (n=1), 1371 METS/week (n=7), and 2925 METS/week (n=8) for age groups 18-39, 
40-49, and 50-65, respectively, (p=0.39).   Overall, the 40-49 age group (5 out of 7 participants 
or 71%) reported more sedentary jobs than the younger (0 out of 1 participants or 0%) or older 
age groups (2 out of 8 or 25%) thus accounting for lower mins/wk and METS/week of 
occupational physical activity in the 40-49 age group. 
 
5.5.2.3 Objective physical activity (Actigraphy) for GXT cohort 
5.5.2.3.1 Demographics and health status by gender  A total of 27 participants in the GXT 
cohort had valid actigraphy data.  Table 5-13 summarizes the demographics and health status of 
these 27 male and female participants.  Similar to the Actigraph cohort, a greater percentage of 
the female participants were black (73%) compared to the male participants (31%) (p=0.06), and 
BMI tended to be greater for female compared to male participants (p=0.08).  In contrast to the 
Actigraph cohort, self-reported health status was significantly different between male and female 
participants (p=0.01).  Female participants tended to report slightly better health status than the 
male participants.  No statistically or clinically significant differences between males and 
females were noted for age, smoking status, psychiatric symptoms or function (p>0.16) 
 
 
 87 
 
Table 5-13   Mean (standard deviation) for demographics and health status at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the 
GXT cohort with valid actigraphy monitoring by gender (n=27). 
 
 
 
Variable 
 
Men 
(n=12) 
 
Women 
(n=15) 
p-value for 
Kruskal-
Wallis Test 
Age (yrs) 48.2 (11.1) 44.9 (9.2) 0.28  
BMI (kg/m2) 35.1 (5.6) 38.8 (6.6) 0.08  
Current Smoker [N (%)] 4 (30.8) 5 (33.3) 1.00a 
Race [N (%)] 
   White 
   Black 
   Other 
 
8 (61.5) 
4 (30.8) 
1 (7.7) 
 
4 (26.7) 
11 (73.3) 
0 (0) 
0.06a 
Positive and Negative Syndrome Scale (PANSS) 58.1 (15.9) 61.3 (16.6) 0.53  
Global Assessment of Functioning Scale  (GAF) Scores 60.9 (9.4) 57.6 (7.4) 0.30 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill 
   Very mild mental illness 
   Mild mental illness 
   Moderate mental illness 
   Severe mental illness 
   Not assessed 
 
0 (0) 
1 (7.7) 
5 (38.5) 
5 (38.5) 
1 (7.7) 
1 (7.7) 
 
0 (0) 
3 (20.0) 
3 (20.0) 
9 (60.0) 
0 (0) 
0 (0) 
0.16 a 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
5 (41.7) 
6 (50.0) 
1 (8.3) 
 
6 (40.0) 
9 (60.0) 
0 (0) 
0.83a 
General Health Status [N (%)]   
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
   Missing 
 
0 (0) 
0 (0) 
7 (53.9) 
4 (30.8) 
2 (15.4) 
0 (0) 
 
0 (0) 
5 (33.3) 
2 (13.3) 
6 (40.0) 
0 (0) 
2(13.3) 
0.01 a 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
6 (50.0) 
6 (50.0) 
0 (0) 
 
7 (46.7) 
6 (40.8) 
2 (13.3) 
0.61a 
a Fisher’s Exact Test 
 
 
5.5.2.3.2  Gender  Objective physical activity measures for the GXT cohort by gender are 
summarized in Table 5-14.  Although there was no statistical difference in the number of days 
the male and female participants wore the actigraphs (~7 days for each group), the men wore the 
actigraphs more minutes per day than the women (~90 minutes per day, p=0.05).  This 90 minute 
difference in monitoring time between the female and male participants accounts for the greater 
sedentary time observed in the males compared to the females (780 versus 690 mins/wk, 
respectively).  Minutes in light, moderate/vigorous, and total physical activity as well as activity 
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counts/day were not statistically or clinically different between the males and female 
participants.  Similar to the results in the actigraph cohort, the differences between females and 
male participants in the percentage of time engaged in sedentary and physical activities were not 
statistically or clinically significant (p>0.17).  
 
Table 5-14  Mean (standard deviation) for valid actigraphy monitoring at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the GXT cohort by 
gender (n=27). 
 
 
 
Variable 
 
Men 
(n=12) 
 
Women 
(n=15) 
p-value for 
Kruskal-Wallis 
Test 
Monitoring  
   Days 
  Mins/day 
 
7.7 (2.9) 
938 (159) 
 
6.8 (2.6) 
851 (101) 
 
0.48  
0.05 
Sedentary  
   Mins/day 
   % of wear time 
 
780 (148) 
83.1 (5.6) 
 
690 (72) 
81.3 (4.0) 
 
0.14 
0.24  
Light Activity  
   Mins/day 
   % of wear time 
 
139 (46) 
14.9 (4.6) 
 
143 (39) 
16.6 (3.3) 
 
0.73 
0.17  
Moderate/Vigorous Activity  
   Mins/day 
   % of wear time 
 
19 (14) 
2.0 (1.2) 
 
18 (10) 
2.1 (0) 
 
0.98 
0.63 
Total Activity  
   Mins/day 
   % of wear time 
 
158 (57) 
16.9 (5.6) 
 
161 (48) 
18.7 (4.0) 
 
0.85 
0.24 
Activity  
   Counts/day 
   Counts/min 
 
145474 (72938) 
154.9 (70.9) 
 
135988 (568407) 
157 (54) 
 
0.85 
0.05  
 
 
 
5.5.2.3.3  Demographics and health status by race  Demographics and health status for the 
GXT cohort with objective measures of physical activity by race are summarized in Table 5-15.  
The differences in black and white participants observed in Table 5-15 are similar to the findings 
reported for the actigraph cohort. The GXT cohort with objective measures of physical activity is 
a subset of the actigraph cohort.  Briefly, black actigraphy participants were younger and a 
greater percentage female than the white actigraphy participants (p<0.05) (Table 5-15).  In 
addition, the clinicians rated the severity of psychiatric symptoms as greater among the black 
(57%) compared to the white (17%) participants (p=0.03).  Although not statistically significant, 
the majority of black actigraphy cohort (57%) tended to report fair or poor general health 
compared to the white actigraphy cohort (33%, p=0.61).  There were no statistically or clinically 
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significant differences between whites and blacks with valid actigraphy data for BMI, smoking 
status, psychiatric symptoms or functioning (p>0.19). 
 
Table 5-15   Mean (standard deviation) for demographics and health status at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the 
GXT cohort with valid actigraphy by race (n=26)a. 
 
 
 
Variable 
 
White 
(n=12) 
 
Black  
(n=14) 
p-value for 
Kruskal-
Wallis Test 
Age (yrs) 50.8 (8.8) 43.0 (9.0) 0.005 
BMI (kg/m2) 35.8 (5.3) 40.1 (9.4) 0.19 
Male [N (%)] 8 (66.7) 4 (26.7) 0.04 a 
Current Smoker [N (%)] 3 (25.0) 6 (40.0) 0.68 b 
Positive and Negative Syndrome Scale (PANSS) 60.9 (16.7) 56.2 (16.3) 0.59 
Global Assessment of Functioning Scale (GAF) Scores 56.4 (8.9) 59.9 (8.1) 0.24 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
Normal, not mentally ill 
Very mild mental illness 
Mild mental illness 
Moderate mental illness 
Severe mental illness 
 Not assessed 
 
0 (0) 
0 (0) 
2 (16.7) 
9 (75.0) 
1 (8.3) 
0 (0) 
 
0 (0) 
3 (21.4) 
5 (35.7) 
5 (35.7) 
0 (0) 
1 (7.1)  
0.09 b 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
2 (16.7) 
10 (83.3) 
0 (0) 
 
8 (57.1) 
5 (35.7) 
1 (7.1) 
0.03 
General Health Status [N (%)]    
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
   Missing 
 
0 (0) 
2 (16.7) 
5 (41.7) 
3 (25.0) 
1 (8.3) 
1 (8.3) 
 
0 (0) 
3 (21.4) 
2 (14.3) 
7 (50.0) 
1 (7.1) 
1 (7.1) 
0.63 b 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
7 (58.3) 
4 (33.3) 
1 (8.3) 
 
5 (35.7) 
8 (57.1) 
1 (7.1) 
0.61b 
a Excluding other race (n=1) due to insufficient sample size for analyses or summary table. 
b Fisher’s Exact Test 
 
 
5.5.2.3.4 Race  Objective measures of physical activity by race are summarized in Table 5-16.  
Although there was no statistical difference in the number of days the black and white 
participants wore the actigraphs (~7 days for each group), the white participants wore the 
actigraphs more minutes per day than the black participants (~150 minutes per day, p=0.005).  
This 150 minute difference in monitoring time can be attributed to more time in sedentary (970 
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versus 825 mins/wk, respectively) and light activity (155 versus 132 mins/wk, respectively) in 
the white compared to the black participants.  Minutes in moderate/vigorous physical activity 
were not statistically or clinically different between the black and white participants.  The 
differences between black and white participants in the percentage of time engaged in sedentary 
and physical activities were not statistically or clinically significant (p>0.47). Activity 
counts/day or activity counts/minute were not statistically different between the black and white 
participants (p>0.18). 
 
 
 
Table 5-16  Mean (standard deviation) for valid actigraphy monitoring at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the GXT cohort by 
race (n=26)a. 
 
 
Variable 
White 
(n=12) 
Black  
(n=14) 
p-value for 
Kruskal-Wallis Test 
Monitoring days 
Mins/day 
7.5 (2.8) 
970 (150) 
7.1 (2.7) 
825 (82) 
0.88 
0.005 
Sedentary  
   Mins/day 
   % of wear time 
 
793 (147) 
81.6 (5.6) 
 
676 (55) 
82.2 (4.1) 
 
0.06 
0.88 
Light Activity  
   Mins/day 
   % of wear time 
 
154.7 (43.3) 
16.2 (4.8) 
 
131.9 (38.3) 
15.8 (3.3) 
 
0.08 
0.84 
Moderate/Vigorous Activity  
   Mins/day 
   % of wear time 
 
22.0 (13.4) 
2.2 (1.2) 
 
17.2 (9.4) 
2.0 (1.0) 
 
0.47 
0.76 
Total Activity  
   Mins/day 
   % of wear time 
 
176.6 (54.3) 
18.4 (5.6) 
 
14.9 (46.3) 
17.8 (4.1) 
 
0.09 
0.88 
Activity  
   Counts/day 
   Counts/min 
 
160393 (66274) 
166.8 (64.6) 
 
129210 (56608) 
154.1 (56.0) 
 
0.18 
0.47 
a Excluding other race (n=1) due to insufficient sample size for analyses or summary table. 
 
 
 
 
5.5.2.3.5 Demographics and health status by age groups  Demographics and health status for 
the GXT cohort with objective measures of physical activity by age groups are summarized in 
Table 5-17.  Statistically significant age differences were noted for BMI (p=0.02) with younger 
participants having greater BMIs than older actigraphy cohort participants (Table 5-17).   In 
addition, the older age group was comprised of fewer smokers (17%) than the younger age 
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groups (~45%) (p=0.04) (Table 5-17).  There were no statistically or clinically significant 
differences between age groups with respect to  psychiatric symptoms, general health status, or 
functioning (p>0.48).  
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Table 5-17 Mean (standard deviation) for demographics and health status at baseline in overweight and obese adults with 
schizophrenia or schizoaffective disorder by age groups in the GXT cohort with valid actigraphy monitoring (n=27). 
 
 
Variable 
18-39 yrs 
(n=5) 
40-49 yrs 
(n=10) 
50-65 yrs 
(n=12) 
p-value for 
Kruskal-Wallis Test 
Age (yrs) 29.4 (2.6) 44.6 (3.0) 55.3 (4.1) <0.0001 
BMI (kg/m2) 42.6 (8.9) 38.1 (5.7) 33.8 (3.6) 0.02 
Male [N (%)] 2 (40.0) 3 (27.3) 8 (66.7) 0.02 a 
Current Smoker [N (%)] 2 (40.0) 5 (45.5) 2 (16.7) 0.04 a 
Race [N (%)] 
   White 
   Black 
   Other 
 
1 (20.0) 
4 (80.0) 
0 (0) 
 
2 (18.2) 
9 (81.8) 
0 (0) 
 
1 (8.3) 
9 (75.0) 
1 (8.3) 
0.04 a 
Positive and Negative Syndrome Scale (PANSS) 50.2 (9.1) 61.3 (16.8) 62.5 (17.1) 0.39 
Global Assessment of Functioning Scale (GAF) Scores 61.5 (6.2) 59.9 (9.4) 57.5 (8.3) 0.72 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill 
   Very mild mental illness 
   Mild mental illness 
   Moderate mental illness 
   Severe mental illness 
   Not assessed 
 
0 (0) 
0 (0) 
3 (60.0) 
1 (20.0) 
0 (0) 
1 (20.0) 
 
0 (0) 
3 (30.0) 
2 (18.2) 
5 (45.5) 
0 (0) 
0 (0) 
 
0 (0) 
0 (0) 
3 (25.0) 
8 (66.7) 
1 (8.3) 
0 (0)  
0.08 a 
Clinical Global Impression of Severity (CGI-S)[N (%)] 
   Normal, not mentally ill; very mild; or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
3 (60.0) 
1 (20.0) 
1 (20.0) 
 
5 (50.0) 
5 (50.0) 
0 (0) 
 
3 (25.0) 
9 (75.0) 
0 (0) 
0.10a 
General Health Status [N (%)]  
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
   Missing 
 
0 (0) 
1 (20.0) 
1 (20.0) 
1 (20.0) 
1 (20.0) 
1 (20.0)  
 
0 (0) 
3 (30.0) 
2 (20.0) 
5 (50.0) 
0 (0) 
0 (0)  
 
0 (0) 
1(8.3) 
5 (41.7) 
4 (33.3) 
1 (8.3) 
1 (8.3)  
0.53 a 
General Health Status [N (%)]   
   Excellent, Very Good, or Good 
   Fair or Poor 
   Missing 
 
2 (40.0) 
2 (40.0) 
1 (20.0) 
 
5 (50.0) 
5 (50.0) 
0 (0) 
 
6 (50.0) 
5 (41.7) 
1 (8.3) 
0.83a 
  a Fisher’s Exact Test
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5.5.2.3.6  Age groups  Objective measures of physical activity by age groups for the GXT cohort 
are summarized in Appendix Table A-26. No statistically or clinically significant differences 
were observed between the age groups for activity counts or any of the physical activity or 
sedentary measures (p>0.19). 
 
5.5.3  Summary 
 
Fitness testing was conducted in 45% (115 of 254) of the WAIST Study participants.  Only 2 
participants were classified as fit among the GXT cohort, both were male.  Male compared to 
female participants had significantly greater fitness levels. Subjective and objective measures of 
physical activity did not clinically or statistically differ between the GXT cohort and non-
participants for GXT testing. Within the GXT cohort, female participants reported more 
household physical activities than the male participants. Objective measures of physical activity 
(minutes/day or percentage of wear time) were not statistically or clinically different between 
males and females, whites and blacks, or age groups in the GXT cohort. 
 
 
 
5.6  CORRELATIONS IN THE WAIST STUDY 
 
5.6.1  Physical activity and fitness measures 
 
No significant associations (p>0.27) were observed between subjective measures of physical 
activity (MAQ scores), objective measures of physical activity (actigraphy), and physical fitness 
(VO2max) (Table 5-18).   
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Table 5-18  Spearman correlations between subjective and objective physical activity measures 
 
 
Variable 
VO2max 
(mL/kg/min) 
Modified MAQ 
Total Activity 
(mins/wk) 
Modified MAQ 
Total Activity 
(METS/wk) 
Physical Fitness 
   VO2max (mL/kg/min) 
      Spearman correlation  
      p-value 
      n 
 
 
----- 
----- 
----- 
 
 
0.004 
0.97 
103 
 
 
0.03 
0.73 
103 
Objective Physical Activity  
   Sedentary (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
 
0.19 
0.35 
27 
 
 
0.17 
0.27 
44 
 
 
0.18 
0.25 
44 
   Sedentary  (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
0.09 
0.64 
27 
 
0.16 
0.31 
44 
 
0.10 
0.51 
44 
   Light Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.04 
0.83 
27 
 
-0.12 
0.44 
44 
 
-0.06 
0.68 
44 
   Light Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.21 
0.30 
27 
 
-0.16 
0.30 
44 
 
-0.12 
0.43 
44 
   Moderate/Vigorous Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
0.18 
0.36 
27 
 
-0.03 
0.83 
44 
 
0.06 
0.69 
44 
   Moderate/Vigorous Activity  (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
0.12 
0.55 
27 
 
-0.06 
0.71 
44 
 
0.03 
0.83 
44 
   Total Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
0.03 
0.87 
27 
 
-0.13 
0.39 
44 
 
-0.07 
0.67 
44 
   Total Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.09 
0.64 
27 
 
-0.16 
0.31 
44 
 
-0.10 
0.50 
44 
   Activity counts/day 
      Spearman correlation  
      p-value 
      n 
 
0.15 
0.45 
27 
 
-0.07 
0.64 
44 
 
0.02 
0.87 
44 
   Activity counts/min 
      Spearman correlation  
      p-value 
      n 
 
0.13 
0.52 
27 
 
-0.09 
0.56 
44 
 
-0.01 
0.93 
44 
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5.6.2  Psychiatric symptoms, function, and general health status with physical activity and 
fitness measures 
 
The clinician’s assessment of psychiatric symptoms (PANSS, CGI-S) were not associated 
(p>0.12) with the objective or subjective measures of physical activity or physical fitness in 
adults with schizophrenia or schizoaffective disorders (Table 5-19).   
The global assessment of function (GAF) was significantly and positively associated with 
the subjective [modified MAQ total activity for mins/wk (rs= 0.16, p=0.02) as well as 
METS/week (rs= 0.17, p=0.01)] and physical fitness (rs=0.23, p=0.02).  With respect to 
accelerometry, only the correlation between function and the percentage of time engaged in light 
physical activity approached statistical significance (rs= -0.27, p=0.08).   
The participant’s assessment of their general health status was negatively associated with 
the subjective physical activity measures [mins/wk (rs=-0.15, p=0.02) and METS/week (rs=-0.17, 
p=0.01)] (Table 5-19). In general, the adults who reported better health status reported greater 
activity and the adults who reported poor health status tended to report lower physical activity.  
No association was observed between the participant’s assessment of their general health status 
and physical fitness (rs=0.12, p=0.24), and the objective physical activity measures (p>0.57) 
(Table 5-19).
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Table 5-19  Spearman correlations between subjective and objective physical activity measures and psychiatric scores,  
function, and general health status 
 
 
 
Positive and 
Negative 
Syndrome 
Scale 
 (PANSS) 
Global 
Assessment of 
Functioning 
Scale (GAF) 
Score 
Clinical 
Global 
Impression of 
Severity 
(CGI-S) 
 
General  
Health 
 Status 
(SF12) 
Physical Fitness 
   VO2max (mL/kg/min) 
      Spearman correlation  
      p-value 
      n 
 
 
-0.15 
0.12 
109 
 
 
0.23 
0.02 
99 
 
 
-0.15 
0.13 
99 
 
 
0.12 
0.24 
105 
Objective Physical Activity   
  Sedentary (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.001 
0.99 
46 
 
0.18 
0.25 
44 
 
-0.06 
0.69 
44 
 
-0.09 
0.57 
44 
 Sedentary (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
0.05 
0.75 
46 
 
0.22 
0.16 
44 
 
-0.15 
0.32 
44 
 
0.02 
0.88 
44 
   Light Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.07 
0.62 
46 
 
-0.20 
0.19 
44 
 
0.19 
0.21 
44 
 
.009 
0.96 
44 
   Light Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.06 
0.69 
46 
 
-0.27 
0.08 
44 
 
0.18 
0.25 
44 
 
-0.3 
0.84 
44 
   Moderate/Vigorous Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.04 
0.82 
46 
 
0.03 
0.87 
44 
 
-0.004 
0.98 
44 
 
-0.03 
0.87 
44 
   Moderate/Vigorous Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.04 
0.79 
46 
 
0.007 
0.97 
44 
 
-0.02 
0.92 
44 
 
-0.007 
0.96 
44 
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Table 5-19  (continued) Spearman correlations between subjective and objective physical activity measures and psychiatric scores, 
function, and general health status. 
 
 
 
Positive and 
Negative 
Syndrome 
Scale 
 (PANSS) 
Global 
Assessment of 
Functioning 
Scale (GAF) 
Score 
Clinical 
Global 
Impression of 
Severity 
(CGI-S) 
 
General  
Health 
 Status 
(SF12) 
   Total Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.07 
0.64 
46 
 
-0.18 
0.24 
44 
 
0.18 
0.24 
44 
 
0.04 
0.82 
44 
   Total Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.05 
0.75 
46 
 
-0.22 
0.16 
44 
 
0.15 
0.32 
44 
 
-0.02 
0.88 
44 
   Activity (counts/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.09 
0.56 
46 
 
-0.09 
0.55 
44 
 
0.14 
0.38 
44 
 
-0.02 
0.88 
44 
   Activity (counts/min) 
      Spearman correlation  
      p-value 
      n 
 
-0.06 
0.68 
46 
 
-0.13 
0.39 
44 
 
0.13 
0.41 
44 
 
0.01 
0.94 
44 
Subjective Physical Activity 
   Modified MAQ Total (mins/wk) 
      Spearman correlation  
      p-value 
      n 
 
 
0.05 
0.41 
243 
 
 
0.16 
0.02 
217 
 
 
-0.09 
0.21 
215 
 
 
-0.15 
0.02 
233 
   Modified MAQ Total (METS/wk) 
      Spearman correlation  
      p-value 
      n 
 
0.05 
0.48 
243 
 
0.17 
0.01 
217 
 
-0.10 
0.14 
215 
 
-0.15 
0.02 
233 
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5.6.3 Age and BMI with physical activity and fitness measures 
 Age was negatively associated with physical fitness (rs = -0.20, p<0.01) (Table 5-20).  In 
general, maximal oxygen consumption was greater among the younger adults with schizophrenia 
and schizoaffective disorders than the older adults with schizophrenia and schizoaffective 
disorders.  No association was observed between age and objective or subjective measures of 
physical activity (p>0.16).   
BMI was negatively associated with physical fitness (rs = -0.26, p<0.01) and approached 
statistical significance for subjective measures of physical activity (rs = -0.11, p<0.10) (Table 5-
20).  Finally, no statistically or clinically significant associations were observed between BMI 
and objective measures of physical activity (p>0.51) (Table 5-20). 
 
 
Table 5-20  Spearman correlations between subjective and objective physical activity measures 
and demographics 
 
Variable Age (yrs) BMI (kg/m2) 
Physical Fitness 
   VO2max (mL/kg/min) 
      Spearman correlation  
      p-value 
      n 
 
 
-0.20 
0.03 
109 
 
 
-0.26 
0.006 
109 
Objective Physical Activity 
   Sedentary (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
 
0.21 
0.16 
46 
 
 
-0.08 
0.58 
46 
  Sedentary (% of wear time)  
      Spearman correlation  
      p-value 
      n 
 
0.08 
0.60 
46 
 
-0.04 
0.77 
46 
   Light Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
0.05 
0.72 
46 
 
-0.05 
0.76 
46 
   Light Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.06 
0.69 
46 
 
0.01 
0.94 
46 
   Moderate/Vigorous Activity (mins/day) 
      Spearman correlation  
      p-value 
      n 
 
-0.04 
0.78 
46 
 
0.10 
0.51 
46 
   Moderate/Vigorous Activity (% of wear time) 
      Spearman correlation  
      p-value 
      n 
-0.03 
0.83 
46 
0.06 
0.70 
46 
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Table 5-20  (continued) Spearman correlations between subjective and objective physical 
activity measures and demographics 
 
Variable Age (yrs) BMI (kg/m2) 
   Total Activity (mins/day)      
      Spearman correlation  
      p-value 
      n  
 
0.06 
0.68 
46 
 
-0.03 
0.86 
46 
   Total Activity  (% of wear time) 
      Spearman correlation  
      p-value 
      n 
 
-0.08 
0.60 
46 
 
0.04 
0.77 
46 
   Activity (counts/day) 
      Spearman correlation  
      p-value 
      n 
 
0.003 
0.99 
46 
 
0.02 
0.91 
46 
   Activity (counts/min) 
      Spearman correlation  
      p-value 
      n 
 
-0.08 
0.61 
46 
 
0.04 
0.79 
46 
Subjective Physical Activity 
   Modified MAQ Total (mins/wk)       
      Spearman correlation  
      p-value 
      n 
 
 
0.05 
0.40 
243 
 
 
-0.11 
0.10 
243 
   Modified MAQ Total (METS/wk) 
      Spearman correlation  
      p-value 
      n 
 
0.03 
0.65 
243 
 
-0.11 
0.07 
243 
 
 
5.6.4 Summary 
No association was observed between the subjective and objective physical activity measures 
and physical fitness.  In addition, the clinician’s assessment of psychiatric symptoms was not 
associated with the objective or subjective measures of physical activity or physical fitness in 
adults with schizophrenia or schizoaffective disorders.  Finally, participants with greater function 
or better general health status tended to report greater levels of physical activity.   As expected, 
age and BMI were negatively associated maximal oxygen consumption.  However, no 
association was observed between age and BMI and objective or subjective measures of physical 
activity.   
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5.7 LINEAR REGRESSION FOR SUBJECTIVE PHYSICAL ACTIVITY (MODIFIED 
MAQ) IN THE WAIST STUDY 
 
5.7.1 Univariate linear regression models for modified MAQ (mins/wk) 
Table 5-21 provides a summary of univariate linear regression models for the subjective physical 
activity measures of total activity (mins/wk), total activity without occupational activity 
(mins/wk), and total activity without household physical activities (mins/wk).  Significant gender 
variations were noted for total activity and total activity without occupational activities (p<0.05).  
Female participants self-reported approximately 200 mins/wk more of total physical activities 
and total physical activities without occupational activities than male participants. As previously 
reported, these activity differences due to gender were attributed to household physical activities.  
Significant BMI variations were noted for total physical activity without household physical 
activities (p=0.04).  Each unit increase in BMI (kg/m2) was associated with 5 minute decrease in 
total physical activities excluding household physical activities. Finally, the objective physical 
activity or fitness measures were not statistically associated with any of the subjective activity 
measures(mins/wk).
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Table 5-21  Univariate models for subjective physical activity (mins/wk) in overweight and obese adults with schizophrenia and 
schizoaffective disorders in the WAIST Study 
 
 Subjective Physical Activity (Modified MAQ) 
 
 
 
Independent Variable 
 
 
Total Activity 
(mins/wk) 
 
Total w/o 
occupational 
activities (mins/wk) 
Total w/o 
household 
physical activities 
(mins/wk) 
Age (years) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
2.5 (4.2) 
0.36 
0.55 
243 
 
3.5 (3.9) 
0.80 
0.37 
250 
 
-1.7 (1.8) 
0.89 
0.35 
243 
BMI (kg/m2) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-3.5 (5.6) 
0.38 
0.54 
243 
 
-1.3 (5.1) 
0.07 
0.80 
250 
 
-5.0 (2.4) 
4.39 
0.04 
243 
Gender (0=male, 1=female) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
176.7 (90.1) 
3.85 
0.05 
243 
 
213.0 (82.0) 
6.75 
0.01 
250 
 
-11.2 (39.3) 
0.08 
0.78 
243 
Race (0=White, 1=Black) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
36.1 (89.0) 
0.16 
0.69 
237 
 
53.2 (81.2) 
0.43 
0.51 
243 
 
-24.5 (38.6) 
0.40 
0.53 
237 
Smoking status (0=no, 1=current) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
4.9 (87.9) 
0.00 
0.96 
243 
 
-16.4 (80.3) 
0.04 
0.84 
250 
 
-26.5 (38.0) 
0.49 
0.49 
243 
Anti-Psychotic Medications 
Polypharmacy (0=no, 1=yes) 
   β (SE) 
   F Statistics 
   p-value 
   n  
 
 
-53.3 (38.7) 
1.89 
0.17 
243 
 
 
-30.5 (35.2) 
0.75 
0.39 
250 
 
 
-27.4 (16.7) 
2.69 
0.10 
243 
 102 
 
 Table 5-21  (continued)  Univariate models for subjective physical activity (mins/wk) in overweight and obese adults with 
schizophrenia and schizoaffective disorders in the WAIST Study 
 
 
  
 Subjective Physical Activity (Modified MAQ) 
 
 
 
Independent Variable 
 
 
Total Activity 
(mins/wk) 
 
Total w/o 
occupational 
activities (mins/wk) 
Total w/o 
household 
physical activities 
(mins/wk) 
Weight gaining properties for single anti-psychotic medications  
(0=low/none, 1=yes) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
 
-155.6 (113.3) 
1.89 
0.17 
202 
 
 
-80.8 (104.0) 
0.60 
0.43 
207 
 
 
-119.8 (51.0) 
5.52 
0.02 
202 
Fitness (0=unfit, 1=fit) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-30.0 (464.9) 
0.00 
0.95 
103 
 
62.6 (397.4) 
0.02 
0.88 
105 
 
290.6 (264.1) 
1.21 
0.27 
103 
Maximal Oxygen Consumption (mL/kg/min) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-1.8 (11.0) 
0.03 
0.87 
103 
 
-7.2 (9.2) 
0.61 
0.44 
105 
 
9.7 (6.2) 
2.41 
0.12 
103 
Objective Physical Activity  
    (Activity counts/day) x 100 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
 
-0.27 (1.37) 
0.04 
0.84 
46 
 
 
-1.17 (1.24) 
0.88 
0.35 
47 
 
 
1.13 (0.67) 
2.88 
0.10 
46 
Activity counts/mins 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-0.45 (1.30) 
0.12 
0.73 
46 
 
-1.21 (1.18) 
1.05 
0.31 
47 
 
0.83 (0.64) 
1.69 
0.20 
46 
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Table 5-21  (continued)  Univariate models for subjective physical activity (mins/wk) in overweight and obese adults with 
schizophrenia and schizoaffective disorders in the WAIST Study. 
 
 Subjective Physical Activity (Modified MAQ) 
 
 
 
Independent Variable 
 
 
Total Activity 
(mins/wk) 
 
Total w/o 
occupational 
activities (mins/wk) 
Total w/o 
household 
physical activities 
(mins/wk) 
  Total activity (light, moderate and vigorous) (mins/day) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-0.73 (1.55) 
0.22 
0.64 
46 
 
-1.39 (1.40) 
0.99 
0.32 
47 
 
0.08 (0.77) 
0.95 
0.34 
46 
Total activity (light, moderate and vigorous) (% of monitoring time) 
      β (SE) 
      F Statistics 
      p-value 
      n   
 
-1143.8 (1488.9) 
0.59 
0.45 
46 
 
-1650.2 (1342.9) 
1.51 
0.23 
47 
 
330.3 (752.8) 
0.19 
0.66 
46 
    Sedentary (mins/day) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
0.46 (0.61) 
0.55 
0.46 
46 
 
0.48 (0.57) 
0.71 
0.40 
47 
 
0.22 (0.31) 
0.51 
0.48 
46 
Sedentary (% of monitoring time) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
1143.8 (1488.9) 
0.59 
0.45 
46 
 
1650.2 (1342.9) 
1.51 
0.23 
47 
 
-330.3 (752.4) 
0.19 
0.66 
46 
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5.7.2 Univariate linear regression models for modified MAQ (METS/wk) 
Table 5-22 provides a summary of univariate linear regression models for the subjective physical 
activity measures of total activity (METS/week), total activity without occupational activity 
(METS/week), and total activity without household physical activities (METS/week). Similar 
patterns of association were observed with the subjective physical activity measures in 
METS/week as the subjective physical activity measures in mins/wk for the demographic, fitness 
and objective physical activity measures (Tables 5-21 and 5-22). Briefly, significant gender 
variations were noted for total activity without occupational activities (p<0.05).  Female 
participants self-reported 362 METS/week more of total physical activities and 505 METS/week 
of total physical activities without occupational activities than male participants.  As previously 
reported, these activity differences due to gender were attributed to household physical activities.  
Variations in BMI were noted for total physical activity without household physical activities 
(p=0.05).  Each unit increase in BMI was associated with a decrease of approximately 20 
METS/week of physical activity.  
Finally, the objective physical activity or fitness measures were not statistically 
associated with 2 out of three subjective activity measures, specifically total activity and total 
activity without occupational activity (p>0.34) . However, subjective physical activity total 
without household physical activities approached statistically significant associations with fitness 
(p=0.16) and objective total physical activity measured as activity counts per day (p=0.06) or 
activity counts per min (p=0.13). The fit participants averaged 1600 METS/week more of total 
physical activity excluding household physical activities than the unfit participants.  Both 
objective measures of physical activity (activity counts/minute and activity counts/day) were 
positively associated with total physical activity without household physical activities 
(METS/day).  Each activity count per minute increase was associated with an approximately 4 
METS/week increase in total physical activity excluding household physical activities.   
 
5.7.3. Multivariate linear regression model-building and models for modified MAQ (mins 
or METS/wk) 
 
5.7.3.1 Total subjective physical activity (mins or METS/wk)  Candidates for the multivariate 
model- building process were gender and polypharmacy medications for total physical activity 
measured subjectively (mins/wk) (p<0.20). After the multivariate model-building process, 
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gender was the only variable significantly associated with total physical activity (mins/wk) 
(p<0.05).  None of the candidates in the multivariate model-building process (gender and 
polypharmacy medications) were found to be significantly associated (p<0.05) with total 
physical activity (METS/wk).  
 
5.7.3.2 Total subjective physical activity excluding occupation activities (mins or 
METS/wk)  Multivariate model-building was not conducted for total activity without 
occupational physical activities (mins/wk or METS/wk) since gender was the only candidate for 
the multivariate models (p<0.05). 
 
5.7.3.3  Total subjective physical activity excluding household activities (mins or 
METS/wk)  Candidates for the multivariate model- building process for total physical activity 
excluding household activities measured in METS/wk were exactly the same as total physical 
activity excluding household activities measured in mins/wk.  The candidates for each outcome 
were BMI, polypharmacy medications, weight gaining properties for single anti-psychotic 
medications, maximal oxygen consumption, and activity counts/day for total activity without 
household physical activities (METS/wk or mins/wk) (p<0.20).  BMI and weight gaining 
properties for single anti-psychotic medications) were found to be significantly associated 
(p<0.05) with total physical activity excluding household activities (METS/wk and mins/wk) 
(Table 5-22 and 5-23).  Each unit increase in BMI was associated with an approximate decrease 
of 6 mins/wk or 24 METS/wk of physical activity excluding household activities (Table 5-22 and 
5-23). Participants taking a single anti-psychotic medication with weight gaining properties 
reported approximately 113 mins/wk or 471 METS/wk less physical activity excluding 
household activities than those who took a single anti-psychotic medication without weight 
gaining properties (Table 5-22 and 5-23). 
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Table 5-22 Final multivariate linear model predicting total physical activity excluding household 
activities (mins/day) in adults with schizophrenia or schizoaffective disorders (n=202). 
 
Variable β + SE F 
Statistics 
p-value 
BMI (kg/m2) -6.4 + 3.0 4.52 0.03 
Weight gaining properties for single anti-psychotic 
medications 
 
-113.0 + 50.7 
 
4.97 
 
0.03 
Intercept 515.3 + 119.3 NA  
R2 = 4.9% 
 
 
Table 5-23 Final multivariate linear model predicting total physical activity excluding household 
activities (METS/day) in adults with schizophrenia or schizoaffective disorders (n=202). 
 
Variable β + SE F 
Statistics 
p-value 
BMI (kg/m2) -24.2 + 12.4 3.81 0.05 
Weight gaining properties for single anti-psychotic 
medications 
 
-471.3 + 210.1 
 
5.03 
 
0.03 
Intercept 2030.8 + 494.7 NA  
R2 = 4.5% 
 
 
 
 
5.8 LINEAR REGRESSION FOR OBJECTIVE PHYSICAL ACTIVITY 
(ACTIGRAPHY) IN THE WAIST STUDY 
 
5.8.1 Univariate models for objective physical activity (Actigraphy) 
Table 5-24 provides a summary of univariate linear regression models for the objective physical 
activity measures of total activity (counts/day), total activity for light, moderate, and vigorous 
activities (mins/day), and sedentary time (mins/day). Smoking status was significantly associated 
with total activity in counts or minutes (p<0.05) but not sedentary time (p=0.77).  Smokers 
averaged approximately 39,000 more counts per day and 35 minutes/day of physical activity than 
non-smokers. Race only approached statistical significance (p=0.06) for sedentary time/day; 
whites averaging 80 minutes more of sedentary time than black participants.  Neither the 
subjective physical activity (p>0.13) nor fitness (p>0.09) measures were statistically associated 
with the objective activity measures. 
.
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Table 5-24  Univariate linear regression models for objective physical activity measures in the WAIST Study (n=46). 
 Objective Physical Activity (Actigraphy) 
 
 
Independent Variable 
 
Total Activity 
(counts/min) 
Total activity (light, 
moderate, and 
vigorous) (mins/day) 
 
Sedentary 
(mins/day) 
Age (yrs) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-0.74 (0.98) 
0.57 
0.45 
46 
 
0.31 (0.84) 
0.14 
0.71 
46 
 
2.9 (2.1) 
1.93 
0.17 
46 
BMI (kg/m2) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
0.21 (1.19) 
0.03 
0.86 
46 
 
0.35 (1.01) 
0.12 
0.73 
46 
 
-1.58 (2.58) 
0.37 
0.54 
46 
Gender (0=male, 1=female) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-12.6 (19.7) 
0.41 
0.53 
46 
 
14.1 (16.7) 
0.71 
0.40 
46 
 
-1.7 (43.1) 
0.00 
0.97 
46 
Racea (0=White, 1=Black) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
0.17 (19.3)a 
0.00 
0.99 
45 
 
-11.4 (16.4)a 
0.48 
0.49 
45 
 
-79.6 (41.4)a 
3.7 
0.06 
45 
Smoking status (0=no, 1=current) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
32.1 (19.5) 
2.70 
0.11 
46 
 
29.8 (16.4) 
3.27 
0.08 
46 
 
-10.7 (43.7) 
0.06 
0.81 
46 
Anti-Psychotic Medications  
   Polypharmacy (0=no, 1=yes) 
      β (SE) 
      F Statistics 
      p-value 
      n  
 
 
14.3 (8.1) 
3.11 
0.08 
46 
 
 
5.3 (7.1) 
0.55 
0.46 
46 
 
 
-25.9 (17.9) 
2.10 
0.15 
46 
a n=45, excluded other race (n=1) due to insufficient sample size for summary or analyses. 
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Table 5-24 (continued)  Univariate linear regression models for objective physical activity measures in the WAIST Study 
(n=46). 
 
 
 
  
 Objective Physical Activity (Actigraphy) 
 
 
Independent Variable 
 
Total Activity 
(counts/min) 
Total activity (light, 
moderate, and 
vigorous) (mins/day) 
 
Sedentary 
(mins/day) 
Weight gaining properties for single anti-psychotic       
 medications  (0=low/none, 1=yes) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
 
-4.2 (32.1) 
0.02 
0.90 
38 
 
 
-0.001 (0.29) 
0.00 
0.97 
38 
 
 
-0.08 (2.86) 
0.00 
0.98 
39 
Fitness (0=unfit, 1=fit) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-83.9 (61.2)b 
1.88 
0.18 
27 
 
-73.7 (51.2)b 
2.07 
0.16 
27 
 
200.6 (116.7)b 
2.94 
0.10 
27 
Maximal Oxygen Consumption (mL/min/kg) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
0.11 (1.96) 
0.00 
0.95 
27 
 
-0.96 (1.64) 
0.34 
0.56 
27 
 
4.98 (3.69) 
1.82 
0.19 
27 
Subjective Physical Activity (mins/wk) 
   Total       
      β (SE) 
      F Statistics 
      p-value 
      n 
 
 
-1.70 (1.72)c 
0.93 
0.34 
44 
 
 
-1.46 (1.48)c 
0.98 
0.33 
44 
 
 
3.2 (3.9)c 
0.70 
0.41 
44 
   Total Activity (METS/week)/1000 
      β (SE) 
      F Statistics 
      p-value 
      n    
 
3.2 (6.1)c 
0.27 
0.60 
45 
 
-3.47 (5.09)c 
0.47 
0.50 
45 
 
10.3 (13.3)c 
0.60 
0.44 
45 
a n=45, excluded other race (n=1) due to insufficient sample size for summary or analyses. 
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Table 5-24 (continued)  Univariate linear regression models for objective physical activity measures in the WAIST Study 
(n=46). 
 
 
  
 Objective Physical Activity (Actigraphy) 
 
 
Independent Variable 
 
Total Activity 
(counts/min) 
Total activity (light, 
moderate, and 
vigorous) (mins/day) 
 
Sedentary 
(mins/day) 
Total w/o occupational activities (mins/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-1.79 (1.83) 
0.95 
0.33 
45 
 
-1.63 (1.54) 
1.12 
0.30 
45 
 
3.1 (4.0) 
0.59 
0.45 
45 
   Total w/o occupational activities (METS/wk)/1000 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-3.4 (6.4) 
0.28 
0.60 
45 
 
-4.2 (5.4) 
0.61 
0.44 
45 
 
9.5 (13.8) 
  0.47 
0.50 
45 
   Total w/o household activities (mins/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
0.38 (4.84) 
0.01 
0.94 
44 
 
0.42 (4.06) 
0.01 
0.92 
44 
 
13.9 (10.4) 
1.78 
0.19 
44 
   Total w/o household activities (METS/wk)/1000 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
4.9 (12.1) 
0.16 
0.69 
44 
 
3.9 (10.2) 
0.15 
0.70 
44 
 
31.4 (26.2) 
1.43 
0.24 
44 
a n=45, excluded other race (n=1) due to insufficient sample size for summary or analyses. 
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Table 5-25 provides a summary of univariate linear regression models for the objective 
physical activity measures of total activity (counts/day), percentage of time per day engaged in 
light, moderate or vigorous activities, and percentage of sedentary time per day.  Since the 
percentage time of total activity and sedentary time total 100%, the beta coefficients for 
percentage time of total activity and sedentary time are the inverses of each other.  Smoking 
status was significantly associated with the three objective physical activity measures (p<0.07).  
Smokers spent a greater percentage of their day physically active and averaged 35,000 
counts/day more than the non-smokers.  Fitness was positively associated with percentage of 
time engaged in physical activities and percentage of sedentary time (p=0.05).  Subjective 
measures of physical activity (mins/wk or METS/week) were not associated with the percentage 
of time engaged in total activity or percentage of sedentary time (p>0.23) measured objectively. 
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Table 5-25  Univariate linear regression models for the objective physical activity measures of 
total activity (counts/day), percentage of time engaged in total physical activities (%/day), and 
percentage of sedentary time (%/day) (n=46). 
 
  
 Objective Physical Activity (Actigraphy) 
 
 
 
 
 
Independent Variable 
 
 
 
 
 
Total (counts/day) 
Total activity 
(light, moderate, 
and vigorous) 
 (% of monitor-
ing time) 
x 100,000 
 
 
Sedentary  
(% of monitor-
ing time) 
 x 100,000 
Age (yrs) 
   β (SE) 
   F Statistics 
   P 
   n 
 
-17.9 (937.8) 
0.04 
0.85 
46 
 
- 0.03(0.09) 
0.10 
0.75 
46 
 
0.03(0.09) 
0.10 
0.75 
46 
BMI (kg/m2) 
   β (SE) 
   F Statistics 
   P 
   n 
 
225.0 (1130.6) 
0.04 
0.84 
46 
 
0.04(0.10) 
0.11 
0.74 
46 
 
-0.04(0.10) 
0.11 
0.74 
46 
Gender (0=male, 1=female) 
   β (SE) 
   F Statistics 
   P 
   n 
 
-9780.8 (18785.3) 
0.27 
0.61 
46 
 
1.2(1.7) 
0.48 
0.49 
46 
 
-1.2(1.7) 
0.48 
0.49 
46 
Race (0=White, 1=Black) 
   β (SE) 
   F Statistics 
   P 
   n 
 
-13771.2 (18138.0) 
0.58 
0.45 
46 
 
0.42(1.71) 
0.06 
0.81 
46 
 
-0.42(1.71) 
0.06 
0.81 
46 
Smoking status (0=no, 1=current) 
   β (SE) 
   F Statistics 
   P 
   n 
 
27202.3 (18651.0) 
2.13 
0.15 
46 
 
3.3(1.7) 
3.82 
0.06 
46 
 
-3.3(1.7) 
3.82 
0.06 
46 
Anti-Psychotic Medications  
Polypharmacy (0=no, 1=yes) 
   β (SE) 
   F Statistics 
   P 
   n 
 
 
11043.3 (7823.5) 
1.99 
0.17 
46 
 
 
0.89(0.72) 
1.50 
0.23 
46 
 
 
-0.89(0.72) 
1.50 
0.23 
46 
   Weight gaining properties for single anti-psychotic       
 medications  (0=low/none, 1=yes) 
   β (SE) 
   F Statistics 
   P 
   n 
 
 
-20154.9 (29001.8) 
0.48 
0.49 
37 
 
 
82.8(2858.9) 
0.00 
0.98 
38 
 
 
-0.08(2.86) 
0.00 
0.98 
39 
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Table 5-25  (continued) Univariate linear regression models for the objective physical activity 
measures of total activity (counts/day), percentage of time engaged in total physical activities 
(%/day), and percentage of sedentary time (%/day) (n=46). 
  
 Objective Physical Activity (Actigraphy) 
 
 
 
 
 
Independent Variable 
 
 
 
 
 
Total (counts/day) 
Total activity 
(light, moderate, 
and vigorous) 
 (% of monitor-
ing time) 
x 100,000 
 
 
Sedentary  
(% of monitor-
ing time) 
 x 100,000 
Fitness (0=Unfit, 1=Fit) 
   β (SE) 
   F Statistics 
   P 
   n 
 
-66257.0 (64493.4) 
1.06 
0.31 
27 
 
-9.5(4.6) 
4.32 
0.05 
27 
 
9.5(4.6) 
4.32 
0.05 
27 
Maximal Oxygen Consumption (mL/min/kg) 
   β (SE) 
   F Statistics 
   P 
   n 
 
259.4 (2037.6) 
0.02 
0.90 
27 
 
-142.7 (150.6) 
0.90 
0.35 
27 
 
0.14 (0.15) 
0.90 
0.35 
27 
Subjective Physical Activity 
   Total Activity (mins/wk) 
      β (SE) 
      F Statistics 
      P 
      n    
 
 
-13.9 (16.7) 
0.69 
0.41 
44 
 
 
-1.96(153) 
1.64 
0.21 
44 
 
 
1.96(1.53) 
1.64 
0.21 
44 
   Total Activity(METS/wk)/1000 
      β (SE) 
      F Statistics 
      P 
      n    
 
-2.0 (5.7) 
0.13 
0.73 
44 
 
-0.53(0.53) 
1.03 
0.32 
44 
 
0.53(0.53) 
1.03 
0.32 
44 
   Total w/o occupational activities (mins/wk) 
      β (SE) 
      F Statistics 
      P 
      n 
 
-15.6 (17.3) 
0.81 
0.37 
45 
 
-0.20(0.16) 
1.63 
0.21 
45 
 
0.20(0.16) 
1.63 
0.21 
45 
     Total w/o occupational activities (METS/wk)/1000 
      β (SE) 
      F Statistics 
      P 
      n 
 
-2.6 (6.0) 
0.19 
0.67 
45 
 
-0.57(0.56) 
1.05 
0.31 
45 
 
0.57(0.56) 
1.05 
0.31 
45 
   Total w/o household activities (mins/wk) 
      β (SE) 
      F Statistics 
      P 
      n 
 
25.3 (45.5) 
0.31 
0.58 
44 
 
0.25(0.42) 
0.36 
0.55 
44 
 
-0.25(0.42) 
0.36 
0.55 
44 
   Total w/o household activities (METS/wk)/1000 
      β (SE) 
      F Statistics 
      P 
      n 
 
10.0 (11.3) 
0.78 
0.38 
43 
 
0.34(1.06) 
0.10 
0.75 
44 
 
-0.34(1.06) 
0.10 
0.75 
44 
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5.8.2 Multivariate linear regression model-building and models for objective physical 
activity (Actigraphy) 
 
5.8.2.1 Total physical activity (counts per day) measured objectively   Candidates for the 
multivariate model-building process for total physical activity (counts per day) were smoking 
status and polypharmacy medications.  The interaction term (smoker status x polypharmacy 
medication) was significantly associated with total physical activity (counts per day) (p=0.004) 
(Table 5-26).  As depicted in Figure 5-3, smokers were more active than non-smokers regardless 
of the number of medications taken.  In smokers, participants on single medications were more 
active than participants on polypharmacy medications. Among non-smokers, the converse was 
observed i.e. participants on polypharmacy medications were more active than participants on 
single medications. The final multivariate model explained 24.7% of the variance in total 
physical activities (counts per day). 
 
 
Table 5-26  Final multivariate linear model predicting total physical activity (counts/day) in adults with 
schizophrenia or schizoaffective disorders (n=46). 
 
Variable β + SE F Statistics p-value 
Smoker status 
   No (0) 
   Current (1) 
 
Reference 
94096 + 28574 
10.84 0.12 
Polypharmacy Medication 
   Single (0) 
   Two (1) 
 
Reference 
30105 + 9807 
 
9.42 
 
0.19 
Interaction between smoker status x 
polypharmacy medication 
-44246 + 143989 9.44 0.004 
Intercept 99427 + 16987  <0.0001 
R2 = 24.7% 
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Figure 5-3  Interaction between smoking status and medications in the final multivariate linear 
model predicting total physical activity (counts/day) in adults with schizophrenia or 
schizoaffective disorders (n=46). 
 
 
5.8.2.2 Total physical activity (mins/day) measured objectively  Candidates for the 
multivariate model- building process for objective physical activity measured as total activity 
(minutes/day) were smoking status and fitness level (p<0.20).  However, none of these 
candidates or the interaction term were found to be significantly associated with total activity 
(mins/day) (p<0.05). 
Based on the final multivariate model candidates for total physical activity (counts/day),  
another model containing smoking status, polypharmacy medications, and the associated 
interaction term was built for total activity (mins/day).   All of these candidates were 
significantly associated with total activity (mins/day) (p<0.02) (Table 5-27).  The interaction 
term (smoker status x polypharmacy medication) was significantly associated with total physical 
activity (mins/day) (p=0.003) (Table 5-27).  As depicted in Figure 5-4, smokers were more 
active than non-smokers regardless of the number of medications taken.  In smokers, participants 
on single medications were more active than participants on polypharmacy medications. Among 
non-smokers, the converse was observed i.e. participants on polypharmacy medications were 
more active than participants on single medications. The final multivariate model explained 
24.8% of the variance in the minutes per day engaged in physical activities. 
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Table 5-27 Final multivariate linear model predicting total physical activity (mins/day) in adults 
with schizophrenia or schizoaffective disorders (n=46). 
 
Variable β + SE F Statistics p-value 
Smoker status 
   No (0) 
   Current (1) 
 
Reference 
91.9 + 25.5 
13.01 0.0008 
Polypharmacy Medication 
   Single (0) 
   Two (1) 
 
Reference 
22.0 + 8.8 
 
6.34 
 
0.02 
Interaction between smoker status x polypharmacy 
medication 
-39.9 + 12.8 9.67 0.003 
Intercept 99427 + 16987 NA <0.001 
R2 = 24.8% 
 
 
 
 
Figure 5-4  Interaction between smoking status and medications in the final multivariate linear 
model predicting total physical activity (mins/day) in adults with schizophrenia or 
schizoaffective disorders (n=46). 
 
 
5.8.2.3 Percentage of time per day engaged in physical activities measured objectively  
Fitness level was not considered a candidate for the multivariate model because too few 
participants were classified as fit (n=2) and the sample size (n=28) was not adequate to support 
main effects and interaction terms in the multivariate model.   Maximal oxygen consumption, the 
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continuous variable for fitness, was not considered a candidate for the multivariate model 
because its association with percentage of time per day engaged in physical activities was non-
significant (p=0.35).    
Candidates for the multivariate model-building process for percentage of time per day 
engaged in physical activities were smoking status and polypharmacy medications (p<0.23).  The 
interaction term (smoker status x polypharmacy medication) was significantly associated with 
total physical activity (percentage of time per day) (Table 5-28) (p<0.01).  As depicted in Figure 
5-5, smokers engaged in physical activity a greater percentage time than non-smokers regardless 
of the number of medications taken.  In smokers, participants on single medications engaged in 
physical activity a greater percentage time than participants on polypharmacy medications. 
Among non-smokers, the converse was observed i.e. participants on polypharmacy medications 
engaged in physical activity a greater percentage time than participants on single medications.  
The final multivariate model explained 18.0% of the variance in the percentage of time per day 
engaged in physical activities. 
 
 
Table 5-28  Final multivariate linear model predicting percentage time per day engaged in 
physical activity in adults with schizophrenia or schizoaffective disorders (n=46). 
 
Variable β + SE F Statistics p-value 
Smoker status 
   No (0) 
   Current (1) 
 
Reference 
0.07 + 0.03 
7.44 0.009 
Polypharmacy Medication 
   Single (0) 
   Two (1) 
 
Reference 
0.02 + 0.009 
4.49 0.04 
Interaction between smoker status x 
polypharmacy medication 
-0.03 + 0.01 4.08 0.05 
Intercept 0.15 + 0.02  <0.0001 
R2 = 18.0% 
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Figure 5-5  Interaction between smoking status and polypharmacy medications for 
schizophrenia or schizoaffective disorders in the final multivariate linear model predicting 
percentage of time engaged in physical activity in adults with schizophrenia or schizoaffective 
disorders (n=46). 
 
5.8.2.4  Sedentary time (mins/day) measured objectively 
The candidates for multivariate model-building for sedentary time (mins/day) were age, 
race, and fitness level (p<0.20).  In the multivariate model-building process, polypharmacy 
medications and race were significantly associated with sedentary time.  The interaction term 
between race and polypharmacy medications was not significantly associated with sedentary 
time (p=0.66). The final multivariate model for sedentary time (mins/day) is presented in Table 
5-29.  Based on the multivariate linear models, blacks were less sedentary than whites 
(approximately 95 minutes), and participants on polypharmacy medications were less sedentary 
than participants on single medications (approximately 35 minutes).  
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Table 5-29  Final multivariate linear model predicting sedentary time (mins/day) by 
accelerometry in adults with schizophrenia or schizoaffective disorders (n=45). 
 
Variable β + SE F 
Statistics 
p-value 
Polypharmacy Medication a -34.1 + 17.6 3.76 0.06 
Race 
   White 
   Black 
 
Reference 
94.5 + 40.8 
 
 
5.36 
 
 
0.03 
Intercept 958.6 + 77.0  <0.0001 
a dichotomized as 0=single medication or 1= two medications  
R2 = 15.5% 
 
5.8.2.5  Percentage of sedentary time per day measured objectively 
 Candidates for the multivariate model-building process for percentage of sedentary time 
per day were smoking status, and polypharmacy medications (p<0.23). Since percentage of 
sedentary time is the inverse of percentage of total physical activity, the candidates for the 
multivariate models were identical. Fitness level was not considered a candidate for the 
multivariate model because too few participants were classified as fit and the sample size (n=28) 
was not adequate to support main effects and interaction terms in the multivariate model.   The 
interaction term (smoker status x polypharmacy medication) approached statistical significance 
for the percentage of sedentary time per day (Table 5-30) (p<0.13).   The interaction term was 
retained in the multivariate model since it explained 5% more of the variance than the 
multivariate model with only main effects.  As depicted Figure 5-6, smokers were less sedentary 
(more active) than non-smokers regardless of the number of medications taken.  In smokers, 
participants on single medications were less sedentary (more active) than participants on 
polypharmacy medications. Among non-smokers, the converse was observed i.e. participants on 
polypharmacy medications were less sedentary (more active) than participants on single 
medications.  The final multivariate model explained 15.1% of the variance in the percentage of 
sedentary time per day. 
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Table 5-30  Final multivariate linear model predicting percentage of sedentary time per day in 
adults with schizophrenia or schizoaffective disorders (n=46). 
 
 
 
 
 
 
Figure 5-6  Interaction between smoking status and medications in the final multivariate linear 
model predicting percentage of sedentary time per day in adults with schizophrenia or 
Schizoaffective disorders (n=46). 
 
 
 
 
 
 
 
 
 
 
Variable β + SE F 
Statistics 
p-value 
Smoker status 
   No (0) 
   Current (1) 
 
Reference 
-7.0 + 1.6 
6.59 0.01 
Polypharmacy Medication 
 Single (0) 
 Two (1) 
 
Reference 
-1.2 + 0.9 
1.82 0.18 
Interaction between smoker status x polypharmacy 
medication 
2.1 + 1.4 2.33 0.13 
Intercept 84.1 + 1.6  <0.0001 
R2 = 15.1% 
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5.9. LINEAR REGRESSION FOR POSITIVE AND NEGATIVE SYNDROME SCALE 
(PANSS) AND GLOBAL ASSESSMENT OF FUNCTIONING (GAF) IN THE WAIST 
STUDY 
 
5.9.1 Positive and Negative Syndrome Scale (PANSS) 
 
5.9.1.1  Univariate linear regression models for Positive and Negative Syndrome Scale 
(PANSS)  Age was significantly associated with psychiatric symptoms as measured by the 
PANSS (Table 5-31).  Age exhibited a linear relationship with the PANSS total scores meaning 
that older participants were more likely to have higher PANSS scores or experience more 
psychiatric symptoms than younger participants. Gender, race, smoking status and polypharmacy 
medications were not associated with the PANSS score in this sample (p>0.21).  None of the 
objective measures of physical activity or fitness levels were associated with PANSS scores 
(p>0.58).  The majority of the subjective physical activity measures (METS/week or mins/wk) 
either approached statistical significance or were significantly associated with the PANSS total 
scores.   
 
Table 5-31  Univariate linear regression for Positive and Negative Syndrome Scale (PANSS) 
and Global Assessment of Functioning (GAF) in the WAIST Study. 
 
 
 
 
 
 
Independent Variable 
Positive and 
Negative 
Syndrome 
Scale (PANSS)  
x 100 
(n=258) 
 
Global 
Assessment of 
Functioning 
(GAF) x 100 
(n=231) 
Age (yrs) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
16.6 (7.0) 
5.71 
0.02 
258 
 
-8.8 (4.9) 
3.19 
0.08 
231 
BMI (kg/m2) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
13.0 (9.2) 
2.00 
0.16 
258 
 
-4.3 (6.2) 
0.48 
0.49 
231 
Gender (0=male, 1=female) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
102.0 (153.3) 
0.44 
0.51 
258 
 
-104.9 (103.5) 
1.03 
0.31 
231 
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Table 5-31 (continued)  Univariate linear regression for Positive and Negative Syndrome Scale 
(PANSS) and Global Assessment of Functioning (GAF) in the WAIST Study. 
 
  
 
 
 
 
 
Independent Variable 
Positive and 
Negative 
Syndrome 
Scale (PANSS)  
x 100 
(n=258) 
 
Global 
Assessment of 
Functioning 
(GAF) x 100 
(n=231) 
Race (0=White, 1=Black) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
76.4 (148.8) 
0.26 
0.61 
252 
 
-187.0 (100.3) 
3.47 
0.06 
226 
Smoking status (0=no, 1=current) 
   β (SE) 
   F Statistics 
   p-value 
   n  
 
-186.0 (147.5) 
1.59 
0.21 
258 
 
62.7 (100.3) 
0.39 
0.53 
231 
Anti-Psychotic Medications Polypharmacy (0=no, 1=yes) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
55.2 (64.5) 
0.73 
0.39 
258 
 
-21.1 (44.7) 
0.22 
0.64 
231 
Weight gaining properties for single anti-psychotic medications  
(0=low/none, 1=yes) 
     β (SE) 
     F Statistics 
     p-value 
     n 
 
 
139.8 (189.0) 
0.55 
0.46 
213 
 
 
-216.3 (124.1) 
3.04 
0.08 
193 
Maximal oxygen consumption (mL/min/kg) 
   β (SE) 
   F Statistics 
   p-value 
   n 
 
-20.1 (1.95) 
1.06 
0.31 
109 
 
18.1 (12.6) 
2.06 
0.15 
99 
Objective physical activity 
   (Activity counts/day)/100 
     β (SE) 
      F Statistics 
      p-value 
      n 
 
 
-2.1(3.7) 
0.32 
0.58 
48 
 
 
-0.37(1.98) 
0.03 
0.85 
46 
   Activity counts/minute 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-1.5 (3.5) 
0.19 
0.67 
48 
 
-0.95 (1.87) 
0.26 
0.61 
46 
   Total activity (light, moderate and vigorous) (mins/day) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-2.1(4.2) 
0.26 
0.61 
48 
 
-1.7(2.2) 
0.59 
0.44 
46 
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Table 5-31 (continued)  Univariate linear regression for Positive and Negative Syndrome Scale 
(PANSS) and Global Assessment of Functioning (GAF) in the WAIST Study. 
 
 
 
 
 
 
Independent Variable 
Positive and 
Negative 
Syndrome 
Scale (PANSS)  
x 100 
(n=258) 
 
Global 
Assessment of 
Functioning 
(GAF) x 100 
(n=231) 
   Total activity (light, moderate and vigorous) (% of monitoring time) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-15.7(40.7) 
0.15 
0.70 
48 
 
-24.7(21.2) 
1.37 
0.25 
46 
   Sedentary (mins/day) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-0.18(1.7) 
0.01 
0.92 
48 
 
0.66(0.89) 
0.55 
0.46 
46 
Sedentary (% of monitoring time) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
15.7(40.7) 
0.15 
0.70 
48 
 
0.02(0.02) 
1.37 
0.25 
46 
Subjective Physical Activity (modified MAQ) 
   Total Activity (mins/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
 
20.1 (11.1) 
3.29 
0.07 
243 
 
 
18.2 (7.3) 
6.26 
0.01 
217 
   Total Activity (METS/week)/1000 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
45.1 (35.9) 
1.58 
0.21 
243 
 
60.3 (24.2) 
6.21 
0.03 
217 
   Total w/o occupational activities (mins/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
30.3 (11.7) 
6.71 
0.01 
250 
 
16.5 (7.9) 
4.37 
0.04 
224 
   Total w/o occupational activities (METS/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
89.5 (39.9) 
5.04 
0.03 
250 
 
59.7 (27.8) 
4.62 
0.03 
224 
   Total w/o household physical activities (mins/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-37.9 (25.6) 
2.18 
0.14 
243 
 
40.1 (17.3) 
5.39 
0.02 
217 
Total w/o household physical activities (METS/wk) 
      β (SE) 
      F Statistics 
      p-value 
      n 
 
-95.3 (62.1) 
2.36 
0.13 
243 
 
94.4 (42.6) 
4.91 
0.03 
217 
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5.9.1.2  Multivariate linear regression models for Positive and Negative Syndrome Scale 
(PANSS)  Candidates for multivariate model-building process for PANSS were age, BMI, and 
several of the subjective measures of physical activity (p<0.20).  Since the subjective measures 
of physical activity were correlated, total activity (mins/wk) was selected as the candidate for the 
multivariate model.  All three variables (age, BMI, and total activity) were in the final 
multivariate model for PANSS (Table 5-32).  No biologically feasible interactions were 
significant in the model building process.  
In the final multivariate model, age exhibited a positive linear relationship with 
psychiatric symptoms; older participants were rated with more severe psychiatric symptoms than 
younger participants.   Also, BMI exhibited a positive linear relationship with psychiatric 
symptoms; participants with greater BMI were rated with more severe psychiatric symptoms 
than leaner participants.  Finally, those participants with greater total physical activity (mins/wk) 
were rated with more severe psychiatric symptoms than those participants with lower physical 
activity levels.  The final multivariate model (Table 5-32) explained 5.5% the variance of 
PANSS. 
 
 
Table 5-32  Final multivariate linear model predicting Positive and Negative Psychiatric 
Symptoms (PANSS) in adults with schizophrenia or schizoaffective disorders (n=250). 
 
Variable β + SE F 
Statistics 
p-value 
Age (yrs) 0.18 + 0.07 6.33 0.01 
BMI 0.16 + 0.09 2.78 0.10 
Subjective total physical activity (mins/wk) 0.29 + 0.12 6.23 0.01 
Intercept 39.8 + 5.4   
R2 =5.5 % 
 
5.9.2 Linear Regression for Global Assessment of Functioning (GAF) in the WAIST Study 
 
5.9.2.1 Univariate linear regression models for Global Assessment of Functioning (GAF) 
 
Age approached statistical significance association with function as measured by the GAF (Table 
5-31).  Age exhibited a negative linear relationship with the GAF total scores meaning that older 
participants were more likely to have lower GAF scores or more functional impairments. In 
addition, race approached statistical significance (p=0.06) with function; black participants 
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having more functional impairments than white participants.  Gender, BMI, smoking status and 
polypharmacy medications were not associated with functioning in this sample (p>0.24).  None 
of the objective measures of physical activity or fitness levels (continuous and categorical 
variables) were associated with function (p>0.25).  All of the subjective physical activity 
measures (METS/wk or mins/wk) were significantly associated with the function scores 
(p<0.05). Specifically, those participants with greater total physical activity were rated with less 
functional impairments than those participants with lower physical activity levels. 
 
5.9.2.2 Multivariate linear regression model for Global Assessment of Functioning (GAF) 
Candidates for multivariate model for GAF were age, race, weight gaining properties for single 
anti-psychotic medications, and all of the subjective measures of physical activity (METS/week 
as well as mins/wk) (p<0.20).  Due to the high correlations between the subjective measures of 
physical activity, total subjective physical activity (mins/wk) was selected as the candidate for 
the multivariate model.  Separate multivariate models were built for 1) the MAQ cohort (n=212) 
and 2) MAQ cohort participants taking single anti-psychotic medications only (n=179).  Weight 
gaining properties for single anti-psychotic medications was not considered a candidate for the 
multivariate model for the MAQ cohort (n=212). 
For the MAQ cohort (n=212), all three variables (age, race, and total subjective physical 
activity (mins/wk)) as well as race by age interaction term were predictors in the final 
multivariate model for GAF (Table 5-33).  Among black participants, functioning improved with 
age (Figure 5-7).  In contrast, functioning declined with age among the white participants (Figure 
5-7).   On average, greater functional impairments were found among participants whom 
reported low levels of physical activity.  Conversely, fewer functional impairments were 
observed among participants whom reported higher levels of physical activity. Overall, the final 
multivariate model (Table 5-33) explained 11% of the variance of GAF.   
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Table 5-33  Final multivariate linear model predicting global functioning (GAF) in adults with 
schizophrenia or schizoaffective disorders (n=212). 
 
Variable β + SE F Statistics p-value 
Age (years) -0.58 + 0.15 14.65 0.0002 
Race (0=white, 1=black) -17.4 + 4.9 12.41 0.0005 
Age x Race Interaction 0.35 + 0.11 10.95 0.001 
Subjective total physical activity (mins/wk) 0.19 + 0.07 7.42 0.007 
Intercept 86.2 + 67.0  <0.0001 
R2 = 10.5% 
 
 
 
 
 
Figure 5-7  Interaction between race and age in the final multivariate linear model predicting 
global functioning (GAF) in adults with schizophrenia or schizoaffective disorders (n=212). 
 
 
 
For the MAQ cohort taking single anti-psychotic medications only (n=179), all four 
variables (age, race, weight gaining properties for single anti-psychotic medications, and total 
subjective physical activity (mins/wk)) as well as race by age interaction term were predictors in 
the final multivariate model for GAF (Table 5-34).  On average, greater functional impairments 
were found among participants whom single anti-psychotic medication was associated with  
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weight gain.  In this subsample, the relationships between age, race and total subjective physical 
activity with GAF were similar to the model presented in Table 5-33.  Overall, the final 
multivariate model (Table 5-34) explained 14% of the variance of GAF.   
 
 
Table 5-34  Final multivariate linear model predicting global functioning (GAF) in adults with 
schizophrenia or schizoaffective disorders for participants taking a single anti-psychotic 
medication (n=179). 
 
 
Variable β + SE F Statistics p-value 
Age (years) -0.48 + 0.16 14.65 0.003 
Race (0=white, 1=black) -17.0 + 5.2 12.41 0.001 
Age x Race Interaction 0.31 + 0.11 10.95 0.006 
Subjective total physical activity (mins/wk) 0.002 + 0.0007 7.42 0.02 
Weight gaining properties for single anti-
psychotic medication   
(0=low/none, 1=yes) 
-2.8 + 1.2 5.16 0.02 
Intercept 86.7 + 7.4   
R2 = 13.6% 
 
 
 
5.10 LOGISTIC REGRESSION FOR CLINICAL GLOBAL IMPRESSION OF 
SEVERITY (CGIS) AND GENERAL HEALTH STATUS (SF12) IN THE WAIST STUDY 
 
5.10.1 Logistic regression for Clinical Global Impression of Severity (CGIS) 
 
5.10.1.1  Univariate logistic regression models for Clinical Global Impression of Severity 
(CGIS)  In the univariate and multivariate models for CGIS, age was modeled as a binary 
variable as indicated by testing the assumption of linearity in the logit.  Specifically, the plot of 
the estimated coefficients versus the age midpoints of each age group suggested a dichotomous 
variable with the youngest tertile being the reference group (18-39 years) compared to the 2 
older tertiles (18-65 years).  Older adults with schizophrenia or schizoaffective disorders were 
2.6 times more likely to have severe versus mild psychiatric symptoms than the younger adults 
with schizophrenia and schizoaffective disorders based on the univariate models (Table 5-35).   
In the univariate and multivariate models, BMI was modeled as a binary variable as 
indicated by testing the assumption of linearity in the logit.  Specifically, the plot of the 
estimated coefficients versus the BMI midpoints of each BMI category suggested a dichotomous 
variable with the overweight group being the reference group (27- 30 kg/m2) compared to the 
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obese and extremely obese groups (> 30 kg/m2).  Obese or extremely obese adults with 
schizophrenia or schizoaffective disorders were 2.0 times more likely to have severe versus mild 
psychiatric symptoms than the overweight adults with schizophrenia and schizoaffective 
disorders (Table 5-35).   
Race was significantly associated with the severity of psychiatric symptoms (p=0.04). 
Specifically, black adults with schizophrenia and schizoaffective disorders were almost twice as 
likely to have severe versus mild psychiatric symptoms than white adults with schizophrenia and 
schizoaffective disorders (Table 5-35).   
Gender approached being statistically significantly associated with the severity of 
psychiatric symptoms (p=0.07). Specifically, female adults with schizophrenia and 
schizoaffective disorders were almost twice as likely to have severe versus mild psychiatric 
symptoms than male adults with schizophrenia and schizoaffective disorders (Table 5-35).  
Severity of psychiatric symptoms was significantly associated with the weight gaining 
properties of the single anti-psychotic medications (p<0.05) (Table 5-35).  Participants taking 
single anti-psychotic medications with weight gaining properties were more than twice as likely 
to have severe versus mild psychiatric symptoms than participants not taking single anti-
psychotic medications with weight gaining properties (Table 5-35). No statistically significant or 
clinical meaningful associations were observed between severity of psychiatric symptoms and 
smoking status, and polypharmacy medications (p>0.30) (Table 5-35). 
None of the objective measures of physical activity or fitness measures were predictive of 
severity of psychiatric symptoms among adults with schizophrenia or schizoaffective disorders 
(p>0.24). Only one subjective measure of physical activity (total physical activity excluding 
household physical activities in METS/wk or mins/wk) was significantly associated with severity 
of psychiatric symptoms (p=0.02).  Total physical activity excluding household activity was 
protective against psychiatric symptoms i.e. the more active participants generally experienced 
less severe psychiatric symptoms than the less active participants. 
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Table 5-35  Odds ratio and 95% CI based on univariate logistic regression models for Clinical 
Global Impression of Severity (CGIS)a  in the WAIST Study. 
 
 
 
Independent Variable 
CGIS a 
 (n=229) 
Odds ratio (95% CI) 
Age Categories 
   18-39 years 
   40-65 years 
p-value  
 
1.0 (reference) 
2.6 (1.4, 4.9) 
0.002 
BMI Categories  
   Overweight  
   Obese or Extremely Obese 
p-value 
 
1.0 (reference) 
1.96 (0.87, 4.44) 
0.10 
Gender 
   Female 
   Male 
p-value 
 
1.65 (0.95, 2.84) 
1.0 (reference) 
0.07 
Race 
   White 
   Black 
p-value 
 
1.0 (reference) 
1.76 (1.03, 3.01) 
0.04 
Current smoking status 
   Non-smoker 
   Smoker 
 p-value 
 
1.0 (reference) 
0.94 (0.55, 1.59) 
0.81 
Anti-psychotic Medications  
    Polypharmacy  
       No 
      Yes  
 p-value 
  
     Weight gaining properties for single anti-psychotic medications  
 (0=low/none, 1=yes)(n=191) 
       None/low 
       Yes  
 p-value 
 
      Weight gaining properties for single anti-psychotic medications (n=191) 
      None/low (Aripiprazole and Ziprasidone) 
       Moderate  (Quetiapine, Risperidone, and Haloperidol)  
       High (Clozapine and Olanzapine) 
 p-value 
 
 
1.0 (reference) 
1.14 (0.89,1.44) 
0.30 
 
 
 
1.0 (reference) 
2.28 (1.13, 4.61) 
0.02 
 
 
1.0 (reference) 
3.56 (1.64, 7.74) 
1.35 (0.62, 2.98) 
0.002 
Maximal oxygen consumption (mL/kg/min)(n=99) 0.97 (0.91, 1.04) 
0.36 
a Coded as mild (0=not ill, very mild, or mild illness) (reference group)or severe (1=moderate, severe, and 
extremely severe illness). 
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Table 5-35  (continued)  Odds ratio and 95% CI based on univariate logistic regression models 
for Clinical Global Impression of Severity (CGIS)a  in the WAIST Study. 
 
 
 
Independent Variable 
CGIS a 
 (n=229) 
Odds ratio (95% CI) 
Objective Physical Activity 
   Activity counts/day/1000 
 p-value 
   Activity counts/minute 
 p-value 
   Total activity (light, moderate and vigorous) (mins/day) 
 p-value  
   Total activity (light, moderate and vigorous) (% of monitoring time)  x 100 
 p-value 
   Sedentary (mins/day) 
 p-value 
   Sedentary (% of monitoring time) x 100 
 p-value 
 
1.002 (0.99,1.01) 
0.63 
1.00 (0.99, 1.01) 
0.52 
1.006 (0.995, 1.017) 
0.31 
1.07 (0.96, 1.19) 
0.24 
1.0 (1.0,1.003) 
0.68 
0.94 (0.84, 1.05) 
0.24 
Subjective Physical Activity (MAQ) 
   Total Activity (mins/wk) 
 p-value 
   Total Activity (METS/wk) 
 p-value 
   Total  w/o occupational activities (mins/wk) 
 p-value 
   Total w/o occupational activities (METS/wk) 
 p-value 
   Total w/o household physical activities (mins/wk) 
    p-value   
   Total w/o household physical activities (METS/wk) 
 p-value 
 
0.98 (0.94, 1.02) 
0.23 
0.91 (0.79, 1.03) 
0.14 
0.99 (0.95, 1.03) 
0.70 
0.96 (0.83, 1.11) 
0.62 
0.87 (0.78, 0.98) 
0.02 
0.72 (0.54, 0.95) 
0.02 
a Coded as mild (0=not ill, very mild, or mild illness) (reference group)or severe (1=moderate, severe, and 
extremely severe illness). 
 
 
5.10.1.2 Multivariate logistic regression model for Clinical Global Impression of Severity 
(CGIS) 
Candidates for the multivariate logistic model for CGIS were age categories, BMI 
categories, race, gender and total physical activity without household activities (METS/week) 
(p<0.20). These five main effects were included in the multivariate model and backwards step-
wise elimination of non-significant main effects was conducted using a p-value cutoff of 0.20.  
In the backwards step-wise elimination process, race (p=0.46, data not shown) was removed first 
followed by gender (p=0.28, data not shown).  The remaining 3 variables were associated with 
the severity of psychiatric symptoms (p<0.10).  None of the interaction terms between age 
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categories, BMI categories and total physical activity without household activities (METS/week) 
were significant (p>0.20, data not shown).   
The final predictive logistic model for CGIS contained age and BMI categories and total 
physical activity without household activities (METS/week) (Table 5-36).  The odds of severe 
psychiatric symptoms increased 2-fold for obese and extremely obese adults with schizophrenia 
and schizoaffective disorders compared to overweight adults with schizophrenia and 
schizoaffective disorders.  Older adults with schizophrenia and schizoaffective disorders had an 
approximately 3 times greater likelihood of severe psychiatric symptoms than the younger adults 
with schizophrenia or schizoaffective disorders.  Finally, adults with schizophrenia or 
schizoaffective disorder that self-reported more occupational and leisure activities had a lower 
likelihood of severe psychiatric symptoms than adults that self-reported less occupational and 
leisure activities.  In other words, occupational and leisure physical activities were protective 
against severe psychiatric symptoms. 
 
 
Table 5-36  Final logistic model predicting Clinical Global Impression of Severity (CGIS) a in 
adults with schizophrenia or schizoaffective disorders (n=215). 
 
 
Variable 
 
β + SE 
Wald Chi-
Square 
 
p-value 
Odds Ratio 
(95% CI) 
Age Category 
   18-39 years 
   40-65 years 
 
Reference 
0.52 + 0.17 
 
-- 
9.5 
 
-- 
0.002 
 
1.00 
2.82 (1.46, 5.45) 
BMI Categories 
   Overweight 
   Obese or Extremely  Obese  
 
Reference 
0.37  + 0.23 
 
-- 
2.6 
 
-- 
0.10 
 
1.00 
2.11 (0.86, 5.20) 
Subjective physical activity w/o 
household activities 
(METS/week)/1000 
 
-0.31 + 0.14 
 
4.7 
 
0.03 
 
0.73 (0.55, 0.97) 
Intercept -0.08 + 0.27  0.001 NA 
a Coded as mild (0=not ill, very mild, or mild illness) (reference group)or severe (1=moderate, severe, 
and extremely severe illness) 
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For the MAQ cohort taking single anti-psychotic medications only (n=181), the 
predictors of severity of psychiatric symptoms were age, weight gaining properties of single anti-
psychotic medications, and total subjective physical activity (mins/wk)(Table 5-37).  On average, 
greater severity of psychiatric symptoms were found among participants whom single anti-
psychotic medication was associated with weight gain.  In this subsample, the relationships 
between age and total subjective physical activity with CGIS were similar to the model presented 
in Table 5-37.   
 
 
Table 5-37  Final logistic model predicting Clinical Global Impression of Severity (CGIS) a in 
adults with schizophrenia or schizoaffective disorders for participants taking a single anti-
psychotic medication (n=181). 
 
 
Variable 
 
β + SE 
Wald Chi-
Square 
 
p-value 
Odds Ratio 
(95% CI) 
Age Category 
   18-39 years 
   40-65 years 
 
Reference 
0.90 + 0.36 
 
-- 
6.2 
 
-- 
0.01 
 
1.00 
2.45 (1.21, 4.99) 
Weight gaining properties of single 
anti-psychotic medications 
 No 
 Yes  
 
 
Reference 
0.76  + 0.38 
 
 
-- 
3.9 
 
 
-- 
0.05 
 
 
1.00 
2.14 (1.01, 4.54) 
Subjective physical activity w/o 
household activities 
(METS/week)/1000 
 
-0.31 + 0.16 
 
4.0 
 
0.05 
 
0.73 (0.54, 1.00) 
Intercept -0.88 + 0.46 3.6 0.06 NA 
a Coded as mild (0=not ill, very mild, or mild illness) (reference group)or severe (1=moderate, severe, 
and extremely severe illness) 
 
 
5.10.2 Logistic regression for General Health Status (SF12) 
 
5.10.2.1 Univariate logistic models for General Health Status (SF12)  Only BMI was 
significantly associated with health status (p<0.01) (Table 5-38).  The odds of poor health status 
increased 5% for every unit increase in BMI.  In other words, more obese participants were at 
greater risk of poor health status than less obese participants.  Race (p=0.11), medications with 
weight gaining properties (p=0.15) and age categories (p=0.20) approached statistical significant 
associations with general health status.  Black participants tended to be at higher odds of poorer  
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health than white participants (approximately 50% increase in risk).  No associations were 
observed between gender, smoking status, and polypharmacy medications and general health 
status (p> 0.42). 
None of the fitness or objective measures of physical activity was predictive of general 
health status among adults with schizophrenia or schizoaffective disorders.  Only total physical 
activity excluding occupational activities was significantly associated with general health status 
(p=0.05).  Specifically, leisure and household activities were protective against poor health 
status.  Neither total physical activity (p=0.12) nor total physical activity excluding household 
activities (p=0.31) (mins/wk or METS/wk) were significantly associated with general health 
status. 
 
Table 5-38  Odds ratio and 95% CI based on univariate logistic regression models for General 
Health Status (SF12)a in the WAIST Study (n=247). 
 
 
 
 
Independent Variable 
General Health Status 
(SF12)a 
(n=247) 
Odds Ratio (95% CI) 
Age Categories 
   18-39 years 
   40-49 years 
   50-65 years 
p-value 
 
1.77 (0.94, 3.33) 
1.29 (0.72, 2.33) 
1.0 (reference) 
0.20 
BMI (kg/m2) 
p-value 
1.05 (1.01, 1.09) 
0.006 
BMI Categories  
   Overweight  
   Obese  
   Extremely Obese 
p-value 
 
0.63 (0.27, 1.45) 
0.65 (0.37, 1.14) 
1.0 (reference) 
0.29 
Gender 
   Female 
   Male 
p-value 
 
0.81 (0.48, 1.36) 
1.0 (reference) 
0.42 
Race 
   White 
   Black 
p-value 
 
1.0 (reference) 
1.51 (0.91, 2.51) 
0.11 
Current smoking status 
   Non-smoker 
   Smoker 
p-value 
 
1.0 (reference) 
1.10 (0.67,1.82)) 
0.71 
a dichotomized as 0=good, very good, and excellent (reference group) or 1= fair or poor. 
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Table 5-38  (continued)  Odds ratio and 95% CI based on univariate logistic regression models 
for General Health Status (SF12)a in the WAIST Study (n=247). 
 
 
 
 
Independent Variable 
General Health Status 
(SF12)a 
(n=247) 
Odds Ratio (95% CI) 
Anti-psychotic medications  
    Polypharmacy  
      No 
      Yes  
 p-value 
 
1.0 (reference) 
0.98 (0.78,1.22) 
0.84 
 
Weight gaining properties for single anti-psychotic  medications 
(0=low/none, 1=yes)(n=206) 
      None/low 
       Yes  
 p-value   
 
 
1.0 (reference) 
0.90 (0.47, 1.73) 
0.76 
Weight gaining properties for single anti-psychotic medications (n=206) 
       None/low (Aripiprazole and Ziprasidone) 
       Moderate  (Quetiapine, Risperidone, and Haloperidol)  
       High  (Clozapine and Olanzapine) 
 p-value 
 
1.0 (reference) 
1.28 (0.63, 2.60) 
0.57 (0.27, 1.20) 
0.05 
Maximal Oxygen Consumption (mL/kg/min) 
p-value 
1.02 (0.96, 1.09) 
0.58 
Objective Physical Activity 
   Activity counts/day/1000 
   p-value 
   Activity counts/minute 
 p-value 
   Total activity (light, moderate and vigorous) (mins/day) 
 p-value 
   Total activity (light, moderate and vigorous)  (% of monitoring time) x 
 100 
 p-value  
   Sedentary (mins/day) 
 p-value 
   Sedentary (% of monitoring time) x 100 
 p-value 
 
1.00 (1.0,1.0) 
0.28 
1.003 (0.994,1.011) 
0.56 
1.003 (0.99, 1.014) 
0.53 
 
1.06 (0.95, 1.18) 
0.28 
1.00 (0.99, 1.00) 
0.41 
0.94 (0.85, 1.05) 
0.28 
Subjective Physical Activity (modified MAQ) 
   Total Activity (mins/wk) 
 p-value 
   Total Activity (METS/wk) 
 p-value 
   Total w/o occupational activities (mins/wk) 
 p-value 
   Total w/o occupational activities (METS/wk) 
 p-value  
   Total w/o household physical activities (mins/wk) 
 p-value  
  Total w/o household physical activities (METS/wk) 
 p-value  
 
0.97 (0.93, 1.01) 
0.12 
0.92 (0.81, 1.04) 
0.17 
0.96 (0.91, 0.99) 
0.05 
0.86 (0.74, 1.00) 
0.05 
0.95 (0.87, 1.05) 
0.31 
0.89 (0.71, 1.11) 
0.30 
a dichotomized as 0=good, very good, and excellent (reference group) or 1= fair or poor. 
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5.10.2.2 Multivariate logistic regression model for General Health Status (SF12)  
Candidates for the multivariate logistic model for SF12 were age categories, race, BMI, 
and total physical activity without occupational activities (METS/week) (p<0.20).  These four 
main effects were included in the multivariate model and backwards step-wise elimination of 
non-significant main effects was conducted using a cutoff of 0.20 for the p-value.   In the 
backwards step-wise elimination process, age categories were removed first (p=0.41, data not 
shown), followed by race (p=0.19, data not shown) and finally total physical activity without 
occupational activities (METS/week) (p=0.06). The final predictive multivariate model for SF12 
contained only BMI (p=0.01) (Table 5-39). The odds of fair or poor self-reported health status 
increased 62% for every 10 kg/m2 increase in BMI among adults with schizophrenia and 
schizoaffective disorders.   
 
 
Table 5-39  Final multivariate logistic model predicting SF12a in adults with schizophrenia or 
schizoaffective disorders. 
 
 
Variable 
 
β + SE 
Wald  
Chi-Square 
 
p-value 
Odds Ratio  
(95% CI) 
BMI (kg/m2) b 0.48 + 0.18 7.54 0.006 1.62 (1.15, 2.29) 
Intercept -1.92 + 0.68 8.05 0.005 NA 
a dichotomized as 0=good, very good, and excellent (reference group) or 1= fair 
or poor  
b BMI modeled as BMI/10 
 
 
 
5.11 SUMMARY 
 
A summary of the significant predictors for psychiatric symptoms (PANSS and CGI-S), 
function, and general health status is provided in Table 5-40.  Age and BMI were predictors in 
three of the four outcomes.  Only subjective measures of physical activity and not objective 
measures of physical activity or fitness were significant predictors in the regression models. 
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Table 5-40. Summary of significant predictors of psychiatric symptoms, function and general 
health status in the WAIST Study 
 
 Outcomes for regression models 
 
 
 
 
 
Predictors 
Positive 
and 
Negative 
Syndrome 
Scale 
(PANSS) 
 
Clinical 
Global 
Impression 
of Severity  
(CGIS) 
 
Global 
Assessment 
of 
Functioning 
(GAF) 
 
 
General 
Health  
Status  
(SF12) 
Age X X X  
Race   X  
Age x race interaction   X  
BMI X X  X 
Subjective total physical activity (mins/wk)   X  
Subjective physical activity w/o occupational 
(mins/wk) 
X    
Subjective physical activity w/o occupational 
(METS/wk) 
  
 
 X 
Subjective physical activity w/o household 
(METS/wk) 
 X   
 
 
 
A summary of the significant predictors for subjective and objective measures of physical 
activity is provided in Table 5-41.  Gender was the only significant predictor for the various 
subjective measures of physical activity, and the physical activity differences were attributed to 
household activities.  Smoking status and polypharmacy medications were the primary 
significant predictors of objective measures of physical activity and sedentary time. 
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Table 5-41.  Summary of significant predictors of subjective and objective measures of physical 
activity in the WAIST Study 
 
 
 
 
Outcome 
 
 
 
Gender 
 
 
Smoking 
Status 
 
Poly- 
pharmacy 
Medications 
Smoking Status 
x Polypharmacy 
Medications 
Interaction 
 
 
 
Race 
 
No 
significant 
predictors 
Subjective total physical 
activity (mins/wk) 
X      
Subjective total physical 
activity (METS/wk) 
     X 
Subjective physical activity 
w/o occupational (mins/wk) 
X      
Subjective physical activity 
w/o occupational (METS/wk) 
X      
Subjective physical activity 
w/o household (mins/wk) 
     X 
Subjective physical activity 
w/o household (METS/wk) 
     X 
Objective physical activity 
(counts/day) 
 X X X   
Objective total physical 
activity (mins/day) 
 X X X   
Objective total physical 
activity (% time/day) 
 X X X   
Objective sedentary time 
(mins/day) 
  X  X  
Objective sedentary time  
(% time/day) 
 X X X   
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6.0 DISCUSSION 
6.1 PHYSICAL ACTIVITY OF ADULTS WITH SCHIZOPHRENIA AND 
SCHIZOAFFECTIVE DISORDERS 
 
6.1.1 WAIST Study 
Overall, the present study found that overweight and obese adults with schizophrenia and 
schizoaffective disorders were sedentary based on a comprehensive profile of physical activity.  
Regardless if measured subjectively or objectively, physical activity was consistently limited and 
classified as sedentary or light physical activity among overweight and obese adults with 
schizophrenia and schizoaffective disorders.  In addition, less than 2% (2/105) participants were 
classified as fit based on ACSM guidelines (83).   As expected, adults with schizophrenia and 
schizoaffective disorders primarily engaged in unstructured, intermittent, and low-intensity 
activity such as walking and housework.  Occupational physical activities were extremely 
limited due to the low employment rate among the participants.  
 
6.1.2 Findings from published studies compared to the WAIST Study 
 
Regardless of the survey instrument, self-reported physical activity by adults with schizophrenia 
or schizoaffective disorders were similar in prior studies (15, 18, 47, 49, 52, 85) compared to the 
WAIST Study.  Generally, these previous studies found that adults with schizophrenia or 
schizoaffective disorders were inactive (15, 18, 52, 85), less active than controls (18, 85) or 
national populations (15), and few achieved national guidelines for recommended levels of 
physical activity (47, 51) or participated in vigorous or strenuous physical activity (15, 18, 47, 
49, 52, 85).  Direct comparisons of physical activity levels across studies is difficult because of 
the variety of physical activity instruments used in the studies (IPAQ, modified MAQ, YPAS, 
Godin) as well as the different definitions for physical activity and their corresponding physical 
activity scores for each physical activity instrument.  However, the findings highlight that the 
vast majority of adults with schizophrenia or schizoaffective disorders engaged in light to low-
moderate physical activities such as walking (15, 49, 50, 52, 56, 85).  In addition, the studies 
suggest the possibility of regional differences in physical activity levels among adults with 
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schizophrenia or schizoaffective disorders i.e. a greater percentage of Australians may engage in 
walking, moderate and vigorous activities (approximately 60%) (55) and achieve national 
recommended guidelines for physical activity (49%) (50) than North Americans (less than 20% 
across studies) (15, 47, 49, 51, 52, 56, 85). 
 Comparisons with previous studies that have objectively measured physical activity in 
adults with schizophrenia or schizoaffective disorders is challenging because half of the studies 
did not report the actigraphy data (59, 86) or define the actigraphy measures (17, 19).  Although 
the actigraphy measures were not defined, the results by Gothelf (17) and McKibbin (19) 
approximate the findings from the WAIST Study.  Gothelf and associates (17) approximate that 
4% of the monitoring time was active in male, inpatient adolescents with schizophrenia 
compared to 2% of the monitoring time in adult outpatients with schizophrenia or schizoaffective 
disorder in the WAIST Study.  McKibbin and associates (19) reported that diabetic adults with 
schizophrenia or schizoaffective disorder averaged 23 minutes/day of moderate- vigorous 
activity similar to the 19 minutes/day of moderate-vigorous activity in the WAIST Study 
participants. 
However, two well-designed and reported actigraphy studies (18, 20) found physical 
activity to be greater in their samples compared to the WAIST Study.  In the first study, the 
assessment of physical activity in middle-aged and older adults with schizophrenia by Lindamer 
and associates (18) is directly comparable to the WAIST Study since the actigraphy 
methodology and physical activity definitions were identical and the sample was comprised of 
psychiatrically stable and free-living adults with schizophrenia.  Interestingly, adults with 
schizophrenia in the Lindamer study (n=16)(18) had approximately twice the physical activity 
levels (counts per minute, light activity, and moderate/vigorous activities) of adults in the 
WAIST Study (n=46).  Although speculative, the difference in physical activity may be due to 
climate; the WAIST Study was conducted in Pittsburgh, PA with 4 distinct seasons, and 
Lindamer’s study was conducted in San Diego, CA with a relatively mild and constant 
climate(18).  Also, it is possible that Lindamer’s sample (18) may represent healthier adults with 
schizophrenia than the WAIST Study as suggested by the following characteristics of the 
Lindamer sample; 1) no known current, severe medical conditions, 2) greater percentage 
Caucasian (82%) and ever married (52%), 3) low range for psychiatric symptoms that is 
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typically considered  psychiatrically stable (estimated average PANSS score of 44), and 5) no 
BMI restrictions (18).  
In the second study, Jerome and associates found that moderate vigorous activity 
averaged approximately 17 minutes per day (n=55)(20) which compares favorably with the 
WAIST Study (19 minutes/day of moderate vigorous activity).  In contrast to the WAIST Study, 
Jerome and associates found that physical activity was significantly greater in men than women 
and in younger versus older participants (20).  The physical activity differences between these 2 
studies may be partially due to the differences in the sample characteristics.  The WAIST Study 
was restricted to only adults with schizophrenia and schizoaffective disorder while the Jerome 
study was composed of adults with severe mental illness defined as schizophrenia or 
schizoaffective disorder, bipolar disorder, or major depression(20).  Unfortunately, physical 
activity levels by diagnosis were not presented by Jerome and associates (20). Although 
speculative, physical activity of adults with mood disorders may be greater than physical activity 
of adults with schizophrenia, or schizoaffective disorder due to the different natures of these 
disorders.   The findings from the self-reported physical activity supports this hypothesis; adults 
with schizophrenia and schizoaffective disorders reported significantly less physical activity than 
adults with mood disorders (bipolar disorder or major depression)(51).  Also, gender and age 
differences in diagnosis and prevalence of these severe mental illnesses may be biasing the 
results.  Finally, it should also be noted that Jerome and associates used a less conservative 
definition of moderate physical activity (1316 counts/minute)(20) than the WAIST Study (1952 
counts/minute) and included adults with lower BMIs (>25 versus >27 kg/m2, respectfully). 
However, the age ranges were similar in both studies (18-67 years for the Jerome study and 18-
65 for the WAIST Study).  
 In contrast to findings in other populations, the majority of the objective and subjective 
physical activity measures in the WAIST Study were not significantly associated with age, 
gender, race, or BMI.  However, the WAIST study findings are consistent with other cross-
sectional studies in adults with schizophrenia and/or schizoaffective disorders that have reported 
no association between physical activity and age (50), gender (49, 50, 55), or BMI (50, 51).   A 
floor effect for physical activity levels may account for the non-differential effects of 
demographics in adults with schizophrenia or schizoaffective disorders.  Specifically, the activity 
levels of adults with schizophrenia and schizoaffective disorders are extremely low and may 
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represent the minimal activity profile of an extremely sedentary population.  This hypothesis is 
supported by the current findings that adults with schizophrenia and schizoaffective disorder had 
significantly lower activity levels than users of mental health services in NHANES, a population 
considered sedentary and exhibiting less physical activity than the general US population (65).  
Unexpectedly, objective measures of physical activity were greater in smokers than non-
smokers for overweight and obese adults with schizophrenia and schizoaffective disorder.  
Hypothetically, the smokers may have engaged in more light physical activity than non-smokers 
to support their cigarette smoking habit.  The majority of the participants (90%) lived in 
community or group homes that may have required them to smoke outside due to no smoking 
policies.  Hence the smoking participants may have acquired more steps or light physical activity 
to smoke cigarettes outside their home/institution than the non-smoking participants.   
Although no association was observed between self-reported physical activity and 
smoking in the WAIST Study or among adults with severe mental illness (schizophrenia, 
schizoaffective disorder, bipolar disorder, and major depression) (51), these findings may 
actually reflect known limitations of subjective measures of physical activity rather than 
discrepant results.  Specifically, physical activities of low-intensity, short duration, and 
performed intermittently, such as walking to support a smoking habit, are difficult to recall and 
often under-reported.  For example, test-retest reliability of the YPAS for low-intensity activities 
were unacceptably low (0.04 for leisurely walking and 0.10 for moving) among adults with 
schizophrenia (n=19) (18). Hence, the sensitivity to measure the light activity associated with 
smoking may only be possible with objective and not subjective measures of physical activity in 
adults with schizophrenia and schizoaffective disorders.  It should be emphasized that although 
the smokers exhibited higher activity counts than the non-smokers, the overall level of physical 
activity among the smokers was still considered extremely sedentary and significantly lower than 
the users of mental health users. 
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6.1.3  Association with psychiatric symptoms 
No association was observed between the clinician’s assessment of psychiatric symptoms 
(PANSS or CGI-S) and the subjective or objective measures of physical activity or physical 
fitness.  Feasibly, several factors may explain this lack of association.  First, the study design 
restricted the severity of psychiatric symptoms in the sample thus limiting the range of scores for 
PANSS and CGI-S.  All study participants had PANSS scores that were less than 90 
corresponding to experiencing only mild or moderate psychiatric symptoms.  Second, the range 
and levels of physical activity and physical fitness levels among adults with schizophrenia and 
schizoaffective disorders were also extremely limited and may represent a floor effect as 
discussed above.   
However, the WAIST study findings are consistent with other cross-sectional studies in 
adults with schizophrenia and/or schizoaffective disorders that have reported no association 
between physical activity and various psychiatric symptoms such as depression and stress (20, 
50, 53) and cognitive function (20).  A larger sample of adults with schizophrenia or 
schizoaffective disorder experiencing mild to severe psychiatric symptoms (PANSS scores 
ranging from 30 to 210) is necessary to fully understand the association or lack of association 
between physical activity, physical fitness and severity of psychiatric symptoms.  Although our 
results between psychiatric symptoms and physical activity should be considered tentative, the 
WAIST Study findings provide the largest sample to date to investigate the association between 
symptoms of schizophrenia and schizoaffective disorders and physical activity.   
 
6.1.4 Association with general health findings 
Similar to the general population (87, 88), subjective physical activity and physical fitness 
exhibited a positive linear association with function in adults with schizophrenia and 
schizoaffective disorders in the WAIST Study.  Only one other study has reported function and 
physical activity in adults with schizophrenia (50).  Similar to the WAIST Study, higher 
functioning adults with schizophrenia were found to engage in more physical activities than 
lower functioning adults with schizophrenia (50).   In addition, adults with schizophrenia who 
were rated by clinicians as overactive, aggressive, and disruptive were more likely to get 
sufficient exercise than those that did not exhibit these behaviors(50).  Finally, severe social 
problems as measured by the Health of the Nation Outcome Scales were associated with 
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insufficient exercise defined as less than 150 minutes or more physical activity (walking, 
moderate and vigorous activity) over the preceding week (50). 
Unexpectedly, objective total physical activity was not significantly associated with 
function in the WAIST Study.  In addition, sedentary time (minutes/day and percentage of wear 
time) was not significantly associated with function.  Due to the limited sample size (n=44) in 
the WAIST Study, these results should be cautiously interpreted and warrant further 
investigation in a larger sample.   
Hypothetically, it is possible that the positive and the negative psychiatric symptoms of 
schizophrenia and schizoaffective disorders may influence physical activity levels and function.  
For example, adults with schizophrenia or schizoaffective disorder who experience many 
positive psychiatric symptoms may be more physically active and functioning impaired than 
those who experience fewer positive psychiatric symptoms.  Alternatively, adults with 
schizophrenia or schizoaffective disorder who experience many negative psychiatric symptoms 
may be more sedentary and less functioning impaired than those who experience few negative 
psychiatric symptoms or more positive psychiatric symptoms.  Additional analyses are warranted 
to investigate the effects of positive and negative symptoms on physical activity in adults with 
schizophrenia or schizoaffective disorders. 
 Similar to the general population (89, 90), self-reported general health status and 
subjective physical activity were positively associated; adults with schizophrenia or 
schizoaffective disorders who self-reported better general health status reported more activity.  In 
the present study, no association was observed between general health status and physical fitness 
and objective physical activity among adults with schizophrenia and schizoaffective disorders.  
Previous studies in other populations have generally reported moderate associations between 
general health status and physical fitness (91) and objective measures of physical activity (92, 
93).  The lack of association observed between general health status and physical fitness and 
objective physical activity among adults with schizophrenia and schizoaffective disorders is 
likely due to the smaller sample size (n=44 for objective physical activity measures and n=105 
for physical fitness) and the limited variability in physical fitness and objective measures of 
physical activity in the WAIST Study. 
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6.2 MEASUREMENT OF PHYSICAL ACTIVITY IN ADULTS WITH 
SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS 
 
The WAIST Study provides evidence that physical activity can be measured subjectively and 
objectively in overweight and obese adults with schizophrenia and schizoaffective disorders.  In 
addition, physical fitness can be assessed by maximal oxygen consumption in this population.  
Selection of the appropriate physical activity or fitness measures for adults with 
schizophrenia or schizoaffective disorders will depend on the purpose of the assessment.   For 
patient care, subjective physical activity may be preferred to objective physical activity or fitness 
testing.  The subjective assessment of physical activity is inexpensive, feasible in the clinic 
setting, and provides information on the type and context of the physical activities performed 
(94).  This information may aid the clinician in evaluating the patient’s physical activity levels as 
well as prescribing or promoting physical activity that is tailored to each patient.   
Objective physical activity assessment and fitness levels may not be necessary or 
warranted in the clinical setting.  The WAIST Study findings highlight that overweight and 
obese adults with schizophrenia or schizoaffective disorders are unfit, sedentary and primarily 
engage in light but not moderate or vigorous physical activities.  Since the adults with 
schizophrenia and schizoaffective disorders were found to be considerably less active than users 
of mental health services and the general US population objectively, quantifying the low activity 
or fitness levels of individual patients may not be necessary.  Other than being more expensive, 
time-intensive and burdensome on the patient, the objective physical activity and fitness 
assessments may provide little additional information that was not obtainable via self-reported 
physical activity.  
Since few of the participants reported employment or vigorous or moderate physical 
activities, future studies in adults with schizophrenia and/or schizoaffective disorders may want 
to use a simplified and less complex subjective measure of physical activity than the modified 
MAQ.  In particular, subject burden and data management time could be reduced by focusing 
minimal time and effort on age-neutral physical activities such as occupational and moderate-
vigorous activities that few adults with schizophrenia or schizoaffective disorders self-report.  In 
addition, a validated and reliable survey instrument for older adults may be an appropriate choice 
for studies of schizophrenia and schizoaffective disorders since both populations (older adults 
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and adults with schizophrenia and schizoaffective disorders) experience functional and cognitive 
impairments. 
Although the sample sizes are small, it is interesting to note that two studies (18, 86) and 
the WAIST Study have reported no association between objective and subjective measures of 
physical activity in adults with schizophrenia or schizoaffective disorders.  This lack of 
association between objective and subjective measures of physical activity is not unique to adults 
with schizophrenia or schizoaffective disorders and has been reported in other populations as 
well (95-98).  As suggested by Troiano and associates, these findings suggest that objective and 
subjective measures of physical activity may be measuring different constructs (94).  Hence 
selection of the appropriate measure of physical activity may differ depending on the focus and 
objectives of the research studies, public health program or campaign, and/or clinical practice. 
 
 
 
6.3  LIMITATIONS OF WAIST STUDY 
The WAIST study was limited by its ability to objectively measure physical activity in 
overweight and obese adults with schizophrenia or schizoaffective disorders.   Only 21% of the 
WAIST Study participants were offered the opportunity to wear the actigraphs.  Among those 
consented for objective physical activity monitoring, 84% provided useable actigraphy data in 
the WAIST Study which compares favorably with the 79-80% reported in population based 
studies for adults (64, 65).   Similar or lower rates for useable actigraphy data have been reported 
in other studies that have measured physical activity in adults with schizophrenia and/or 
schizoaffective disorders (31-83%) (18, 20).  Other studies in adults with schizophrenia or 
schizoaffective disorders have reported lost data due to monitor malfunctions or technical 
reasons (18, 19) as well as refusals to wear the activity monitor (20), or non-compliance with 
wearing the actigraph for 3 or more days (18, 20).  These technical issues highlight the 
importance of actigraphy training, field experience, and technical expertise to maximize data 
quality and minimize data collection errors. 
 Unexpectedly, there was no difference in demographics, psychiatric symptoms, function, 
general health status, or subjective physical activity between those who did and did not 
participate in actigraphy monitoring in the WAIST Study.  Generally, we would have expected 
the actigraphy cohort to be more active, and mentally and physically healthier than the non-
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participants.  On a positive note, this finding suggests that the actigraphy cohort’s activity levels 
may be representative of overweight and obese adults with schizophrenia and schizoaffective 
disorders.  On a negative note, this finding suggests that the participation rates for activity 
monitoring may have been limited more by the researcher’s perception rather than the 
participant’s actual ability to comply with activity monitor procedures.  Feasibly, the researchers 
may have been more willing to offer objective monitoring of physical activity to the adults with 
schizophrenia or schizoaffective disorder if a less expensive device such as a pedometer had 
been used in the WAIST Study. 
Paranoia symptoms associated with schizophrenia and schizoaffective disorders may 
partially explain the lower actigraphy compliance rate in this population.  Higher compliance 
rates may be possible in adults with schizophrenia or schizoaffective disorder if the likelihood of 
paranoia from wearing ‘a little black monitoring box’ was reduced.   Although speculative, 
objectively measuring physical activity with an unblinded pedometer rather than a blinded 
actigraph may improve compliance and adherence in this population.  The participant may 
experience less paranoia wearing a physical activity monitor that is visibly providing feedback 
while being worn.   
Another factor that may explain the lower actigraphy compliance and adherence is the 
severity of the mental health disorder.  Schizophrenia and schizoaffective disorders are 
considered the most severe mental health diagnoses and associated with functional and cognitive 
impairments.  These functional and cognitive impairments may limit the abilities of participants 
with schizophrenia or schizoaffective disorders to understand and comply with actigraphy 
monitoring in a free-living environment.  During the active intervention of the WAIST Study, 
pedometers were used by participants to self-monitor their physical activity.  Similar compliance 
and adherence problems were observed with the pedometers as the actigraphs i.e. pedometers 
were regularly lost and broken.  Widely accepted actigraphy and pedometer procedures and 
instructions for the general population may need to be modified to accommodate the functional 
and cognitive impairments of adults with schizophrenia or schizoaffective disorders. 
In contrast to objectively measured physical activity, subjective physical activity was 
measured in 98% of the WAIST Study participants.  Administering the modified MAQ by 
interview rather than completed by the participant may have contributed to this high completion 
rate.  Also, it should be emphasized that training of the interviewers on the administration of any 
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subjective measure of physical activity is essential for high quality data.  Future studies may 
want to consider certification of interviewers for administration of specific physical activity 
instruments as recently suggested by Ainsworth and associates (99). 
Another limitation of the WAIST Study was that the explicit diagnosis (schizophrenia or 
schizoaffective disorder) of each participant was not collected.  Therefore, it was not possible to 
examine if physical activity or fitness differed between adults diagnosed with schizophrenia and 
adults diagnosed with schizoaffective disorder.  Since schizoaffective disorder is considered less 
severe than schizophrenia, it would be interesting to know if physical activity or fitness levels 
correspond to the severity of the diagnosed mental illness.  
It is also important to emphasize that the findings from this study are not representative 
or generalizable to all adults with schizophrenia or schizoaffective disorders.  The primary 
objective of the WAIST Study was to evaluate the efficacy of weight reduction programs in 
clinically stable patients with a diagnosis of schizophrenia or schizoaffective disorders. For this 
reason, the adult sample was restricted to participants with BMI > 27 kg/m2, age 18-70 years, 
experiencing mild to moderate psychiatric illness, prescribed two or fewer anti-psychotic 
medications, not hospitalized, and spontaneously expressed a desire to lose weight.  In other 
words, this study sample represents the mentally healthiest of adults with schizophrenia and 
schizoaffective disorders.   
In addition, adults with schizophrenia or schizoaffective disorder are probably under-
represented among the users of mental health services in NHANES 2003-2004.  NHANES 2003-
2004 restricted the sample to non-institutionalized civilians. Residency in institutions, being 
homeless, or being incarcerated is not trivial among adults with schizophrenia disorders. One 
study estimates the prevalence of homelessness was 20% for patients with schizophrenia in San 
Diego county, US (100).  Another study estimates suggested that approximately 10-24% of state, 
federal and local inmates experience psychotic disorder symptoms such as delusions and 
hallucinations  during incarceration (101).  In the WAIST study, 18-36% of the participants 
would not have been eligible for NHANES 2003-2004 due to their residency in an institution 
(hospital, skilled nursing facility, intermediate care facility) or being homeless. Neither 
NHANES 2003-2004 nor the WAIST Study would have included the prison population of adults 
with schizophrenia and schizoaffective disorders.   
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 As a cross-sectional study, causality cannot be established in the WAIST Study.  
Longitudinal data on physical activity, BMI and psychiatric symptoms and medications may be 
useful in determining causal factors for improving the physical and mental health of adults with 
schizophrenia and schizoaffective disorders.  Identification of these causal factors would assist in 
the planning and promotion of effective health intervention strategies targeting adults with 
schizophrenia and schizoaffective disorder.  
 
 
 
6.4. STRENGTHS OF WAIST STUDY 
Several strengths of the WAIST Study should be highlighted.  First, only patients who met 
diagnostic criteria of schizophrenia and schizoaffective disorders as defined in DSM-IV-TR were 
eligible for the WAIST Study.  Using established and accepted criteria for schizophrenia and 
schizoaffective disorders as well as psychiatric symptoms (PANSS) permits comparison with 
other studies as well as the opportunity for clinical translation.  Second, the WAIST Study used 
three measures of physical activity and fitness to comprehensively profile the pattern of physical 
activity in adults with schizophrenia and schizoaffective disorders at baseline.  Finally, the 
sample was relatively large compared to previous published studies thus permitting the 
exploratory analyses of the association of physical activity with psychiatric symptoms, general 
health status, function, and demographics among overweight and obese adults with 
schizophrenia and schizoaffective disorders. 
Since psychiatric conditions are diagnosed subjectively without any objective measures, 
misdiagnosis may be a major bias in some mental health studies.  Fortunately, misdiagnosis of 
adults with schizophrenia and schizoaffective disorder is less common than other mental health 
conditions for the following reasons; 1) early age of onset (typically adolescence and young 
adulthood), 2) typical progression of the disorder is deteriorating mental and physical health over 
time, 3) unique symptomology that easily differentiates schizophrenia and schizoaffective 
disorders from other mental health disorders, 4) considered the most severe form of mental 
illness along the spectrum of mental health disorders, and 5) the negative stigma associated with 
schizophrenia and schizoaffective disorder.   Hence, over diagnosis of schizophrenia and 
schizoaffective disorder is unlikely.  Under diagnosis of schizophrenia or schizoaffective 
disorders may occur in younger adults (age < 25 years) if full DSM-IV criteria for schizophrenia 
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or schizoaffective disorders has not been experienced or reported by the patient, or clinicians are 
conservative in their diagnosis.  Although speculative, these under-diagnosed adults may have 
fewer negative and positive psychiatric symptoms and possibly exhibit different patterns of 
physical activity than the adults in the WAIST Study.  Feasibly, the under diagnosed adults with 
schizophrenia and schizoaffective disorder may have greater occupational activity as well as 
greater function than the adults in the WAIST Study.   
However, the solid study design of the WAIST Study probably minimized misdiagnosis 
of schizophrenia and schizoaffective disorder.  First, the diagnosis for schizophrenia and 
schizoaffective disorders was defined according to DSM-IV-TR criteria, widely accepted as the 
gold standard for diagnosis of psychiatric conditions for medical treatment and research. Second, 
diagnosis was independently evaluated by trained clinicians rather than relying only on medical 
records or referrals.  Finally, the diagnosis of schizophrenia or schizoaffective disorder was 
verified by 2 out of 3 study psychiatrists.   
 Overall, WAIST Study participants would be considered “mentally healthier” adults with 
schizophrenia and schizoaffective disorders than a random sample of adults diagnosed with 
schizophrenia or schizoaffective disorder.  Participation in the WAIST Study was restricted to 
adults with schizophrenia or schizoaffective disorder who experienced mild to moderate but not 
severe psychiatric symptoms, were prescribed two or fewer anti-psychotics medications, and 
were not hospitalized.  Generally, severity of the mental illness increases with number of anti-
psychotic medications and hospitalization.  The assumption that the WAIST Study represented 
“mentally healthier” adults with schizophrenia or schizoaffective disorders is supported by the 
clinician’s evaluation that the vast majority of participants only experienced mild to moderate 
functional impairments, and self-reported general health status was good or fair.    
Physically compared to mentally, the study sample may be more representative of adults 
with schizophrenia and schizoaffective disorders.  Previous research has shown that adults with 
schizophrenia and schizoaffective disorders tend to be overweight or obese.  For example, the 
prevalence of obesity was 3.5 times higher in persons with schizophrenia (42%, n=183) than the 
general Canadian population (12%)(102).  In addition, only 27% of Canadians with 
schizophrenia had BMIs within the acceptable range(102).   
Similar to BMI, the age range of the WAIST Study (18-70 years) may be representative 
of overweight and obese adults with schizophrenia and schizoaffective disorders.  Generally, the 
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age of onset for schizophrenia and schizoaffective disorders is adolescence and early adulthood 
(prior to age 30).  Second, the one-year prevalence of schizophrenic disorders was estimated to 
be 0.2% for adults 65+ years compared to 1.2% and 1.5% in 18-29 and 30-44 year olds, 
respectively, in the ECA Study (103).   In addition, the odds of being diagnosed with a 
schizophrenic disorder at age 65+ years is slim (OR=0.12) compared to 18-29 (OR=1.0, 
reference) and 30-44 (OR=1.81) year olds (103).  Finally, only 2% (n=124) of a large cohort of 
French individuals with schizophrenia (n=5756) were overweight or obese, and 60 years of age 
or older(104).  It is interesting to note that the oldest participant in the WAIST Study was 65 
years old even though 70 year olds were eligible for the study.   
Also, patients with schizophrenia have been found to have a higher rate of premature 
death than the general population (104-106).  Approximately, two-thirds of the premature deaths 
are due to natural causes and one-third attributed to suicide(107).  Mortality of adults with 
schizophrenia or schizoaffective disorders has been shown to be 9-12 years earlier, on average, 
than the general population (105).  Since life expectancy of an adult with schizophrenia or 
schizoaffective disorder is estimated at 57 years for men and 65 years for women(108), the age 
eligibility criteria used in the WAIST Study (18 to 70 years) should encompass the vast majority 
of adults with schizophrenia and schizoaffective disorders.   
Unlike other psychiatric or medical conditions, psychiatric symptoms of adults with 
schizophrenia and schizoaffective disorders seldom exhibit sustained recovery(109).  Instead the 
psychiatric symptoms tend to deteriorate over time, and often leads to chronic disability (109).  
Since nearly all adults with schizophrenia have their first psychotic episode by age 25 (103, 109, 
110) and the mean age of onset is 20 years for men and 24 years for women(103), few, if any, 
are likely to be experiencing only mild and moderate psychiatric symptoms as older adults.  
Hence, the upper age limit of 70 is less restrictive in this population and may not limit the 
generalizability of the WAIST Study findings.  In other words, the WAIST Study may represent 
well overweight and obese adults with schizophrenia or schizoaffective disorder experiencing 
mild or moderate psychiatric symptoms.   
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6.5 PUBLIC HEALTH IMPLICATIONS 
 
From a public health perspective, the findings from the WAIST Study provide the first 
comprehensive profile of physical activity levels in overweight and obese adults with 
schizophrenia or schizoaffective disorder.  Overweight and obese adults with schizophrenia or 
schizoaffective disorder are extremely sedentary and even less active than the general US adult 
population and users of mental health services.  Since inactivity is a risk factor for many chronic 
diseases that are prevalent in this population, public health campaigns and mental health services 
should focus on the promotion of physical activity as one avenue to reduce the risk of medical 
comorbidities often experienced by adults with schizophrenia or schizoaffective disorder.   
An alternative health approach may be to decrease sedentary time in adults with 
schizophrenia or schizoaffective disorders.  This approach might be more appealing and effective 
since sedentary time was extremely high in adults with schizophrenia and schizoaffective 
disorders.  Interventions to reduce sedentary behavior may focus on increasing light physical 
activities or interspersing light physical activities during traditionally sedentary behaviors.  For 
example, individuals might march in place rather than sit during television commercials. 
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7.0  SUMMARY AND PUBLIC HEALTH SIGNIFICANCE  
My dissertation work has focused on physical activity of adult populations (older men, users of 
mental health services, and adults with schizophrenia and schizoaffective disorders) whom may 
experience functional and cognitive impairments.  My first report investigated the longitudinal 
changes in physical activity measured subjectively among older men in the MrOS study(111).  
Next, I compared physical activity measured objectively among users and non-users of mental 
health services in a representative sample of the civilian, non-institutionalized US 
population(65).  Finally, I investigated physical activity in overweight and obese adults with 
schizophrenia and schizoaffective disorders.  Using subjective and objective measures of 
physical activity, the WAIST Study provides the first comprehensive profile of physical activity 
in overweight and obese adults with schizophrenia and schizoaffective disorder.  In addition, the 
WAIST Study compared physical activity levels measured objectively by accelerometry in adults 
with schizophrenia and schizoaffective disorder with adults who used mental health services in 
the general US population.   
 
7.1 PUBLICATIONS FOR FULFILLMENT OF DOCTORAL REQUIREMENTS 
A brief summary of the objectives and primary findings for each project is provided below.  
Copies of the published papers from the first two projects are located in Appendix C.1, C.2 and 
C.3 of this dissertation. 
 
7.1.1 Summary of “Longitudinal physical activity changes among older men in the MrOS 
study” (111)(Appendix C.3) 
 
Objective: “To describe the change in physical activity (total, leisure, household, occupational) 
in men over a mean 5-year follow-up period and to identify sociodemographic and health factors 
associated with change in physical activity”(111). 
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Summary of Primary Findings:  Over the 5-year follow-up, the majority of community dwelling 
older men reported declines in total, occupational, leisure, and household physical activities 
(111).  Greater declines in physical activity over time were associated with being older, living 
alone, smoking cigarettes, poor health, and higher blood pressure.  “Although average scores 
declined, some older men (n=1,335, 26%) reported increasing physical activity levels.  Better 
physical and mental health, living with others, and being younger were associated with the 
probability of increasing physical activity over time.” (111) 
 
7.1.2 Summary of “Gender, mental health service use and objectively measured physical 
activity: Data from the National Health and Nutrition Examination Survey (NHANES 
2003-2004)” (65) (Appendix C.1 and C.2)  
 
Objective: “To examine the relationship between physical activity levels measured objectively 
by accelerometry and the use of mental health services”(65) in a nationally representative sample 
of the civilian, non-institutionalized US population. 
Summary of Primary Findings:  Approximately 8% of the adults self-reported seeing mental 
health professionals during the past year.  “Men who used mental health services were 
significantly less active than men who did not use mental health services”(65).  Men who used 
mental health services engaged in 38 minutes less of light or moderate-vigorous physical activity 
per day than men who did not use mental health services.  “Physical activity levels of women, 
regardless of mental health use, were significantly lower than men who did not use mental health 
services”(65).  However, “there was no significant differences in the activity pattern of women 
who did and did not see a mental health professional during the previous year”(65).  Overall, 
“men and women who used mental health services were relatively sedentary”(65). 
 
7.1.3 Summary of WAIST Study 
Objective One: To provide a comprehensive physical activity profile of overweight and obese 
adults with schizophrenia and schizoaffective disorder.   
Objective Two: To compare physical activity levels measured objectively by accelerometry in 
overweight and obese adults with schizophrenia and schizoaffective disorder with adults who 
used mental health services in the general US population. 
 
 153 
 
7.1.4 Summary of Primary Findings 
Overweight and obese adults with schizophrenia and schizoaffective disorders were sedentary, 
regardless if physical activity was measured subjectively or objectively. In addition, only 2% 
(2/105) participants were classified as fit based on national guidelines.   As expected, adults with 
schizophrenia and schizoaffective disorders primarily engaged in unstructured, intermittent, and 
low-intensity activity such as walking and housework.  Occupational physical activities were 
extremely limited due to the low employment rate among the participants. Overweight and obese 
adults with schizophrenia and schizoaffective disorder were found to have significantly lower 
activity levels than users of mental health services in NHANES 2003-2004, a population 
considered sedentary and exhibiting less physical activity than the general US population. 
 
 
 
7.2 PUBLIC HEALTH IMPLICATIONS 
My dissertation work underscores that several populations with known functional and cognitive 
impairments have extremely sedentary lifestyles.  In addition, these populations (users of mental 
health services and overweight and obese adults with schizophrenia and schizoaffective 
disorders) are significantly less physical activity than the general U.S. population.  These low 
physical activity levels may negatively impact the mental as well as physical health of these 
populations.  The findings from these reports provide the necessary data to justify targeting 
mental health populations for physical activity interventions.  These findings may also aid policy 
makers, public and medical health professionals, and advocates and consumers for mental health 
to allocate the necessary resources to effectively and efficiently increase physical activity level in 
mental health populations. 
The burden of schizophrenia is tremendous not only for the individual and but also the 
society.  Worldwide, schizophrenia is ranked third as far as global burden of mental, 
neurological and substance-use disorders(112).   In 2001-2002, healthcare costs of community 
dwelling U.S. adults with schizophrenia averaged $3726 with ambulatory care and prescriptions 
accounted for 75% of the expenditures (113).  The investigators found that an additional 20% to 
90% was added to the annual health care costs of adults with schizophrenia if the patient had a 
common comorbidity (diabetes, dyslipidemia, hypertension, or heart disease)(113).  In other 
populations, physical activity has been shown to prevent or to reduce the impairments and 
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medical costs associated with these common medical comorbidities.  Public health programs and 
interventions to increase physical activity and reduce sedentary time in adults with schizophrenia 
and schizoaffective disorders are necessary to address the elevated morbidity, mortality, and 
health care costs associated with the high rates of obesity, diabetes, cardiovascular disease and 
sedentary lifestyles observed in this population.  
 
 
 
7.3  FUTURE DIRECTIONS 
The WAIST Study findings highlight that all aspects of physical activity is extremely limited in 
overweight and obese adults with schizophrenia and schizoaffective disorders. The promotion of 
physical activity in overweight and obese adults with schizophrenia and schizoaffective disorders 
is not only warranted but also necessary for their health.  Since walking was the most prevalent 
activity among adults with schizophrenia or schizoaffective disorder, interventions may want to 
focus on reducing sedentary behavior and increasing walking. Walking may be a sustainable 
physical activity among adults with schizophrenia or schizoaffective disorders for the following 
reasons: familiar activity that does not require learning new skills, low injury rate (114, 115), 
relatively inexpensive, convenient, and effective in improving fitness (116-118) and physical 
health (5-10), and maintaining body weight (11). In this population, interventions focusing on 
moderate-vigorous activities or occupational activities may not be an effective or efficient use of 
limited resources due to the low participation rates and the low employment rates, respectively. 
Additional research on the reliability and validity of subjective measures of physical 
activity in adults with schizophrenia and/or schizoaffective disorders are warranted.  Published 
reports have primarily consisted of pilot studies with small sample sizes.   
Future research should focus on whether physical activity levels and patterns differ by 
mental health diagnosis.  Hypothetically, physical activity levels may be associated with the 
severity of the mental illness.  Individuals with severe mental illness (schizophrenia, 
schizoaffective disorders, bipolar disorders, and major depression) would be expected to have 
lower physical activity levels than less severe mental illnesses such as anxiety or obsessive 
compulsive disorder.  Likewise within severe mental illnesses, adults with schizophrenia would 
be expected to have lower physical activity than adults with schizoaffective disorders, bipolar 
disorders, or major depression.  Adults experiencing depression (bipolar or major depression) 
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would be expected to have lower activity levels than adults with bipolar disorder experiencing 
hypomania, mania or a mixed mood state.  These differences in physical activity levels and 
patterns may not only be associated with the severity of the disorder but also the symptoms of 
the disorders and the anti-psychotic medications prescribed for treatment of the disorder.  
Understanding these differences may shed light on possible mechanisms and treatments for 
improving the mental and physical health of adults with severe mental illnesses. 
Additional research is also warranted on the role of physical activity on mental and 
physical health for specific mental health conditions and symptoms.  A considerable body of 
research literature exists for the beneficial effects of physical activity on depression.  However, 
the effects of physical activity on the other severe mental illnesses (schizophrenia, 
schizoaffective, and bipolar disorders) is sparse.  Hypothetically, physical activity may be 
beneficial for the physical health for adults with schizophrenia and schizoaffective disorders but 
have little influence on the course of the mental health disorder.  In contrast, physical activity 
may be beneficial for the mental and physical health of adults with bipolar disorder. 
It is unknown whether national guidelines for physical activity that were developed for 
the general population are sufficient or appropriate for adults with severe mental illness 
especially those diagnosed with schizophrenia, schizoaffective, or bipolar disorders.  McLeod 
and associates have hypothesized that adults with schizophrenia or schizoaffective disorder may 
need to more physically active than the general population to counteract the known negative side 
effects of poor diet and psychiatric medications on weight (50).  The same hypothesis would be 
valid among adults with bipolar disorder.  Thus, additional research is warranted to determine the 
optimal frequency, dose, duration, and type of physical activity to promote the mental and 
physical health of adults with specific mental health disorders. 
As previously mentioned, additional research on physical activity in adults with 
schizophrenia and schizoaffective disorders is also warranted.  The WAIST Study reported the 
association between physical activity and overall psychiatric symptoms as measured by the total 
PANSS score and CGI-S.  Investigating the association of physical activity with the various 
subscales for PANSS (negative, positive, and general symptoms) may be informative especially 
for a better understanding of the observed association between smoking and physical activity in 
the WAIST Study.  Determining if physical activity levels or patterns differ by specific diagnosis 
(schizophrenia versus schizoaffective disorders) may also be informative. 
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Future studies may want to characterize physical activity levels and patterns of adults 
with schizophrenia and schizoaffective disorders experiencing moderate to severe psychiatric 
symptoms since the WAIST Study was restricted to adults experiencing mild to low moderate 
psychiatric symptoms.  The current literature suggests cultural differences between Australia, 
France and North American countries in the amount and type of physical activities among adults 
with schizophrenia and schizoaffective disorders.  Understanding these cultural differences 
(lifestyle, medical care, residency, family and/or community support) may be informative and 
potentially guide improvements in clinical as well as public health practices. 
Another interesting line of investigation would be the effect of physical activity on 
function and quality of life for adults with schizophrenia and schizoaffective disorders.  
Although limited, encouraging findings have been reported by two studies.  First, McLeod and 
associates found that physically active adults with schizophrenia and schizoaffective disorder 
had fewer psychiatric hospitalizations over a three year period  (50).  Second, the WAIST Study 
found that less functional impairments were observed among the more active participants. 
Hence, physical activity may be one avenue to improve the poor functional outcomes primarily 
associated with the “negative symptoms (loss of will, anhedonia, poverty of thought) and 
cognitive deficits (reduced working memory, poor cognitive control)”(109) of schizophrenia and 
schizoaffective disorders. In addition, physical activity should positively impact the common 
medical comorbidities of schizophrenia, such as obesity, diabetes, and poor cardiovascular health 
that often leads to chronic disability and premature death.   
Even though the number of studies are limited, the WAIST Study and previously 
published reports have consistently found that adults with schizophrenia or schizoaffective 
disorders are sedentary regardless how physical activity is measured. By describing and 
quantifying the physical activity levels of overweight and obese adults with schizophrenia and 
schizoaffective disorders, the WAIST Study provides a solid foundation for further studying the 
effects of physical activity on the psychiatric and physical health of adults with schizophrenia 
and schizoaffective disorders. Physical activity may be one avenue to address the severe medical 
complications, functional impairments, and premature morbidity and mortality observed among 
adults with schizophrenia and schizoaffective disorders.   
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APPENDIX A:  STUDY MEASUREMENTS 
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A.1  Modified Modifiable Activity Questionnaire (MAQ)(33) 
Interviewer: Read through the list of activities in each section (work, gardening/yardwork, caretaking, and 
leisure).  For each activity, ask the participant to indicate whether he/she did that activity for 10 minutes 
or longer during the past week.  For all activities the individual responded “yes” to ask how much time 
(minutes per week) they spent doing this activity during the past week.  If needed, use the worksheet 
provided. 
 
Housework   
Activity Yes or No Time (mins/wk) 
Shopping (grocery, clothes) □ Yes 
□ No 
 
Laundry (time loading, unloading, hanging, folding only) □ Yes 
□ No  
 
Light Housework (tidying, dusting, sweeping, collecting trash in home, 
polishing, indoor gardening, ironing) 
□ Yes 
□ No 
 
Heavy Housework (vacuuming, mopping, scrubbing floors or walls, moving 
furniture, boxes, or garbage bags) 
□ Yes 
□ No 
 
Food Preparation (chopping, stirring, moving about to get food items or pans) □ Yes 
□ No 
 
Food Service (setting table, washing/drying dishes, putting dishes away) □ Yes 
□ No 
 
Dish Washing (clearing table, washing/drying dishes, putting dishes away) □ Yes 
□ No 
 
Light Home Repair (small appliance repair, light home maintenance/repair) □ Yes 
□ No 
 
Heavy Home Repair (painting, carpentry, washing/polishing car) □ Yes 
□ No 
 
Other □ Yes 
□ No  
 
 
Gardening/Yardwork   
Activity Yes or No Time (mins/wk) 
Gardening (planting, weeding, digging, hoeing) □ Yes 
□ No 
 
Lawn Mowing (walking only) □ Yes 
□ No  
 
Cleaning Walks/Driveway (sweeping, shoveling, raking) □ Yes 
□ No 
 
Other □ Yes 
□ No 
 
 
Caretaking   
Activity Yes or No Time (mins/wk) 
Older or disabled person (lifting, pushing wheelchair) □ Yes 
□ No 
 
Childcare (lifting, carrying, pushing stroller) □ Yes 
□ No  
 
Other □ Yes 
□ No 
 
 
Transportation   
Activity Yes or No Time (mins/wk) 
Walking (to a store, church, friend’s house, volunteer work, paid work, etc.) 
* Do not include walking for exercise 
□ Yes 
□ No 
 
Bicycling (to a store, church, friend’s house, volunteer work, paid work, etc.) 
* Only include pedal bicycling.  Do not include bicycling for exercise 
□ Yes 
□ No  
 
Other □ Yes 
□ No 
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Leisure    
Activity Yes or No Time (mins/wk) 
Jogging (outdoor, treadmill) □ Yes 
□ No 
 
Swimming (laps, snorkeling) □ Yes 
□ No  
 
Bicycling (indoor, outdoor) 
*Only include pedal bicycling. Do not include bicycling for transportation 
□ Yes 
□ No 
 
Softball/Baseball □ Yes 
□ No  
 
Bowling □ Yes 
□ No 
 
Basketball □ Yes 
□ No  
 
Calisthenics/Toning Exercises □ Yes 
□ No 
 
Wood Chopping □ Yes 
□ No  
 
Aerobic Dance/Step Aerobics □ Yes 
□ No 
 
Strength/Weight Training □ Yes 
□ No  
 
Jumping Rope □ Yes 
□ No 
 
Yoga □ Yes 
□ No  
 
Pilates □ Yes 
□ No 
 
Walking for Exercise 
* Do not include walking for transportation 
□ Yes 
□ No 
 
Other □ Yes 
□ No 
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Please answer the following questions pertaining to the past week. 
 Hours Minutes 
1. On average, how many hours of sleep did you get each night? 
 
  
2. On average, how many hours do you nap per day? 
 
  
3.    On average, how many hours do you usually spend watching television, 
videos,/DVDs, or playing video games? 
 
  
 
4. Do you have difficulty doing any of the following activities?   Yes  No 
a. Getting in or out of bed?          □  □ 
b. Walking across a small room without resting?     □  □ 
c. Walking for 10 minutes without resting?      □  □ 
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List all JOBS that the individual held over the past week. If unemployed, disabled, retired, homemaker, student 
during all or part of the past week, list as such and probe for job activities of a normal 8 hour day, 5 day week. 
 
 
 
 
 
 
Out of the total # of "Hrs/Day" the individual 
reported working at this "job", how much of this 
time was usually spent sitting?  Enter this # in 
"Hrs Sitting" column, then place a check "" in 
the category which best describes their job 
activities when they were not sitting. 
 
 
 
 
PAST WEEK JOB 
SCHEDULE 
Hrs spent 
sitting at 
work 
Check the category that best 
describes job activities when 
not sitting 
 
Job Name 
 
Day/Wk 
 
Hrs/Day 
 
Hrs Sitting 
 
A 
 
B 
 
C 
       
       
       
       
 
Category A 
 
Category B 
 
Category C 
(includes all sitting activities) (includes most indoor activities) (heavy industrial work, outdoor 
construction, farming) 
 
Sitting Carrying light loads Carrying moderate to heavy loads 
 
Standing still w/o heavy lifting Continuous walking Heavy construction 
Light cleaning (ironing, cooking, 
washing, dusting) 
Heavy cleaning (mopping, sweeping, 
scrubbing, vacuuming) 
Farming (hoeing, digging, mowing, 
raking) 
Driving a bus, taxi, tractor Gardening (planting, weeding) Digging ditches, shoveling 
 
Jewelry making/weaving Painting/Plastering Chopping (ax), sawing wood 
 
General office work Plumbing/Welding Tree/pole climbing 
Occasional/short distance walking Electrical work 
Sheep herding 
Water/coal/wood hauling 
 
For Interviewer 
In general, during the past week, were there any days that were not conducive to outdoor activity? 
Yes  No 
          □  □ 
a. If yes, how many days during the past week were not conductive to outdoor activity? 
    ___________ days 
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MET Values assigned to MAQ items 
Housework 
ACTIVITY METS Value 
Shopping (grocery, clothes) 2.3 
Laundry (time loading, unloading, hanging, folding only) 2.3 
Light Housework (tidying, dusting, sweeping, collecting trash in home, polishing, 
indoor gardening, ironing) 
2.5 
Heavy Housework (vacuuming, mopping, scrubbing floors or walls, moving 
furniture, boxes, or garbage bags) 
3.5 
Food Preparation (chopping, stirring, moving about to get food items or pans) 2.0 
Food Service (setting table, washing/drying dishes, putting dishes away) 2.5 
Dish Washing (clearing table, washing/drying dishes, putting dishes away) 2.3 
Light Home Repair (small appliance repair, light home maintenance/repair) 3.0 
Heavy Home Repair (painting, carpentry, washing/polishing car) 4.5 
Gardening/Yardwork 
ACTIVITY METS Value 
Gardening (planting, weeding, digging, hoeing) 3.5 
Lawn Mowing (walking only) 5.5 
Cleaning Walks/Driveway (sweeping, shoveling, raking) 4.5 
Caretaking 
ACTIVITY METS Value 
Older or disabled person (lifting, pushing wheelchair) 4.0 
Childcare (lifting, carrying, pushing stroller) 4.0 
Transportation 
ACTIVITY METS Value 
Walking (to a store, church, friend’s house, volunteer work, paid work, etc.)  * Do 
not include walking for exercise 
3.5 
Bicycling (to a store, church, friend’s house, volunteer work, paid work, etc.) * 
Only include pedal bicycling.  Do not include bicycling for exercise 
4.5 
Leisure 
ACTIVITY METS Value 
Jogging (outdoor, treadmill) 7.0 
Swimming (laps, snorkeling) 7.0 
Bicycling (indoor, outdoor) 
*Only include pedal bicycling. Do not include bicycling for transportation 
4.5 
Softball/Baseball 4.0 
Bowling 2.5 
Basketball 7.0 
Calisthenics/Toning Exercises 4.0 
Wood Chopping 6.0 
Aerobic Dance/Step Aerobics 6.0 
Strength/Weight Training 4.5 
Jumping Rope 9.0 
Yoga 3.0 
Pilates 4.5 
Walking for Exercise* Do not include walking for transportation 3.5 
JOB 
ACTIVITY METS Value 
Category A 0.0 
Category B 4.0 
Category C 7.0 
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A.2 PSYCHIATRIC ASSESSMENTS 
 
A.2.1 Positive and Negative Syndrome Scale (PANSS)(71) 
POSITIVE AND NEGATIVE SYNDROME SCALE FOR SCHIZOPHRENIA (PANSS) 
Enter the appropriate score for each item, refer to the Rating Manual for item definitions, description of anchoring points and 
scoring procedures  
1. Positive Subscale Absent 
1 
Minimal 
2 
Mild 
3 
Moderate 
4 
Moderate Severe 
5 
Severe 
6 
Extreme 
7 
P1 Delusions □ □ □ □ □ □ □ 
P2 Conceptual 
Disorganization 
□ □ □ □ □ □ □ 
P3 Hallucinatory Behavior □ □ □ □ □ □ □ 
P4 Excitement □ □ □ □ □ □ □ 
P5 Grandiosity □ □ □ □ □ □ □ 
P6 Suspiciousness/ 
persecution 
□ □ □ □ □ □ □ 
P7 Hostility □ □ □ □ □ □ □ 
Subtotal □□ 
 
 
2. Negative Subscales Absent 
1 
Minimal 
2 
Mild 
3 
Moderate 
4 
Moderate Severe 
5 
Severe 
6 
Extreme 
7 
N1 Blunted affect □ □ □ □ □ □ □ 
N2 Emotional withdrawal □ □ □ □ □ □ □ 
N3 Poor rapport □ □ □ □ □ □ □ 
N4 Passive/apathetic social 
withdrawal 
□ □ □ □ □ □ □ 
N5 Difficulty in abstract 
thinking 
□ □ □ □ □ □ □ 
N6 Lack of spontaneity and 
flow of conversation 
□ □ □ □ □ □ □ 
N7 Stereotyped thinking □ □ □ □ □ □ □ 
Subtotal □□ 
 
General Psychopathology 
Subscales 
Absent 
1 
Minimal 
2 
Mild 
3 
Moderate 
4 
Moderate Severe 
5 
Severe 
6 
Extreme 
7 
G1 Somatic Concern □ □ □ □ □ □ □ 
G2 Anxiety □ □ □ □ □ □ □ 
G3 Guilt feelings □ □ □ □ □ □ □ 
G4 Tensions □ □ □ □ □ □ □ 
G5 Mannerisms and posturing □ □ □ □ □ □ □ 
G6 Depression □ □ □ □ □ □ □ 
G7 Motor retardation □ □ □ □ □ □ □ 
G8 Uncooperativeness □ □ □ □ □ □ □ 
G9 Unusual thought content □ □ □ □ □ □ □ 
G10 Disorientation □ □ □ □ □ □ □ 
G11 Poor attention □ □ □ □ □ □ □ 
G12 Lack of judgment and 
insight 
□ □ □ □ □ □ □ 
G13 Disturbance of volition □ □ □ □ □ □ □ 
G14 Poor impulse control □ □ □ □ □ □ □ 
G15 Preoccupation □ □ □ □ □ □ □ 
G16 Active social avoidance □ □ □ □ □ □ □ 
Subtotal □□ 
Raters Initials  ___  ___  ____                                                      Total □□□ 
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A.2.2 Clinical Global Impression of Severity (CGIS)(72, 73) 
Severity of Illness 
Considering your total clinical experience with this particular population, how mentally ill is the patient at this time? 
□0 = Not Assessed 
□1 = Not Ill 
□2 = Very Mild 
□3 = Mild 
□4 = Moderate 
□5 = Severe 
□7 = Extremely Severe 
 
 
A.3 FUNCTION AND HEALTH STATUS ASSESSMENTS 
A.3.1 Global Assessment of Functioning (GAF) Scale (3) 
Instructions: Consider psychological, social, and occupational functioning on a hypothetical continuum of mental 
health-illness. Do not include impairment in functioning due to physical (or environmental) limitations. Code. (Note: 
Use intermediate codes when appropriate eg 45, 68, 72) 
 
Rater ______________ 
 
GAF Rating: _____________ 
 
 
91 - 100 Superior functioning in a wide range of activities, life's problems never seem to get out of hand, is sought 
out by others because of his or her many positive qualities. No symptoms.  
81 - 90 Absent or minimal symptoms (e.g., mild anxiety before an exam), good functioning in all areas, interested 
and involved in a wide range of activities, socially effective, generally satisfied with life, no more than everyday 
problems or concerns (e.g., an occasional argument with family members).  
71 - 80 If symptoms are present, they are transient and expectable reactions to psychosocial stressors (e.g., difficulty 
concentrating after family argument); no more than slight impairment in social, occupational, or school functioning 
(e.g., temporarily falling behind in schoolwork).  
61 - 70 Some mild symptoms (e.g., depressed mood and mild insomnia) OR some difficulty in social, occupational, 
or school functioning (e.g., occasional truancy, or theft within the household), but generally functioning pretty well, 
has some meaningful interpersonal relationships.  
51 - 60 Moderate symptoms (e.g., flat affect and circumstantial speech, occasional panic attacks) OR moderate 
difficulty in social, occupational, or school functioning (e.g., few friends, conflicts with peers or co-workers).  
41 - 50 Serious symptoms (e.g., suicidal ideation, severe obsessional rituals, frequent shoplifting) OR any serious 
impairment in social, occupational, or school functioning (e.g., no friends, unable to keep a job).  
31 - 40 Some impairment in reality testing or communication (e.g., speech is at times illogical, obscure, or irrelevant) 
OR major impairment in several areas, such as work or school, family relations, judgment, thinking, or mood (e.g., 
depressed man avoids friends, neglects family, and is unable to work; child frequently beats up younger children, is 
defiant at home, and is failing at school).  
21 - 30 Behavior is considerably influenced by delusions or hallucinations OR serious impairment, in 
communication or judgment (e.g., sometimes incoherent, acts grossly inappropriately, suicidal preoccupation) OR 
inability to function in almost all areas (e.g., stays in bed all day, no job, home, or friends)  
11 - 20 Some danger of hurting self or others (e.g., suicide attempts without clear expectation of death; frequently 
violent; manic excitement) OR occasionally fails to maintain minimal personal hygiene (e.g., smears feces) OR gross 
impairment in communication (e.g., largely incoherent or mute).  
1 - 10 Persistent danger of severely hurting self or others (e.g., recurrent violence) OR persistent inability to maintain 
minimal personal hygiene OR serious suicidal act with clear expectation of death.  
0  Inadequate Information 
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A.3.2 General Health Status Question from Medical Outcomes Study Short Form Health Survey 
(SF-12) (74) 
Instructions: This questionnaire asks for your views about your health.  This information will help keep track of how you feel and 
how well you are able to do your usual activities. 
Please answer every question by marking one box.  If you are unsure about how to answer: please give the best answer you can 
1. In general, would you say your health is:  
□ 
Excellent 
□ 
Very Good 
□ 
Good 
□ 
Fair 
□ 
Poor 
 
A.3.3 Living Situation from the Quality of Life Interview (Brief Version) (77) 
1. LIVING SITUATION 
“What is your current living situation?”   
(Interviewer:  IF RESPONDENT IS CURRENTLY IN THE HOSPITAL AND THIS HOSPITALIZATION HAS 
LASTED LESS THAN 3 MONTHS, USE LIVING SITUATION JUST PRIOR TO HOSPITALIZATION.  IF THE 
HOSPITALIZATION HAS BEEN FOR 3 MONTHS OR MORE, CODE “HOSPITAL”). IF HOMELESS (CODE 13 
OR 15) 
 (Circle #) 
Hospital 1 
Skilled nursing facility – 24 hour nursing service 2 
Intermediate care facility – less than 24 hour nursing care facility 3 
Supervised group living (generally long term) 4 
Transitional group home (halfway or quarterway house) 5 
Family foster care 6 
Cooperative apartment, supervised (staff on premise) 7 
Cooperative apartment, unsupervised (staff not on premise) 8 
Board and care home (private proprietary home for adults, with program and supervision) 9 
Boarding house (includes meals, no program or supervision) 10 
Rooming or boarding house or hotel (includes single room occupancy, no meals are  provided, cooking 
facilities may be available) 
11 
Private house or apartment 12 
Shelter 13 
Jail 14 
No current residence (including the streets, bus stations, missions, etc) 15 
Other 16 
No information 99 
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B. Supplemental Tables 
 
Table A-1 Continuous demographic and health information for overweight and obese adults with 
schizophrenia or schizoaffective disorder by MAQ Administration (WAIST Study) (n=258). 
 
 
 
Variable 
Waist 
Study 
(n=258) 
MAQ 
Cohort 
(n=252) 
 MAQ not 
administered 
(n=6) 
Age (yrs)  
   Mean + STD 
   Median 
   Range 
   95% CI 
   N (missing) 
 
45.0 + 10.5 
47.0 
18.0, 65.0 
37.0, 53.0 
258 (0) 
 
44.7 + 10.3 
47.0 
18.0, 63.0 
36.5, 53.0 
252 (0) 
 
57.7 + 8.4 
60.0 
45.0, 65.0 
51.0, 65.0 
6 (0) 
BMI (kg/m2) 
   Mean + STD 
   Median 
   Range 
   95% CI 
   N (missing) 
 
38.0 + 8.0 
37.0 
27.0, 83.4 
32.0, 41.6 
258 (0) 
 
38.0 + 7.9 
37.0 
27.0, 83.4 
32.3, 41.5 
252 (0) 
 
37.3 + 11.0 
37.3 
27.2, 57.5 
28.2, 49.7 
6 (0) 
Positive and Negative Syndrome Scale (PANSS) a 
   Mean + STD 
   Median 
   Range 
   95% CI 
   N (missing) 
 
55.7 + 11.8 
56.0 
30.0, 89.0 
48.0, 63.0 
258 (0) 
 
55.7 + 11.8 
60.0 
30, 89 
48.0, 63.0 
252 (0) 
 
56.2 + 13.1 
57.0 
43, 66 
48.0, 63.0 
6 (0) 
Global Assessment of Functioning Scale (GAF) a 
   Mean + STD 
   Median 
   Range 
   95% CI 
   N (missing) 
 
59.4 + 7.5 
60.0 
35.0, 88.0 
54.0, 65.0 
231 (27) 
 
59.4 + 7.6 
60.0 
35.0, 88.0 
54.0, 65.0 
226 (16) 
 
59.2 + 5.2 
61.0 
50.0, 62.0 
61.0, 62.0 
5 (1) 
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Table A-2 Categorical demographic and health information for overweight and obese adults with 
schizophrenia or schizoaffective disorder by MAQ administration (WAIST Study) (n=258) 
. 
 
 
Variable N (%) 
Waist  
Study 
(n=258) 
MAQ  
Cohort 
(n=252) 
MAQ not 
administered 
(n=6) 
Gender 
   Men    
   Women 
 
92 (35.7) 
166 (64.3) 
 
90 (35.7) 
162 (64.3) 
 
2 (33.3) 
4 (66.7) 
Age Category 
   18-39 yrs 
   40-49 yrs 
   50-65 yrs 
 
70 (27.1) 
86 (33.3) 
102 (39.5) 
 
70 (27.8) 
85 (33.7) 
97 (38.5) 
 
0 (0) 
1 (16.7) 
5 (83.3) 
BMI categories 
   Overweight (27.0-29.9 kg/m2) 
   Obese (30.0-39.9 kg/m2) 
   Extreme Obese (40.0 + kg/m2) 
 
33 (12.8) 
146 (56.6) 
79 (30.6)  
 
30 (11.9) 
145 (57.5) 
77 (30.6)  
 
3 (50.0) 
1 (16.7) 
2 (33.3)  
Race 
   White/Caucasian 
   Black/ African American 
   Other 
 
128 (49.6) 
124 (48.1) 
6 (2.3) 
 
124 (49.2) 
122 (48.4) 
6 (2.4) 
 
4 (66.7) 
2 (33.3) 
0 (0) 
Marital Status 
   Never Married 
   Married 
   Separated/Divorced 
   Widowed 
   Don’t Know/Refused 
 
160 (62.0) 
20 (7.8) 
43 (16.7) 
0 (0) 
35 (13.6) 
 
158 (62.7) 
20 (7.9) 
40 (15.8) 
0 (0) 
34 (13.5) 
 
2 (33.3) 
0 (0) 
3 (50.0) 
0 (0) 
1 (16.7) 
Education 
   < High School 
   High School Graduate 
   College Educated 
   Don’t Know/Refused 
 
29 (11.2) 
90 (34.9) 
91 (35.3) 
48 (18.6) 
 
27 (10.7) 
89 (35.3) 
89 (35.3) 
47 (18.7) 
 
2 (33.3) 
1 (16.7) 
2 (33.3) 
1 (16.7) 
Employment 
    Unemployed  
    Employed 
   Occupational/Vocational Therapy  
   Precision Production Crafts or Repairs  
   Volunteer  
   Professional Specialty 
   Other Services  
   Administrative or clerical support 
   Transportation or material moving 
   Technician and related support 
   Handlers, equipment cleaners, helpers 
   Sales 
   Don’t Know/Refused 
 
179 (69.4) 
44 (17.1) 
3 (1.2) 
1 (0.4) 
4 (1.6) 
4 (1.6) 
14 (5.4) 
5 (1.9) 
2 (0.8) 
2 (0.8) 
4 (1.6) 
5 (1.9) 
35 (13.6) 
 
176 (69.8) 
42 (16.7) 
3 (1.2) 
1 (0.4) 
3 (1.2) 
4 (1.6) 
14 (5.6) 
5 (2.0) 
2 (0.8) 
2 (0.8) 
3 (1.2) 
5 (2.0) 
34 (13.5) 
 
3 (50.0) 
2 (33.3) 
0 (0) 
0 (0) 
1 (16.7) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
1 (16.7) 
0 (0) 
1 (16.7) 
Current Smoker 
   No 
   Yes 
 
144 (55.8) 
114 (44.2) 
 
141 (56.0) 
111 (44.1) 
 
3 (50.0) 
3 (50.0) 
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Table A-2 (continued) Categorical demographic and health information for overweight and obese adults with 
schizophrenia or schizoaffective disorder by MAQ administration (WAIST Study) (n=258). 
 
 
 
Variable N (%) 
Waist  
Study 
(n=258) 
MAQ  
Cohort 
(n=252) 
MAQ not 
administered 
(n=6) 
Medications 
   Aripiprazole 
   Clozapine 
   Haloperidol 
   Olanzapine 
   Polypharmacy 
   Quetiapine 
   Risperidone 
   Ziprasidone 
 
36 (14.0) 
47 (18.2) 
1 (0.4) 
25 (9.7) 
45 (17.4) 
29 (11.2) 
61 (23.6) 
14 (5.4) 
 
35 (13.9) 
46 (18.3) 
1 (0.4) 
25 (9.9) 
43 (17.1) 
29 (11.5) 
59 (23.4) 
14 (5.6) 
 
1 (16.7) 
1 (16.7) 
0 (0) 
0 (0) 
2 (33.3) 
0 (0) 
2 (33.3) 
0 (0) 
Antipsychotic Medication 
   Single  
   Polypharmacy 
 
213 (82.6) 
45 (17.4) 
 
209 (82.9) 
43 (17.1) 
 
4 (66.7) 
2 (33.3) 
Weight Gaining Properties of single anti-
psychotic medications (n=213) 
   High 
   Low/Moderate 
   No 
 
 
72 (33.8) 
91 (42.7) 
50 (23.5) 
 
 
71 (34.0) 
89 (42.6) 
49 (23.4) 
 
 
1 (25.0) 
2 (50.0) 
1 (25.0) 
Clinical Global Impression of Severity (CGI-S)a 
   Normal, not mentally ill 
   Very mild mental illness 
   Mild mental illness 
   Moderate mental illness 
   Severe mental illness 
   Extremely severe mental illness 
   Not Assessed 
 
6 (2.3) 
13 (5.0) 
83 (32.2) 
123 (47.7) 
4 (1.6) 
0 (0) 
29 (11.2) 
 
6 (2.4) 
13 (5.2) 
81 (32.1) 
120 (47.6) 
4 (1.6) 
0 (0) 
0 (0) 
 
0 (0) 
0 (0) 
2 (33.3) 
3 (50.0) 
0 (0) 
0 (0) 
1 (16.7) 
Positive and Negative Syndrome Scale PANSS)a 
   Mild illness (<60) 
   Moderate illness (60-129) 
   Severe illness (>130) 
 
170 (65.9) 
88 (34.1) 
0 (0) 
 
166 (65.9) 
86 (34.1) 
0 (0) 
 
4 (66.7) 
2 (33.3) 
0 (0) 
Global Assessment of Functioning Scale (GAF) 
Categoriesa 
   Impairment (31-40) 
   Serious symptoms (41-50) 
   Moderate symptoms (51-60) 
   Mild symptoms (61-70) 
   Transient symptoms (71-80) 
   Symptoms absent or minimal (81-90) 
   Superior functioning (91-100) 
   Inadequate Information  to assess 
 
 
2 (0.8) 
14 (5.4) 
111 (43.0) 
91 (35.3) 
11 (4.3) 
2 (0.8) 
0 (0) 
27 (10.5) 
 
 
2 (0.8) 
13 (5.2) 
111 (44.1) 
87 (34.5) 
11 (4.4) 
2 (0.8) 
0 (0) 
26 (10.3) 
 
 
0 (0) 
1 (16.7) 
0 (0) 
4 (66.7) 
0 (0) 
0 (0) 
0 (0) 
1 (16.7) 
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Table A-2 (continued) Categorical demographic and health information for overweight and obese adults with 
schizophrenia or schizoaffective disorder by MAQ administration (WAIST Study) (n=258) 
 
 
 
Variable N (%) 
Waist  
Study 
(n=258) 
MAQ  
Cohort 
(n=252) 
MAQ not 
administered 
(n=6) 
Global Assessment of Functioning Scale (GAF) 
Categories a 
   Impairments and serious symptoms 
   Moderate symptoms 
   Mild or absent symptoms 
   Inadequate information to assess 
 
 
16 (6.2) 
111 (43.0) 
104 (40.3) 
27 (10.5) 
 
 
15 (6.0) 
111 (44.1) 
100 (39.7) 
26 (10.3) 
 
 
1 (16.7) 
0 (0) 
4 (66.7) 
1 (16.7) 
General Health Status b   
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
   Missing 
 
13 (5.0) 
32 (12.4) 
84 (32.6) 
83 (32.2) 
35 (13.6) 
11 (4.3) 
 
13 (5.2) 
29 (11.5) 
84 (33.3) 
83 (32.9) 
33 (13.1) 
10 (4.0) 
 
0 (0) 
3 (50.0) 
0 (0) 
0 (0) 
2 (33.3) 
1 (16.7) 
General Health Statusb [N (%)]   
   Excellent, Very good, or Good 
   Fair or Poor 
   Missing 
 
129 (50.0) 
118 (45.7) 
11 (4.3) 
 
126 (50.0) 
116 (46.0) 
10 (4.0) 
 
3 (50.0) 
2 (33.3) 
1 (16.7) 
Living Situationb [N (%)]   
   Hospital 
   Skilled nursing facility 
   Intermediate care facility 
   Supervised group living 
   Transitional group home 
   Family foster care 
   Supervised cooperative apartment 
   Board and care home 
   Not assessed 
 
5 (1.9) 
23 (8.9) 
18 (7.0) 
46 (17.8) 
51 (19.8) 
68 (26.4) 
40 (15.5) 
1 (0.4) 
6 (2.3) 
 
5 (2.0) 
23 (9.1) 
17 (6.8) 
46 (18.3) 
48 (19.1) 
68 (27.0) 
38 (15.1) 
1 (0.4) 
6 (2.4) 
 
0 (0) 
0 (0) 
1 (16.7) 
0 (0) 
3 (50.0) 
0 (0) 
2 (33.3) 
0 (0) 
0 (0) 
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Table A-3 Subjective physical activity [Modified MAQ (METS per week)] for overweight and obese adults with 
schizophrenia or schizoaffective disorder (WAIST Study) by gender (n=252). 
 
 
 
Modified MAQ (METS/wk) 
 
MAQ Cohort 
(n=252) 
 
Female 
(n=162) 
 
Male 
(n=90) 
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
214.0 + 987.7 
0 
0, 7200.0 
0, 0 
245 (7) 
 
156.7 + 905.8 
0 
0, 7200.0 
0, 0 
157 (5) 
 
316.4 + 1117.2 
0 
0, 6000.0 
0, 0 
88 (2) 
0.09 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
999.5 + 1266.1 
576.5 
0, 7830.0 
258.5, 1281.3 
252 (0) 
 
1152.9 + 1375.8 
714.3 
0, 7830.0 
356.1, 1429.0 
162 (0) 
 
723.5 + 988.2 
384.3 
0, 6639.0 
195.5, 789.0 
90 (0) 
0.0008 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
39.6 + 220.3 
0 
0, 2940.0 
0, 0 
252 (0) 
 
32.1 + 239.7 
0 
0, 2940.0 
0, 0 
162 (0) 
 
53.1 + 180.7 
0 
0, 1080.0 
0, 0 
90 (0) 
0.09 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
86.4 + 499.0 
0 
0, 5040.0 
0, 0 
252 (0) 
 
91.5 + 524.6 
0 
0, 5040.0 
0, 0 
162 (0) 
 
77.3 + 452.0 
0 
0, 3360.0 
0, 0 
90 (0) 
0.30 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
152.0 + 295.3 
0 
0, 2940 
0, 210.0 
252 (0) 
 
148.6 + 317.7 
0 
0, 2940.0 
0, 210.0 
162 (0) 
 
158.1 + 251.5 
70.0 
0, 1260.0 
0, 210.0 
90 (0) 
0.13 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
338.5 + 639.1 
60.0 
0, 4530 
0, 405.0 
250 (2) 
 
375.0 + 691.5 
37.5 
0, 4530.0 
0, 450.0 
160 (2) 
 
273.5 + 530.9 
80.0 
0, 3240.0 
0, 315.0 
90 (0) 
0.89 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1803.0 + 2097.6 
1027.5 
0, 11715.0 
35.0, 2332.0 
243 (9) 
 
1934.1 + 2303.2 
1168.5 
0, 11715.0 
427.0, 2314.5 
155 (7) 
 
1572.2 + 1662.6 
897.3 
0, 7231.5 
416.9, 2446.0 
88 (2) 
0.32 
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Table A-3 (continued)  Subjective physical activity [Modified MAQ (METS per week)] for overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) by gender (n=252). 
 
 
 
Modified MAQ (METS/wk) 
 
MAQ Cohort 
(n=252) 
 
Female 
(n=162) 
 
Male 
(n=90) 
p-value for 
Kruskal-Wallis 
Test 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1608.4 + 1849.7 
993.5 
0, 11190.0 
413.0, 2181.5 
250 (2) 
 
1790.1 + 2042.2 
1107.5 
0, 11190.0 
472.0, 2296.5 
160 (2) 
 
1285.5 + 1398.72 
727.3 
0, 7231.5 
382.0, 1581.5 
90 (0) 
0.05 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
695.5 + 1212.0 
280.0 
0, 8715.0 
35.0, 780.0 
243 (9) 
 
670.9 + 1211.5 
270.0 
0, 8715.0 
0, 807.5 
155 (7) 
 
738.7 + 1218.4 
302.5 
0, 6070.0 
87.5, 682.5 
88 (2) 
0.41 
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Table A-4 Subjective physical activity [Modified MAQ (METS per week)] for overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) by race (n=246)a. 
 
 
Modified MAQ (METS/wk) 
White  
(n=124) 
Black  
(n=122) 
p-value for Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
287.8 + 1080.8 
0 
0, 7200.0 
0, 0 
118 (6) 
 
152.7 + 912.8 
0 
0, 7200.0 
0, 0 
121 (1) 
0.10 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
934.9 + 1233.0 
577.5 
0, 7830.0 
245.2, 1079.8 
124 (0) 
 
1060.4 + 1318.3 
566.8 
0, 6804.0 
279.0, 1429.0 
122 (0) 
0.48 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
58.8 + 300.3 
0 
0, 2940.0 
0, 0 
124 (0) 
 
16.3 + 66.1 
0 
0, 420.0 
0, 0 
122 (0) 
0.51 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
72.1 + 419.3 
0 
0, 3360.0 
0, 0 
124 (0) 
 
105.2 + 580.5 
0 
0, 5040.0 
0, 0 
122 (0) 
0.75 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
173.4 + 356.3 
0 
0, 2940.0 
0, 210.0 
124 (0) 
 
127.3 + 199.0 
17.5 
0, 1260.0 
0, 210.0 
122 (2) 
0.94 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
303.1 + 544.4 
68.8 
0, 3240.0 
0, 367.5 
124 (0) 
 
380.5 + 735.4 
17.5 
0, 4530.0 
0, 446.3 
120 (2) 
0.95 
a n=1 for other race; size of other race category considered insufficient to include in analyses or summary 
tables 
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Table A-4 (continued)  Subjective physical activity [Modified MAQ (METS per week)] for overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) by race (n=246)a. 
 
 
Modified MAQ (METS/wk) 
White  
(n=124) 
Black  
(n=122) 
p-value for Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1774.1 + 1954.4 
1061.0 
0, 11190.0 
467.0, 2370.0 
118 (6) 
 
1839.2 + 2265.2 
1014.0 
0, 11715.0 
408.0, 2314.5 
119 (3) 
0.72 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1542.3 + 1718.4 
1000.8 
0, 11190.0 
466.5, 2052.3 
124 (0) 
 
1674.5 + 1999.2 
954.5 
0, 10872.5 
398.0, 2293.5 
120 (2) 
0.90 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
734.6 + 1181.6 
303.8 
0, 7200.0 
70.0, 840.0 
118 (6) 
 
669.5 + 1269.8 
270.0 
0, 8715.0 
0, 690.0 
119 (3) 
0.34 
a n=1 for other race; size of other race category considered insufficient to include in analyses or summary 
tables  
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Table A-5 Subjective physical activity [Modified MAQ (METS per week)] by age groups for overweight and 
obese adults with schizophrenia or schizoaffective disorder (WAIST Study) (n=252). 
 
 
Modified MAQ Physical 
Activity (METS/wk) 
 
18-39 yrs 
(n=70) 
 
40-49 yrs 
(n=85) 
 
50-65 yrs 
(n=97) 
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
271.8 + 1110.3 
0 
0, 7200.0 
0, 0 
68 (2) 
 
115.7 + 763.9 
0 
0, 6000 
0, 0 
83 (2) 
 
259.1 + 1069.5 
0 
0, 7200.0 
0, 0 
94 (3) 
0.29 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
851.2 + 1103.8 
477.3 
0, 6804.0 
196.5, 1171.5 
70 (0) 
 
997.0 + 1280.5 
586.5 
0, 7830.0 
213.0, 1429.0 
85 (0) 
 
1108.8 + 1361.0 
590.0 
0, 7422.0 
308.0, 1260.5 
97 (0) 
0.29 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
31.8 + 133.2 
0 
0, 975.0 
0, 0 
70 (0) 
 
53.4 + 328.5 
0 
0, 2940.0 
0, 0 
85 (0) 
 
33.2 + 139.6 
0 
0, 1080.0 
0, 0 
97 (0) 
0.69 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
136.0 + 736.3 
0 
0, 5040.0 
0, 0 
70 (0) 
 
70.9 + 394.6 
0 
0, 3360.0 
0, 0 
85 (0) 
 
64.3 + 350.3 
0 
0, 2640.0 
0, 0 
97 (0) 
0.96 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
150.7 + 242.5 
17.5 
0, 1260.0 
0, 210.0 
70 (0) 
 
158.8 + 391.9 
0 
0, 2940.0 
0, 210.0 
85 (0) 
 
146.9 + 226.3 
35.0 
0, 1050.0 
0, 210.0 
97 (0) 
0.37 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
352.4 + 676.6 
70.0 
0, 4530.0 
0, 420.0 
69 (1) 
 
317.1 + 586.0 
0 
0, 3240.0 
0, 367.5 
85 (0) 
 
347.4 + 662.3 
60.0 
0, 3937.5 
0, 412.5 
96 (1) 
0.87 
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Table A-5 (continued) Subjective physical activity [Modified MAQ (METS per week)] by age groups for 
overweight and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) (n=252). 
 
 
Modified MAQ Physical 
Activity (METS/wk) 
 
18-39 yrs 
(n=70) 
 
40-49 yrs 
(n=85) 
 
50-65 yrs 
(n=97) 
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1789.7 + 2280.5 
1021.0 
0, 10872.5 
382.0, 2302.5 
67 (3) 
 
1654.8 + 1875.9 
908.5 
0, 11190.0 
368.0, 2428.5 
83 (2) 
 
1944.9 + 2160.0 
1069.5 
0, 11715.0 
589.0, 2314.5 
93 (4) 
0.59 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1507.3 + 2032.0 
944.0 
0, 10872.5 
382.0, 2016.0 
69 (1) 
 
1597.2 + 1819.8 
862.0 
0, 11190.0 
368.0, 2332.0 
85 (0) 
 
1691.1 + 1751.9 
1024.3 
0, 8667.0 
520.0, 2181.0 
96 (1) 
0.52 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
796.2 + 1247.6 
380.0 
0, 7200.0 
70.0, 900.0 
67 (3) 
 
549.9 + 938.4 
210.0 
0, 6070.0 
0, 690.0 
83 (2) 
 
752.8 + 1390.1 
292.5 
0, 8715.0  
70.0, 735.0 
93 (4) 
0.23 
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Table A-6  Means (standard deviation) for baseline demographics in overweight and obese adults 
with schizophrenia or schizoaffective disorder who participated in actigraphy monitoring in the 
WAIST study (n=54). 
 
 Valid actigraphy monitoring 
days 
 
 
Varoable 
At least 3 
days   
(n=46) 
0-2  
days  
(n=9) 
Age (yrs) 45.6 (9.8) 45.2 (8.9) 
BMI (kg/m2) 37.9 (8.1) 40.1 (6.4) 
Male [N (%)] 17 (37.0) 4 (44.4) 
Current Smoker [N (%)] 16 (34.8) 4 (44.4) 
Race [N (%)] 
   White 
   Black 
   Other 
 
19 (41.3) 
26 (56.5) 
1 (2.2) 
 
3 (33.3) 
6 (66.7) 
0 (0) 
Positive and Negative Syndrome Scale (PANSS) 58.8 (15.9) 58.2 (10.2) 
Global Assessment of Functioning Scale  (GAF) Score 58.5 (8.2) 58.7 (6.7) 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill, very mild or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
20 (43.5) 
24 (52.2) 
2 (4.4) 
 
3 (33.3) 
6 (66.7) 
0 (0) 
General Health Status [N (%)]   
   Excellent, Very good, or Good 
   Fair or Poor 
   Missing 
 
23 (50.0) 
21 (45.7) 
2 (4.4) 
 
5 (55.6) 
4 (44.4) 
0 (0) 
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Table A-7  Mean (standard deviation) for demographics and objective physical activity monitoring at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by gender 
(n=46). 
 
 
 
Variable 
 
Men 
(n=17) 
 
Women 
(n=29) 
p-value for 
Kruskal-
Wallis Test 
Age (yrs) 45.9 (12.0) 45.4 (8.5) 0.58 
BMI (kg/m2) 35.5 (5.0) 39.4 (9.3) 0.17 
Current Smoker [N (%)] 5 (29.4) 11 (37.9) 0.56a 
Race [N (%)] 
   White 
   Black 
   Other 
 
11 (64.7) 
5 (29.4) 
1 (5.9) 
 
8 (27.6) 
21 (72.4) 
0 (0) 
0.01b 
Positive and Negative Syndrome Scale (PANSS) 58.2 (16.5) 59.2 (15.9) 1.00 
Global Assessment of Functioning Scale (GAF) Scores 60.1 (9.1) 57.7 (7.7) 0.34 
Clinical Global Impression of Severity (CGI-S) [N (%)]    
   Normal, not mentally ill, very mild, or mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
8 (47.1) 
7 (41.2) 
2 (11.8) 
 
12 (41.4) 
17 (58.6) 
0 (0) 
0.15 b 
General Health Status [N (%)]   
   Excellent, Very good, or Good 
   Fair or Poor 
   Missing 
 
9 (52.9) 
8 (47.1) 
0 (0) 
 
14 (48.3) 
13 (44.8) 
2 (6.9) 
0.94 b 
Monitoring Period 
   Days 
   Mins/day 
 
7.2 (2.9) 
925 + 140 
 
7.4 (2.8) 
937 (156) 
 
0.77 
0.79 
Sedentary  
   Mins/day 
   % of wear time 
 
758 (136) 
82 (6) 
 
756 (144) 
81 (6) 
 
0.95 
0.56 
Light Activity  
   Mins/day 
   % of wear time 
 
146 (41) 
16 (4) 
 
164 (51) 
18 (5) 
 
0.39 
0.45 
Moderate/Vigorous Activity  
   Mins/day 
   % of wear time 
 
21 (15) 
2 (2) 
 
17 (9) 
2 (1) 
 
0.60 
0.67 
Total Activity  
   Mins/day 
    % of wear time 
 
167 + 52 
18 (6) 
 
181 (56) 
19 (6) 
 
0.49 
0.56 
Activity  
   Counts/day 
   Counts/min 
 
157202 (73296) 
171 (78) 
 
147421 (53603) 
159 (55) 
 
0.83 
0.67 
a Chi-square test 
b Fischer’s Exact Test 
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Table A-8  Mean (standard deviation) for demographics and objective physical activity monitoring at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by race 
(n=45a). 
 
 
 
Variable 
 
White 
(n=19) 
 
Black  
(n=26) 
p-value for 
Kruskal-Wallis 
Test 
Age (yrs) 48.2 (9.5) 43.0 (9.1) 0.05 
BMI (kg/m2) 34.7 (4.7) 40.6 (9.2) 0.007 
Male [N (%)] 11 (57.9) 5 (19.2) <0.01b 
Current Smoker [N (%)] 3 (15.8) 13 (50.0) 0.02 b 
Positive and Negative Syndrome Scale PANSS) 60.7 (15.0) 56.7 (16.5) 0.26 
Global Assessment of Functioning Scale (GAF) Scores 56.7 (8.4) 59.5 (8.0) 0.26 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
5 (26.3) 
13 (68.4) 
1 (5.3) 
 
10 (38.5) 
15 (57.7) 
1 (3.9) 
0.14 c 
General Health Status [N (%)]   
   Excellent, Very good, or Good 
   Fair or Poor 
   Missing 
 
12 (63.2) 
6 (31.6) 
1 (5.3) 
 
10 (38.5) 
15 (57.7) 
1 (3.9) 
0.08 b 
Monitoring period 
   Days 
   Mins/day 
 
7.9 (2.9) 
987 (150) 
 
7.1 (2.8) 
896 (140) 
 
0.37 
0.02 
Sedentary  
   Mins/day 
   % of wear time 
 
803 (148) 
81 (5) 
 
724 (129) 
81 (6) 
 
0.07 
0.96 
Light Activity  
   Mins/day 
   % of wear time 
 
164 (42) 
17 (4) 
 
155 (52) 
17 (5) 
 
0.29 
0.93 
Moderate/Vigorous Activity  
   Mins/day 
   % of wear time 
 
20 (13) 
2 (1) 
 
18 (11) 
2 (1) 
 
0.32 
0.84 
Total Activity  
   Mins/day 
   % of wear time 
 
184 (50)  
19 (5) 
 
173 (57) 
19 (6) 
 
0.43 
0.81 
Activity  
   Counts/day 
   Counts/min 
 
161197 (60318) 
165 (60) 
 
147426 (59936) 
165 (66) 
 
0.43 
0.70 
a n=1 for other race; size of other race category considered insufficient to include in analyses  
b Chi-square test 
c Fischer’s Exact Test 
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Table A-9  Mean (standard deviation) for demographics and objective physical activity monitoring at baseline in overweight and 
obese adults with schizophrenia or schizoaffective disorder in the actigraphy cohort by age groups (n=46). 
 
 
 
 
Variable 
 
 
18-39 yrs 
(n=11) 
 
 
40-49 yrs 
(n=15) 
 
 
50-65 yrs 
(n=20) 
p-value  
Kruskal-
Wallis 
Test 
Age (yrs) 30.8 (2.8) 45.1 (3.2) 54.1 (3.6) < 0.0001 
BMI (kg/m2) 44.5 (12.2) 37.6 (5.1) 34.6 (4.7) < 0.01 
Male [N (%)] 5 (45.5) 3 (20.0) 9 (45.0) 0.25 a 
Current Smoker [N (%)] 4 (36.4) 7 (46.7) 5 (25.0) 0.41 a 
Race [N (%)] 
   White 
   Black 
   Other 
 
3 (27.3) 
8 (72.7) 
0 (0) 
 
4 (26.7) 
11 (73.3) 
0 (0) 
 
12 (60.0) 
7 (35.0) 
1 (5.0) 
0.05 a,b 
Positive and Negative Syndrome Scale (PANSS) 54.5 (12.5) 63.1 (17.1) 58.0 (16.7) 0.48 
Global Assessment of Functioning Scale (GAF) Scores 60.1 (8.4) 57.8 (9.0) 58.4 (7.8) 0.74 
Clinical Global Impression of Severity (CGI-S) [N (%)] 
   Normal, not mentally ill; very mild; mild mental illness 
   Moderate or severe mental illness 
   Not assessed 
 
6 (54.6) 
3 (27.3) 
2 (18.2) 
 
8 (53.3) 
7 (46.7) 
0 (0) 
 
6 (30.0) 
14 (70.0) 
0 (0) 
0.62 c 
General Health Status [N (%)]   
   Excellent, Very good, or Good 
   Fair or Poor 
   Missing 
 
4 (36.4) 
6 (54.6) 
1 (9.1) 
 
 9 (60.0) 
6 (40.0) 
0 (0) 
 
10 (50.0) 
9 (45.0) 
1 (5.0) 
0.62 c 
Monitoring period 
   Days 
   Mins/day 
 
7.5 (3.4) 
897 (119) 
 
7.0 (2.4) 
897 (125) 
 
7.6 (2.8) 
979 (172) 
 
0.88 
0.23 
Sedentary  
   Mins/day 
   % of wear time 
 
725 (112) 
81 (5) 
 
731 (119) 
82 (5) 
 
792 (164) 
81 (6) 
 
0.32 
0.96 
Light Activity  
   Mins/day 
   % of wear time 
 
151 (46) 
17 (5) 
 
150 (43) 
17 (4) 
 
166 (52.9) 
17 (6) 
 
0.58 
0.99 
Moderate/Vigorous Activity  
   Mins/day 
   % of wear time 
 
20 (13) 
2 (2) 
 
15 (9) 
2 (0.9) 
 
21 (13) 
2 (1) 
 
0.30 
0.46 
Total Activity  
   Mins/day 
   % of wear time 
 
171 (53) 
19 (5) 
 
165 (48) 
18 (5) 
 
187 (60) 
19 (6) 
 
0.49 
0.96 
Activity 
   Counts/day 
   Counts/min 
 
157672 (60292) 
170 (213) 
 
130507 (52731) 
147 (58) 
 
162783 (65930) 
168 (68) 
 
0.19 
0.49 
a Chi-square test 
b Excluded other race category from the analysis due to insufficient numbers for analyses 
c Fischer’s Exact Test 
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Table A-10 Subjective physical activity [Modified MAQ (METS per week)] at baseline in overweight and obese men 
and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by gender (n=46). 
 
 
 
Modified MAQ (MET/ wk)  
Actigraphy 
Cohort 
(n=46) 
 
Female 
(n=29) 
 
Male  
(n=17) 
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
40.0 + 268.3 
0 
0, 1800.0 
0, 0 
45 (1) 
 
64.3 + 340.2 
0 
0, 1800.0 
0, 0 
28 (1) 
 
0 + 0 
0 
0, 0 
0, 0 
17 (0) 
0.44 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1011.7 + 1093.2 
536.8 
0, 4459.5 
229.5, 1429.0 
46 (0) 
 
1108.0 + 
1194.8 
557.5 
0, 4459.5 
305.0, 1759.5 
29 (0) 
 
847.3 + 904.2 
471.0 
0, 2886.0 
229.5, 1064.0 
17 (0) 
0.56 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
47.1 + 168.2 
0 
0, 975.0 
0, 0 
46 (0) 
 
22.2 + 101.5 
0 
0, 540.0 
0, 0 
29 (0) 
 
89.6 + 241.8 
0 
0, 975.0 
0, 0 
17 (0) 
0.11 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
18.3 + 123.9 
0 
0, 840.0 
0, 0 
46 (0) 
 
29.0 + 156.0 
0 
0, 840.0 
0, 0 
29 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
17 (0) 
0.44 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
106.4 + 217.7 
0 
0, 1050.0 
0, 105.0 
46 (0) 
 
92.4 + 225.1 
0 
0, 1050.0 
0, 90.0 
29 (0) 
 
130.1 + 208.8 
0 
0, 700.0 
0, 210.0 
17 (0) 
0.39 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
474.1 + 704.1 
70.0 
0, 2940.0 
0, 780.0 
45 (1) 
 
475.3 + 717.4 
0 
0, 2940.0 
0, 997.5 
28 (1) 
 
472.1 + 703.6 
157.5 
0, 2535.0 
0, 517.5 
17 (0) 
0.62 
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Table A-10 (continued)  Subjective physical activity [Modified MAQ (ETS per week)] at baseline in overweight and 
obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by gender (n=46). 
 
 
 
 
Modified MAQ (MET/ wk)  
Actigraphy 
Cohort 
(n=46) 
 
Female 
(n=29) 
 
Male  
(n=17) 
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1698.8 + 1623.5 
1007.3 
0, 6600.0 
696.3, 2621.5 
44 (2) 
 
1799.3 + 1792.9 
1429.0 
0, 6600.0 
693.0, 2809.5 
27 (2) 
 
1539.2 + 1347.6 
974.5 
0, 4173.0 
719.5, 2434.0 
17 (0) 
0.98 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1633.4 + 1528.1 
974.5 
0, 6600.0 
693.0, 2543.0 
45 (1) 
 
1690.7 + 1649.2 
1112.8 
0, 6600.0 
625.3, 2676.3 
28 (1) 
 
1539.2 + 1347.6 
974.5 
0, 4173.0 
719.5, 2434.0 
17 (0) 
0.88 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
637.0 + 815.5 
363.8 
0, 2940.0 
0, 1062.5 
44 (2) 
 
658.8 + 864.0 
210.0 
0, 2940.0 
0, 1102.5 
27 (2) 
 
602.3 + 765.5 
405.0 
0, 2745.0 
70.0, 577.5 
17 (0) 
0.70 
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Table A-11 Subjective physical activity [Modified MAQ (minutes per week)] at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the 
actigraphy cohort by race (n=45a). 
 
   
 
 
Modified MAQ (mins/wk) 
 
White 
(n=19) 
 
Black  
(n=26)  
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
23.7 + 103.2 
0 
0, 450.0 
0, 0 
19 (0) 
 
0 + 0 
0 
0, 0  
0, 0 
25 (1) 
0.25 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
421.4 + 478.6 
202.0 
0, 1350.0 
99.0, 1020.0 
19 (0) 
 
400.5 + 425.2 
230.0 
0, 1725.0 
90.0, 580.0 
26 (0) 
0.84 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
21.3 + 54.6 
0 
0, 210.0 
0, 0 
19 (0) 
 
3.5 + 12.9 
0 
0, 60.0 
0, 0 
26 (0) 
0.18 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
23.7 + 103.2 
0 
0, 450.0 
0, 0 
19 (0) 
 
0 + 0 
0 
0, 0  
0, 0 
25 (1) 
0.25 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
421.4 + 478.6 
202.0 
0, 1350.0 
99.0, 1020.0 
19 (0) 
 
400.5 + 425.2 
230.0 
0, 1725.0 
90.0, 580.0 
26 (0) 
0.84 
a n=1 for other race; size of other race category considered insufficient to include in analyses 
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Table A-11 (continued)  Subjective physical activity [Modified MAQ (minutes per week)] at 
baseline in overweight and obese men and women with schizophrenia or schizoaffective disorder in 
the actigraphy cohort by race (n=45a). 
 
 
 
Modified MAQ (mins/wk) 
 
White 
(n=19) 
 
Black  
(n=26)  
p-value for 
Kruskal-Wallis 
Test 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0,0 
0,0 
19 (0) 
 
8.1 + 41.2 
0 
0, 210.0  
0, 0 
26 (0) 
0.39 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
39.7 + 82.0 
0 
0, 300.0 
0, 45.0 
19 (0) 
 
23.8 + 43.9 
0 
0, 180.0 
0, 30.0 
26 (0) 
0.89 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
139.3 + 215.6 
20.0 
0, 840.0 
0, 210.0 
19 (0) 
 
101.2 + 135.2 
15.0 
0, 450.0 
0, 135.0 
25 (1) 
0.78 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
645.4 + 655.0 
328.0 
0, 2160.0 
239.0, 1020.0 
19 (0) 
 
529.2 + 482.1 
372.5 
0, 1830.0 
210.0, 861.0 
24 (2) 
0.73 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
621.7 + 610.7 
328.0 
0, 2160.0 
239.0, 1020.0 
19 (0) 
 
517.8 + 475.4 
345.0 
0, 1830.0 
210.0, 775.0 
25 (1) 
0.68 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
202.7 + 255.8 
120.0 
0, 840.0 
0, 360.0 
19 (0) 
 
131.3 + 154.7 
75.0 
0, 510.0 
5.0, 217.5 
24 (2) 
0.62 
a n=1 for other race; size of other race category considered insufficient to include in analyses. 
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Table A-12  Subjective physical activity [Modified MAQ (METS per week)] at baseline in 
overweight and obese men and women with schizophrenia or schizoaffective disorder in the 
actigraphy cohort by race (n=45a). 
 
 
 
Modified MAQ (METS/wk) 
 
White 
(n=19) 
 
Black  
(n=28)  
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
94.7 + 412.9 
0 
0, 0 
0, 1800.0 
19 (0) 
 
0 + 0 
0 
0, 0  
0, 0 
25 (1) 
0.25 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1057.7 + 1189.7 
485.5 
0, 3120.0 
229.5, 2700.0 
19 (0) 
 
979.7 + 1062.7 
554.3 
0, 4459.5 
213.0, 1429.0 
26 (0) 
0.93 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
94.3 + 249.6 
0 
0, 0  
0, 975.0 
19 (0) 
 
14.4 + 56.0 
0 
0, 0  
0, 0 
26 (0) 
0.19 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0, 0 
0, 0 
19 (0) 
 
32.3 + 164.7 
0 
0, 840.0  
0, 0 
26 (0) 
0.39 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
142.2 + 288.0 
0 
0, 1050.0  
0, 157.5 
19 (0) 
 
84.2 + 153.7 
0 
0, 630.0 
0, 105.0 
26 (0) 
0.94 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing)) 
 
545.8 + 807.3 
70.0 
0, 2940.0 
0, 945.0 
19 (0) 
 
435.7 + 638.5 
52.5 
0, 2535.0 
0, 540.0 
25 (1) 
0.85 
a n=1 for other race; size of other race category considered insufficient to include in analyses or 
summary table. 
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Table A-12  (continued)  Subjective physical activity [Modified MAQ (METS per week)] at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by race (n=45a). 
  
 
 
Modified MAQ (METS/wk) 
 
White 
(n=19) 
 
Black  
(n=28)  
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1934.8 + 1935.1 
951.0 
0, 6600.0 
714.5, 3453.0 
19 (0) 
 
1539.4 + 1380.6 
1201.8 
0, 4827.0 
598.5, 2488.5 
24 (2) 
0.70 
 Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1840.1 + 1769.6 
951.0 
0, 6600.0 
714.5, 3453.0 
19 (0) 
 
1500.1 + 1365.7 
974.5 
0, 4827.0 
557.5, 2434.0 
25 (1) 
0.64 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
782.8 + 950.9 
420.0 
0, 2940.0 
0, 1680.0 
19 (0) 
 
545.1 + 703.9 
285.0 
0, 2745.0 
17.5, 826.3 
24 (2) 
0.66 
a n=1 for other race; size of other race category considered insufficient to include in analyses or 
summary table. 
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Table A-13 Subjective physical activity [Modified MAQ (minutes per week)] at baseline in overweight and 
obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by age groups 
(n=46). 
 
 
 
Modified MAQ (mins/wk) 
 
18-39 yrs 
(n=11) 
 
40-49 yrs 
(n=15) 
 
50-65 yrs 
(n=20) 
p-value for 
Kruskal-Wallis 
Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0, 0 
0, 0 
10 (1) 
 
0 + 0 
0 
0, 0 
0, 0 
15 (0) 
 
22.5 + 100.6 
0 
0, 450.0 
0, 0 
20 (0) 
0.54 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
234.3 + 286.3 
195.0 
0, 1050.0 
55.0, 245.0 
11 (0) 
 
510.5 + 498.4 
310.0 
0, 1725.0 
90.0, 857.0 
15 (0) 
 
428.2 + 450.4 
207.5 
0, 1350.0 
114.5, 695.0 
20 (0) 
0.31 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
21.8 + 63.1 
0 
0, 210.0 
0, 0 
11 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
15 (0) 
 
12.8 + 31.3 
0 
0, 120.0 
0, 0 
20 (0) 
0.20 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0, 0 
0, 0 
11 (0) 
 
14.0 + 54.2 
0 
0, 210.0 
0, 0 
15 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
20 (0) 
0.36 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
17.7 + 36.7 
0 
0, 120.0 
0, 20.0 
11 (0) 
 
22.0 + 48.7 
0 
0, 180.0 
0, 30.0 
15 (0) 
 
42.5 + 79.6 
0 
0, 300.0 
0, 60.0 
20 (0) 
0.67 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
113.3 + 14.5 
45.0 
0, 420.0 
0, 250.0 
11 (0) 
 
95.0 + 125.1 
0 
0, 315.0 
0, 180.0 
15 (0) 
 
132.9 + 219.4 
20.0 
0, 840.0 
0, 210.0 
19 (1) 
0.86 
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Table A-13 (continued)  Subjective physical activity [Modified MAQ (minutes per week)] at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by age groups 
(n=46). 
 
 
 
Modified MAQ (mins/wk) 
 
18-39 yrs 
(n=11) 
 
40-49 yrs 
(n=15) 
 
50-65 yrs 
(n=20) 
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
401.3 + 388.8 
316.5 
0, 1200.0 
100.0, 485.0 
10 (1) 
 
641.5 + 545.7 
400.0 
0, 1830.0 
271.0, 1005.0 
15 (0) 
 
617.2 + 637.4 
400.0 
0, 2160.0 
239.0, 990.0 
19 (1) 
0.61 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
387.1 + 371.8 
305.0 
0, 1200.0 
100.0, 485.0 
11 (0) 
 
641.5 + 545.7 
400.0 
0, 1830.0 
271.0, 1005.0 
15 (0) 
 
593.5 + 590.6 
400.0 
0, 2160.0 
239.0, 990.0 
19 (1) 
0.49 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
144.1 + 139.2 
123.0 
0, 420.0 
15.0, 270.0 
10 (1) 
 
117.0 + 151.4 
60.0 
0, 495.0 
0, 180.0 
15 (0) 
 
201.3 + 262.9 
90.0 
0, 840.0 
0, 360.0 
19 (1) 
0.59 
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Table A-14  Subjective physical activity [Modified MAQ (METS per week)] at baseline in overweight and obese men and 
women with schizophrenia or schizoaffective disorder in the actigraphy cohort by age groups (n=46). 
 
 
Modified MAQ (METS/ wk) 
18-39 yrs 
(n=11) 
40-49 yrs 
(n=15) 
50-65 yrs 
(n=20) 
p-value for 
Kruskal-Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0, 0 
0, 0 
10 (1) 
 
0 + 0 
0 
0, 0 
0, 0 
15 (0) 
 
90.0 + 402.5 
0 
0, 1800.0 
0, 0 
20 (0) 
0.54 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
585.0 + 686.6 
451.5 
0, 2487.0 
129.5, 451.5 
11 (0) 
 
1262.6 + 1275.7 
727.5 
0, 4459.5 
213.0, 2074.0 
15 (0) 
 
1058.1 + 1107.2 
518.3 
0, 3120.0 
267.3, 1711.5 
20 (0) 
0.37 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
98.2 + 292.5 
0 
0, 975.0 
0, 0 
11 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
15 (0) 
 
54.4 + 136.5 
0 
0, 540.0 
0, 0 
20 (0) 
0.20 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
0 + 0 
0 
0, 0 
0, 0 
11 (0) 
 
56.0 + 216.9 
0 
0, 840.0 
0, 0 
15 (0) 
 
0 + 0 
0 
0, 0 
0, 0 
20 (0) 
0.36 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
63.9 + 128.7 
0 
0, 420.0 
0, 90.0 
11 (0) 
 
77.0 + 170.5 
0 
0, 630.0 
0, 87.5 
15 (0) 
 
151.8 + 279.6 
0 
0, 630.0 
0, 105.0 
20 (0) 
0.66 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
456.9 + 583.0 
157.5 
0, 1710.0 
0, 1050.0 
11 (0) 
 
383.0 + 511.9 
0 
0, 1440.0 
0, 780.0 
15 (0) 
 
555.9 + 897.3 
70.0 
0, 2940.0 
0, 945.0 
19 (1) 
0.83 
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Table A-14  (continued)  Subjective physical activity [Modified MAQ (METS per week)] at baseline in overweight 
and obese men and women with schizophrenia or schizoaffective disorder in the actigraphy cohort by age groups 
(n=46). 
 
 
Modified MAQ (METS/ wk) 
18-39 yrs 
(n=11) 
40-49 yrs 
(n=15) 
50-65 yrs 
(n=20) 
p-value for 
Kruskal-Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1268.6 + 1251.9 
959.3 
0, 3646.0 
287.0, 1662.5 
10 (1) 
 
1778.6 + 1479.4 
1429.0 
0, 4827.0 
699.5, 2809.5 
15 (0) 
 
1862.2 + 1916.9 
1040.0 
0, 6600.0 
719.5, 2700.0 
19 (1) 
0.72 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1203.9 + 1206.9 
944.0 
0, 3646.0 
287.0, 162.5 
11 (0) 
 
1778.6 + 1479.4 
1429.0 
0, 4827.0 
699.5, 2809.5 
15 (0) 
 
1767.5 + 1745.6 
1040.0 
0, 6600.0 
719.5, 2700.0 
19 (1) 
0.58 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
572.9 + 572.1 
490.5 
0, 1710.0 
52.5, 1075.0 
10 (1) 
 
460.0 + 599.1 
210.0 
0, 1845.0 
0, 780.0 
15 (0) 
 
810.4 + 1042.1 
405.0 
0, 2940.0 
0, 1680.0 
19 (1) 
0.54 
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Table A-15  Subjective physical activity [Modified MAQ (minutes or METS per week)] for overweight and 
obese adults with schizophrenia or schizoaffective disorder by GXT testing (WAIST Study) (n=248)a. 
 
 
 
Modified MAQ [Mean + std] 
GXT   
Cohort  
(n=109b) 
Non-volunteers for  
GXT testing 
(n=139) 
p-value for  
Kruskal-Wallis  
Test 
Mins/wk 
   Occupational 
   Housework 
   Gardening/Yardwork 
   Caretaking 
   Transportation 
   Leisure 
   Total  
   Total w/o occupational activities 
   Total w/o household activities 
 
82.0 + 300.4e 
399.3 + 425.4f 
5.6 + 27.2f 
28.6 + 132.9f 
41.6 + 68.2f 
97.4 + 185.6e 
654.4 + 647.9g 
563.6 + 554.0e 
225.0 + 370.3g 
 
30.9 + 191.7c 
420.9 + 563.5 
13.6 + 76.2 
17.2 + 121.1 
45.4 + 96.4 
69.0 + 105.5 
581.1 + 713.4c 
566.1 + 692.5 
138.5 + 218.4c 
 
0.14 
0.68 
0.70 
0.82 
0.94 
0.92 
0.26 
0.69 
0.54 
METS/wk 
   Housework 
   Gardening/Yardwork 
   Caretaking 
   Transportation 
   Leisure 
   Total  
   Total w/o occupational activities 
   Total w/o household activities 
346.7 + 1227.7e 
971.1 + 1041.8f 
24.1 + 121.3f 
114.4 + 531.6f 
146.3 + 238.7f 
413.4 + 827.9e 
2021.1 + 2173.0g 
1650.8 + 1731.9e 
918.1 + 1544.8g 
123.6 + 766.7c 
1045.7 + 1436.3 
53.2 + 276.6 
68.7 + 484.4 
159.6 + 337.7 
281.7 + 455.1 
1677.8 + 2068.6c 
1608.9 + 1968.6 
536.6 + 876.7c 
0.14 
0.69 
0.70 
0.82 
0.94 
0.93 
0.24 
0.69 
0.52 
a 6 participants had incomplete GXT data 
b 2 participants completed the exercise stress testing but were not administered the MAQ 
c n=134 
e n=105 
f n=107 
g n=103 
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Table A-16  Objective physical activity monitoring by actigraphy for overweight and obese 
adults with schizophrenia or schizoaffective disorder by GXT testing (WAIST Study) 
(n=46). 
 
Actigraphy Variables  
[Mean + std] 
GXT   
(n=29) 
No GXT Testing 
(n=17) 
p-value for Kruskal-
Wallis Test 
Monitoring  
   Days 
   Mins/day 
 
7.3 + 2.7 
889.1 + 131.7 
 
7.5 + 3.1 
1006.8 + 151.0 
 
0.94 
0.01 
Sedentary  
   Mins/day 
   % of wear time 
 
726.4 + 115.5 
81.7+4.8 
 
807.9 +164.4 
79.7+6.7 
0.06 
0.49 
Light Activity  
   Mins/day 
   % of wear time 
 
144.4 + 43.4 
16.3+4.1 
 
179.7 +48.3 
18.3+6.0 
0.01 
0.41 
Moderate/Vigorous 
Activity  
   Mins/day 
   % of wear time 
 
18.3 + 11.5 
2.0+1.1 
 
19.2+12.5 
2.0+1.5 
0.93 
0.58 
Total Activity  
   Mins/day 
   % of wear time 
 
162.7+52.3 
18.3+4.8 
 
198.9+51.7 
20.3+6.7 
0.02 
0.49 
Activity counts/day 
Activity counts/min 
140433 + 61770 
156.6+59.2 
169124 +56888 
174.3+72.4 
0.08 
0.50 
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Table A-17  Summary of graded exercise test results for overweight and obese male adults with schizophrenia or 
schizoaffective disorder (WAIST Study) in GXT cohort by race (n=44). 
 
 
Variable 
White 
(n=31) 
Black 
(n=13) 
p-value for 
Kruskal-
Wallis Test 
VO2 Max (mL/kg/min) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
19.2 + 7.1 
17.5 
4.5, 38.4 
15.2, 21.8 
 
17.2 + 5.1 
17.9 
10.3, 29.4 
14.2, 19.5 
0.43 
Minutes on Treadmill 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
9.3 + 3.9 
8.0 
4.0, 18.0  
6.0, 12.0 
 
8.3 + 4.7 
8.0 
2.0, 19.0  
4.0, 10.0 
0.45 
Resting GXT Heart Rate (bpm)  
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
89.2 + 15.7 
87.0 
60.0, 120.0  
78.0, 99.0 
 
88.6 + 9.3 
90.0 
70.0, 106.0 
85.0, 94.0 
0.91 
Peak GXT Heart Rate (bpm)  
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
143.0 + 19.4 
141.0 
112.0, 190.0 
129.0, 155.0 
 
145.2 + 19.7 
144.0 
115.0, 172.0 
131.0, 169.0 
0.84 
Ratings of Perceived Exertion (RPE) N (%) 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
8 (25.8) 
1 (3.2) 
10 (32.3) 
4 (12.9) 
6 (19.4) 
2 (6.5) 
0 (0) 
0 (0) 
 
1 (7.7) 
0 (0) 
0 (0) 
0 (0) 
2 (15.4) 
0 (0) 
2 (15.4) 
2 (15.4) 
4 (30.8) 
0 (0) 
2 (15.4) 
0 (0) 
0.20a 
Ratings of Perceived Exertion (RPE) Categories N (%) 
   6-12 
   13-20 
  
0 (0) 
31 (100.0) 
 
1 (7.7) 
12 (92.3) 
0.30a 
GXT Categories 
   Fit 
   Unfit 
 
2 (6.5) 
29 (93.6) 
 
0 (0) 
13 (0) 
1.00 a 
a Fischer’s Exact Test 
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Table A-18 Summary of graded exercise test results for overweight and obese female adults with 
schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by race (n=64). 
 
 
 
Variable 
 
White 
(n=19) 
 
Black  
(n=45)  
p-value for 
Kruskal-Wallis 
Test 
VO2 Max (mL/kg/min)    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
14.4 + 5.1 
13.4 
7.5, 27.2 
11.3, 17.7 
 
12.2 + 3.5 
11.9 
4.5, 20.3 
9.9, 14.1 
0.11 
Minutes on Treadmill    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
7.1 + 2.4 
6.0 
4.0, 12.0  
6.0, 8.0 
 
6.4 + 2.4 
6.0 
2.0, 12.0  
4.0, 8.0 
0.45 
Resting GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
87.5 + 12.7 
91.0 
62.0, 108.0  
77.0, 98.0 
 
87.5 + 12.7 
91.0 
62.0, 108.0 
77.0, 98.0 
0.95 
Peak GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
139.7 + 20.4 
142.0 
72.0, 186.0 
123.0, 152.0 
 
139.7 + 20.4 
142.0 
72.0, 186.0 
123.0, 152.0 
0.89 
Ratings of Perceived Exertion (RPE) N (%) 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
4 (22.2) 
2 (11.1) 
6 (33.3) 
1 (5.6) 
4 (22.2) 
1 (5.6) 
0 (0) 
0 (0) 
 
1 (2.4) 
0 (0) 
3 (7.1) 
1 (2.4) 
14 (33.3) 
4 (9.5) 
11 (26.2) 
2 (4.8) 
5 (11.9) 
0 (0) 
0 (0) 
1 (2.4) 
0.78a 
 
Ratings of Perceived Exertion (RPE) Categories N (%) 
   6-12 
   13-20 
  
0 (0) 
18 (100.0) 
 
4 (9.5) 
38 (90.5) 
0.31a 
GXT Categories 
   Fit 
   Unfit 
 
0 (0) 
19 (90.5) 
 
0 (0) 
45 (95.7) 
------ 
a Fischer’s Exact Test 
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Table A-19  Summary of graded exercise test results for overweight and obese male adults with schizophrenia or 
schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=45). 
 
 
 
Variable 
 
18-39 yrs 
(n=6) 
 
40-49 yrs 
(n=16) 
 
50-65 yrs 
(n=23) 
p-value for 
Kruskal-
Wallis Test 
VO2 Max (mL/kg/min)    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
19.3 + 4.6 
18.0 
15.8, 27.8 
15.9, 20.4 
 
19.4 + 7.2 
17.7 
11.2, 38.4 
13.9, 21.9 
 
17.6 + 6.7 
16.7 
4.5, 36.4 
14.2, 19.5 
0.60 
Minutes on Treadmill    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
10.5 + 4.1 
9.0 
7.0, 18.0 
8.0, 12.0 
 
10.3 + 4.7 
8.0 
6.0, 19.0 
6.0, 13.5 
 
7.6 + 3.4 
8.0 
2.0, 16.0 
4.0, 10.0 
0.17 
Resting GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
109.8 + 8.7 
110.0 
97.0, 120.0 
105.0, 117.0 
 
88.4 + 12.8 
87.5 
70.0, 114.0 
77.0, 95.0 
 
84.0 + 10.6 
85.0 
60.0, 99.0 
79.0, 93.0 
0.001 
Peak GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
180.7 + 22.7 
159.5 
129.0, 190.0 
147.0, 179.0 
 
141.6 + 19.5 
142.5 
112.0, 183.0 
129.5, 150.5 
 
142.7 + 19.3 
139.0 
112.0, 192.0 
129.0, 159.0 
0.18 
Ratings of Perceived Exertion (RPE) N (%) 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
3 (50.0) 
0 (0) 
2 (33.3) 
0 (0) 
1 (16.7) 
0 (0) 
0 (0) 
0 (0) 
 
1 (6.3) 
0 (0) 
0 (0) 
0 (0) 
4 (25.0) 
1 (6.3) 
6 (37.5) 
1 (6.3) 
1 (6.3) 
0 (0) 
2 (12.5) 
0 (0) 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
3 (13.0) 
0 (0) 
5 (21.7) 
5 (21.7) 
8 (34.8) 
2 (8.7) 
0 (0) 
0 (0) 
0.12a 
Ratings of Perceived Exertion (RPE) Categories N (%) 
   6-12 
   13-20 
 
0 (0) 
6 (100.0) 
 
1 (6.3) 
15 (93.8) 
 
0 (0) 
23 (100.0) 
0.49a 
GXT Categories 
   Fit 
   Unfit 
 
0 (0) 
6 (100.0) 
 
1 (6.3) 
15 (93.8) 
 
1 (4.4) 
22 (95.7) 
1.00 
a Fischer’s Exact Test 
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Table A-20  Summary of graded exercise test results for overweight and obese female adults with schizophrenia or 
schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=64). 
 
 
 
Variable 
 
18-39 yrs 
(n=17) 
 
40-49 yrs 
(n=26) 
 
50-65 yrs 
(n=21) 
p-value for 
Kruskal-
Wallis Test 
VO2 Max (mL/kg/mins)    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
15.1 + 5.3 
15.1 
7.6, 27.2 
11.5, 18.1 
 
12.4 + 3.3 
12.2 
4.5, 20.2 
10.5, 13.8 
 
11.5 + 3.4 
11.4 
5.4, 20.7 
9.1, 13.6 
0.11 
Minutes on Treadmill    
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
8.3 + 2.7 
8.0 
4.0, 12.0 
6.0, 11.0 
 
6.5 + 2.0 
6.0 
4.0, 12.0 
6.0, 8.0 
 
5.5 + 2.1 
6.0 
2.0, 8.0 
4.0, 8.0 
0.007 
Resting GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
86.0 + 16.7 
82.0 
62.0, 126.0 
76.0, 95.0 
 
91.2 + 11.2 
91.5 
66.0, 114.0 
83.0, 99.0 
 
85.2 + 14.2 
84.0 
61.0, 105.0 
73.0, 98.0 
0.24 
Peak GXT Heart Rate (bpm) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
 
150.1 + 18.1 
150.0 
118.0, 186.0 
136.0, 159.0 
 
136.8 + 21.3 
142.0 
72.0, 169.0 
123.0, 152.0 
 
136.6 + 22.3 
139.0 
97.0, 187.0 
120.0, 151.0 
0.10 
Ratings of Perceived Exertion (RPE) N (%) 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
 
0 (0) 
0 (0) 
1 (5.9) 
0 (0) 
4 (23.5) 
0 (0) 
6 (35.3) 
2 (11.8) 
4 (23.5) 
0 (0) 
0 (0) 
0 (0) 
 
1 (4.4) 
0 (0) 
1 (4.4) 
0 (0) 
5 (21.7) 
4 (17.4) 
7 (30.4) 
1 (4.4) 
4 (17.4) 
0 (0) 
0 (0) 
0 (0) 
 
0 (0) 
0 (0) 
1 (5.0) 
1 (5.0) 
9 (45.0) 
2 (10.0) 
4 (20.0) 
0 (0) 
1 (5.0) 
1 (5.0) 
0 (0) 
1 (4.6) 
0.37a 
Ratings of Perceived Exertion (RPE) Categories N (%) 
   6-12 
   13-20 
 
1 (5.9) 
16 (94.1) 
 
2 (8.7) 
21 (91.3) 
 
1 (5.0) 
19 (95.0) 
1.00 
GXT Categories 
   Fit 
   Unfit 
 
0 (0) 
17 (100.0) 
 
0 (0.0) 
26 (100.0) 
 
0 (0.0) 
21 (100.0) 
----- 
a Fischer’s Exact Test 
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Table A-21  Subjective physical activity [MAQ (METS per week)] of overweight and obese adults with 
schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by gender (n=109). 
 
 
 
Variable 
 
GXT Cohort 
(n=109) 
 
Male 
(n=45) 
 
Female  
(n=64) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
341. 7 + 1227.7 
0 
0, 5847.0 
0, 0 
105 (4) 
 
429.8 + 1389.2 
0 
0, 6000.0 
0, 0 
43 (2) 
 
280.6 + 1110.0 
0 
0, 7200.0 
0, 0 
62 (2) 
0.76 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing)) 
 
971.1 + 1041.8 
580.5 
0, 5847.0 
292.0, 1368.0 
107 (2) 
 
661.5 + 723.7 
387.3 
0, 3132.0 
238.2, 709.5 
44 (1) 
 
1187.4 + 1173.4 
842.0 
0, 5847.0 
357.0, 1706.0 
63 (1) 
0.005 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
24.1 + 121.3 
0 
0, 1080.0 
0, 0 
107 (2) 
 
41.6 + 169.7 
0 
0, 0 
0, 1780.0 
44 (1) 
 
11.9 + 69.3 
0 
0, 540.0 
0, 0 
63 (1) 
0.29 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing)) 
 
114.4 + 531.6 
0 
0, 3600.0 
0, 0 
107 (2) 
 
76.4 + 506.5 
0 
0, 3360.0 
0, 0 
44 (1) 
 
141.0 + 550.9 
0 
0, 3600.0 
0, 0 
63 (1) 
0.10 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
146.3 + 238.7 
0 
0, 1225.0 
0, 210.0 
107(2) 
 
146.9 + 266.7 
0 
0, 1225.0 
0, 157.5 
44 (1) 
 
145.9 + 219.3 
0 
0, 1050.0 
0, 210.0 
63 (1) 
0.70 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing)) 
 
413.4 + 827.9 
0 
0, 4530.0 
0, 360.0 
105 (4) 
 
223.2 + 546.0 
35.0 
0, 3240.0 
0, 210.0 
44 (1) 
 
550.5 + 963.8 
0 
0, 4530.0 
0, 735.0 
61 (4)  
0.23 
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Table A-21  (continued) Subjective physical activity [MAQ (METS per week)] of overweight and obese adults with 
schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by gender (n=109). 
 
 
 
 
Variable 
 
GXT Cohort 
(n=109) 
 
Male 
(n=45) 
 
Female  
(n=64) 
p-value for 
Kruskal-
Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
2021.1 + 2173.0 
1067.5 
0, 11715.0 
490.5, 2700.0 
103 (6) 
 
1596.8 + 1705.2 
902.5 
0, 6211.0 
446.0, 2181.5 
43 (2) 
 
2325.2 + 2422.5 
1839.8 
0, 11715.0 
618.6, 3279.8 
60 (5) 
0.13 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1650.8 + 1731.9 
951.0 
0, 9836.0 
477.0, 2300.5 
105 (4) 
 
1150.0 + 1189.0 
723.5 
0, 5278.0 
408.9, 1494.5 
44 (1) 
 
2012.4 + 1966.9 
1603.5 
0, 9836.0 
641.5, 2611.5 
61 (4) 
0.02 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing)  
 
918.1 + 1544.8 
315.0 
0, 8715.0 
0, 1140.0 
103 (6) 
 
806.0 + 1485.2 
215.0 
0, 6070.0 
0, 560.0 
43 (2) 
 
998.4 + 1593.7 
435.0 
0, 8715.0 
0, 1233.8 
60 (5) 
0.37 
  
 198 
 
 
  
Table A-22  Subjective physical activity [Modified MAQ (minutes per week)] of overweight and 
obese adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by race 
(n=108)a 
. 
 
 
Variable 
 
White 
(n=50) 
 
Black  
(n=58)  
p-value for 
Kruskal-Wallis 
Test 
Occupational (mins/wk) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
92.6 + 284.9 
0 
0, 1200.0 
0, 0 
0 (0) 
 
74.7 + 317.1 
0 
0, 1800.0 
0, 0 
0 (0) 
0.58 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
320.7 + 343.6 
195.0 
0, 1320.0 
110.0, 345.0 
49 (1) 
 
467.3 + 480.8 
310.0 
0, 2490.0 
135.0, 735.0 
57 (1) 
0.13 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
11.2 + 39.4 
0 
0, 240.0 
0, 0 
49 (1) 
 
0.9 + 4.3 
0 
0, 30.0 
0, 0 
57 (1) 
0.07 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
27.3 + 136.9 
0 
0, 840.0 
0, 0 
49 (1) 
 
30.2 + 131.7 
0 
0, 900.0 
0, 0 
57 (1) 
0.57 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
53.9 + 86.7 
0 
0, 350.0 
0, 60.0 
49 (1) 
 
31.8 + 45.7 
0 
0, 180.0 
0, 60.0 
57 (1) 
0.88 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
60.7 + 153.2 
0 
0, 840.0 
0, 50.0 
49 (1) 
 
131.5 + 207.3 
35.0 
0, 875.0 
0, 210.0 
55 (3) 
0.07 
a Other race (n=1) excluded from analyses and summary due to insufficient numbers 
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Table A-22 (continued)   Subjective physical activity [Modified MAQ (minutes per week)] of overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by race (n=108)a 
 
 
Variable 
 
White 
(n=50) 
 
Black  
(n=58)  
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
578.2 + 553.3 
350.0 
0, 2160.0 
190.0, 745.0 
47 (3) 
 
724.1 + 721.7 
540.0 
0, 3390.0 
170.0, 998.0 
55 (3) 
0.41 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
473.8 + 474.5 
315.0 
0, 2160.0 
185.0, 625.0 
49 (1) 
 
646.6 + 613.3 
465.0 
0, 2630.0 
150.0, 975.0 
55 (3) 
0.23 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
209.8 + 328.7 
60.0 
0, 1320.0 
0, 210.0 
47 (3) 
 
241.8 + 407.1 
105.0 
0, 2130.0 
0, 315.0 
55 (3) 
0.56 
a Other race (n=1) excluded from analyses and summary due to insufficient numbers 
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Table A-23 Subjective physical activity [Modified MAQ (METS per week)] of overweight 
and obese adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT 
cohort by race (n=108)a. 
 
 
Subjective Physical Activity 
(METS/wk) 
 
White 
(n=50) 
 
Black  
(n=58)  
p-value for 
Kruskal-Wallis 
Test 
Occupational (mins/wk) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
370.2 + 1139.8 
0 
0, 4800.0 
0, 0 
47 (3) 
 
324.2 + 1314.9 
0 
0, 7200.0 
0, 0 
57 (1) 
0.59 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
789.6 + 859.3 
490.5 
0, 3229.0 
283.0, 842.0 
49 (1) 
 
1127.1 + 1169.6 
749.0 
0, 5847.0 
306.0, 1706.0 
57 (1) 
0.15 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
49.1 + 176.2 
0 
0, 1080.0 
0, 0 
49 (1) 
 
3.1 + 15.2 
0 
0, 105.0 
0, 0 
57 (1) 
0.06 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
109.4 + 547.6 
0 
0, 3360.0 
0, 0 
49 (1) 
 
120.7 + 526.9 
0 
0, 3600.0 
0, 0 
57 (1) 
0.57 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
189.8 + 303.7 
0 
0, 1225.0 
0, 245.0 
49 (1) 
 
111.5 + 159.8 
0 
0, 630.0 
0, 210.0 
57 (1) 
0.86 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
250.1 + 646.8 
0 
0, 3240.0 
0, 210.0 
49 (1) 
 
565.0 + 947.9 
140.0 
0, 4530.0 
0, 975.0 
55 (3) 
0.07 
a  Other race (n=1) excluded from analyses and summary due to insufficient numbers. 
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Table A-23 (continued)  Subjective physical activity [Modified MAQ (METS per week)] of overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by race (n=108)a. 
 
 
  
 
Subjective Physical Activity 
(METS/wk) 
 
White 
(n=50) 
 
Black  
(n=58)  
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1795.2 + 1808.2 
951.0 
0, 6600.0 
490.5, 2700.0 
47 (3) 
 
2232.1 + 2454.9 
1662.5 
0, 11715.0 
446.0, 2809.5 
55 (3) 
0.47 
Total w/o occupational 
activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1388.0 + 1438.8 
902.5 
0, 6600.0 
490.5, 1879.0 
49 (1) 
 
1896.1 + 1950.8 
1530.0 
0, 9836.0 
345.0, 2543.0 
55 (3) 
0.27 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
820.9 + 1316.0 
245.0 
0, 5160.0 
0, 735.0 
47 (3) 
 
1016.6 + 1732.4 
380.0 
0, 8715.0 
0, 1207.5 
55 (3) 
0.51 
a  Other race (n=1) excluded from analyses and summary due to insufficient numbers. 
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Table A-24  Subjective physical activity [Modified MAQ (minutes per week)] of overweight and obese adults 
with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=109). 
 
 
Subjective Physical Activity 
(mins/wk) 
 
18-39 yrs 
(n=23) 
 
40-49 yrs 
(n=42) 
 
50-65 yrs 
(n=44) 
p-value for 
Kruskal-Wallis 
Test 
Occupational (mins/wk) 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
31.3 + 150.1 
0 
0, 720.0 
0, 0 
23 (0) 
 
57.1 + 267.0 
0 
0, 1500.0 
0, 0 
42 (0) 
 
137.3 + 384.2 
0 
0, 1800.0 
0, 0 
40 (4) 
0.17 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
332.9 + 312.0 
215.0 
0, 1050.0 
90.0, 570.0 
23 (0) 
 
397.6 + 402.4 
297.5 
0, 1725.0 
135.0, 600.0 
42 (0) 
 
437.4 + 499.7 
207.5 
0, 2490.0 
130.0, 540.0 
42 (2) 
0.70 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
2.2 + 6.7 
0 
0, 30.0 
0, 0 
23 (0) 
 
2.7 + 10.7 
0 
0, 60.0 
0, 0 
42 (0) 
 
10.4 + 41.7 
0 
0, 240.0 
0, 0 
42 (2) 
0.93 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
40.0 + 187.5 
0 
0, 900.0 
0, 0 
23 (0) 
 
32.4 + 138.4 
0 
0, 840.0 
0, 0 
42 (0) 
 
18.6 + 86.4 
0 
0, 480.0 
0, 0 
42 (2) 
0.74 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
27.0 + 43.1 
0 
0, 180.0 
0, 40.0 
23 (0) 
 
41.2 + 73.0 
0 
0, 350.0 
0, 60.0 
42 (0) 
 
50.0 + 74.1 
0 
0, 300.0 
0, 60.0 
42 (2) 
0.69 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
104.5 + 190.8 
20.0 
0, 780.0 
0, 120.0 
22 (1) 
 
91.0 + 169.7 
0 
0, 840.0 
0, 90.0 
42 (0) 
 
100.1 + 202.1 
15.0 
0, 875.0 
0, 90.0 
41 (1) 
0.99 
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Table A-24  (continued) Subjective physical activity [Modified MAQ (minutes per week)] of overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=109). 
 
 
  
 
Subjective Physical Activity 
(mins/wk) 
 
18-39 yrs 
(n=23) 
 
40-49 yrs 
(n=42) 
 
50-65 yrs 
(n=44) 
p-value for 
Kruskal-Wallis 
Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
513.7 + 547.3 
340.0 
0, 2320.0 
100.0, 735.0 
22 (1) 
 
622.0 + 529.0 
452.5 
0, 1830.0 
205.0, 975.0 
42 (0) 
 
768.6 + 795.7 
465.0 
0, 3390.0 
190.0, 1050.0 
39 (5) 
0.39 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
481.0 + 531.3 
340.0 
0, 2320.0 
100.0, 735.0 
22 (1) 
 
564.9 + 504.8 
347.5 
0, 1830.0 
95.0, 815.0 
42 (0) 
 
606.7 + 618.8 
340.0 
0, 2630.0 
185.0, 905.0 
41 (3) 
0.55 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
165.5 + 229.2 
60.0 
0, 780.0 
10.0, 230.0 
22 (1) 
 
189.3 + 304.4 
60.0 
0, 1520.0 
0, 210.0 
42 (0) 
 
297.2 + 479.8 
110.0 
0, 2130.0 
0, 315.0 
39 (5) 
0.75 
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Table A-25  Subjective physical activity [Modified MAQ (METS per week)] of overweight and obese adults with 
schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=109). 
 
 
Subjective Physical Activity 
(mins/wk) 
 
18-39 yrs 
(n=23) 
 
40-49 yrs 
(n=42) 
 
50-65 yrs 
(n=44) 
p-value for 
Kruskal-
Wallis Test 
Occupational 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
125.2 + 600.5 
0 
0, 2280.0 
0, 0 
23 (0) 
 
228.6 + 1068.0 
0 
0, 6000.0 
0, 0 
42 (0) 
 
585.0 + 1585.8 
0 
0, 7200.0 
0, 0 
40 (4) 
0.16 
Housework 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
821.7 + 743.7 
580.5 
0, 2487.0 
240.0, 1381.5 
23 (0) 
 
969.4 + 1018.1 
694.8 
0, 4459.5 
328.5, 1431.0 
42 (0) 
 
1054.6 + 1205.4 
481.3 
0, 5847.0 
305.0, 1260.5 
42 (2) 
0.78 
Gardening/Yardwork 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
8.0 + 24.1 
0 
0, 105.0 
0, 0 
23 (0) 
 
11.8 + 47.9 
0 
0, 270.0 
0, 0 
42 (0) 
 
45.2 + 186.2 
0 
0, 1080.0 
0, 0 
42 (2) 
0.93 
Caretaking 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
160.0 + 750.1 
0 
0, 3600.0 
0, 0 
23 (0) 
 
129.5 + 553.5 
0 
0, 3360.0 
0, 0 
42 (0) 
 
74.3 + 345.5 
0 
0, 1920.0 
0, 0 
42 (2) 
0.74 
Transportation 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
95.2 + 150.9 
0 
0, 630.0 
0, 140.0 
23 (0) 
 
144.2 + 255.5 
0 
0, 1225.0 
0, 210.0 
42 (0) 
 
176.4 + 259.7 
0 
0, 1050.0 
0, 270.0 
42 (2) 
0.68 
Leisure 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
503.3 + 1013.4 
80.0 
0, 4530.0 
0, 540.0 
22 (1) 
 
381.3 + 740.3 
0 
0, 3240.0 
0, 360.0 
42 (0) 
 
398.0 + 821.9 
60.0 
0, 3937.5 
0, 315.0 
41 (3) 
0.94 
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Table A-25  (continued) Subjective physical activity [Modified MAQ (METS per week)] of overweight and obese 
adults with schizophrenia or schizoaffective disorder (WAIST Study) in GXT cohort by age groups (n=109). 
 
 
 
Subjective Physical Activity 
(mins/wk) 
 
18-39 yrs 
(n=23) 
 
40-49 yrs 
(n=42) 
 
50-65 yrs 
(n=44) 
p-value for 
Kruskal-
Wallis Test 
Total 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1669.2 + 2147.0 
897.5 
0, 9836.0 
287.0, 2225.0 
22 (1) 
 
1864.8 + 1700.0 
1439.8 
0, 6211.0 
492.5, 2543.0 
42 (0) 
 
2388.1 + 2602.4 
1040.0 
0, 11715.0 
589.0, 3904.5 
39 (5) 
0.44 
Total w/o occupational activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
1538.3 + 2086.3 
897.5 
0, 9836.0 
287.0, 2170.5 
22 (1) 
 
1636.2 + 1523.7 
947.8 
0, 5596.0 
490.5, 2428.5 
42 (0) 
 
1726.2 + 1766.5 
951.0 
0, 6600.0 
528.0, 2300.5 
41 (3) 
0.65 
Total w/o household activities 
   Mean + STD 
   Median 
   Range 
   25th, 75th percentile 
   N (missing) 
 
733.8 + 1129.6 
212.5 
0, 4530.0 
35.0, 1140.0 
22 (1) 
 
754.0 + 1241.9 
212.5 
0, 6070.0 
0, 735.0 
42 (0) 
 
1198.8 + 1976.4 
405.0 
0, 8715.0 
0, 1470.0 
39 (5) 
0.72 
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Table A-26  Mean (standard deviation) for valid actigraphy monitoring at baseline in overweight and 
obese adults with schizophrenia or schizoaffective disorder by age groups in the GXT cohort (n=27). 
 
 
Variable 
18-39 yrs 
(n=5) 
40-49 yrs 
(n=10) 
50-65 yrs 
(n=12) 
p-value for 
Kruskal-Wallis 
Test 
Monitoring days 
Mins/day 
5.2 (2.5) 
853 (127) 
7.6 (2.5) 
844 (74) 
7.7 (2.7) 
944 (164) 
0.21 
0.23 
Sedentary  
   Mins/day 
   % of wear time 
 
705.2 (117.0) 
82.7 (4.3) 
 
687.0 (58.8) 
81.6 (5.0) 
 
776.2 (145.6) 
82.2 (5.1) 
 
0.48 
0.93 
Light Activity  
   Mins/day 
   % of wear time 
 
129.8 (34.8) 
15.3 (3.6) 
 
139.4 (44.2) 
16.4 (4.3) 
 
146.9 (43.8) 
15.7 (4.0) 
 
0.60 
0.98 
Moderate/Vigorous 
Activity  
   Mins/day 
   % of wear time 
 
 
17.7 (8.3) 
17.3 (4.3) 
 
 
17.1 (9.4) 
2.0 (1.1) 
 
 
20.6(14.9) 
2.1 (1.3) 
 
 
0.94 
0.95 
Total Activity  
   Mins/day 
   % of wear time 
 
147.4 (42.2) 
17.3 (4.3) 
 
156.5 (51.0) 
18.4 (5.0) 
 
167.4 (57.4) 
17.8 (5.1) 
 
0.59 
0.93 
Activity  
   Counts/day 
   Counts/min 
 
12904 (4939) 
151.6 (42.8) 
 
134181 (61075) 
157.5 (62.8) 
 
149599 (74737) 
157.3 (70.0) 
 
0.83 
0.99 
a Fisher’s Exact Test 
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Table A-27  Comparison of adults who used mental health services in NHANES 2003-2004 with 
overweight and obese adults with schizophrenia or schizoaffective disorder in WAIST study.  Age 
restricted to 18-70 yrs. 
 
 
 
 
Variable 
NHANES  
Users of mental 
health services 
(n=230) 
WAIST Study 
Adults with schizophrenia or 
schizoaffective disorder 
 (n=46) 
 
p-value 
 for  
t-distribution 
Age (yrs) [Mean + STD] 42.2 + 0.7 45.6 + 9.8 0.07 
BMI (kg/m2) [Mean + STD] 28.6 + 0.6 37.9 + 8.1 <0.0001 
Men [N (%)]  99 (43.0%) 17 (37.0) 0.45 
Current Smoker [N (%)] 87 (37.8%) 16 (34.8) 0.55 
Race [N (%)] 
   White  
   Black  
   Other 
 
139 (60.4) 
48 (20.9) 
43 (28.7) 
 
19 (41.3) 
26 (56.5) 
1 (2.2) 
0.28 
General Health Status [N (%)]   
   Excellent, Very Good/ Good 
   Fair or Poor 
   Missing 
 
156 (67.8) 
58 (25.2) 
16 (7.0) 
 
23 (50.0) 
21 (45.7) 
2 (4.4) 
0.007 
 
 
Monitoring [Mean + STD] 
   Days 
   Mins/day 
 
6.1 + 0.1 
941 + 10 
 
7.4 + 2.8 
933 + 149 
 
0.006 
0.81 
Sedentary [Mean + STD] 
  Mins/day 
   % of wear time 
 
608 + 11 
64 + 0.7  
 
756 + 140 
81 + 6 
 
<0.0001 
<0.0001 
Light Activity [Mean + STD] 
   Mins/day 
   % of wear time 
 
308 + 6 
33 + 7  
 
157 + 48 
17 + 5 
 
<0.0001 
<0.0001 
Moderate/Vigorous Activity  
[Mean + STD] 
   Mins/day 
   % of wear time 
 
 
25 + 2 
3 + 0.2 
 
 
19 + 12 
2 + 1 
 
  
 0.39 
0.45 
Total Activity [Mean + STD] 
   Mins/day 
   % of wear time 
 
333 + 6 
36 + 0.7 
 
176 + 54 
19 + 6 
 
<0.0001 
<0.0001 
Activity [Mean + STD] 
   Counts/day 
   Counts/min 
 
253332 + 7069 
271 + 8 
 
151036 + 60998 
163 + 64 
 
<0.0001 
<0.0001 
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Table 4-28 Univariate models for subjective physical activity (METS/week) in overweight and obese 
adults with schizophrenia and schizoaffective disorders in the WAIST Study 
 
 Subjective Physical Activity (Modified MAQ) 
 
 
 
 
Independent Variable 
 
 
Total 
Activity 
(METS/day) 
 
Total w/o 
occupational 
activities 
(METS/day) 
Total w/o 
household 
physical 
activities 
(METS/day) 
Age (yrs) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
0.51 + 13.1 
0.00 
0.97 
243 
 
5.3 + 11.4 
0.22 
0.64 
250 
 
-7.6 + 7.6 
1.01 
0.32 
243 
BMI (kg/m2) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
-15.8 + 17.2 
0.84 
0.36 
243 
 
-7.3 + 14.9 
0.24 
0.63 
250 
 
-19.4 + 9.9 
3.84 
0.05 
243 
Gender (0=male, 1=female) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
362.0 + 279.6 
1.68 
0.20 
243 
 
504.6 + 242.1 
4.34 
0.04 
250 
 
-67.8 + 162.0 
0.18 
0.68 
243 
Race (0=White, 1= Black) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
65.1 + 274.9 
0.06 
0.81 
237 
 
132.2 + 238.4 
0.31 
0.58 
244 
 
-65.1 + 159.4 
0.17 
0.68 
237 
Smoking status (0=no, 1=current) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
-80.1 + 271.6 
0.09 
0.77 
243 
 
-93.6 + 103.4 
0.82 
0.49 
250 
 
-109.3 + 156.8 
0.49 
0.49 
243 
Psychiatric Medications (0=no, 1=yes) 
   Polypharmacy 
   β + SE 
   F-statistics 
   p-value 
   n 
 
 
-189.5 + 119.4 
2.52 
0.11 
243 
 
 
-93.6 + 103.4 
0.82 
0.37 
250 
 
 
117.4 + 68.9 
2.90 
0.09 
243 
Weight gaining properties of single anti-
psychotic medications (0=no, 1=yes) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
 
-623.5 + 354.9 
3.09 
0.08 
202 
 
 
-348.4 + 308.3 
1.28 
0.26 
207 
 
 
-497.3 + 211.1 
5.55 
0.02 
202 
Fitness (0=unfit, 1=fit) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
731.6 + 1557.7 
0.22 
0.64 
103 
 
1108.8 + 1237.6 
0.80 
0.37 
105 
 
1572.5 + 1097.5 
2.05 
0.16 
103 
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Table 4-28 (continued) Univariate models for subjective physical activity (METS/week) in overweight and obese 
adults with schizophrenia and schizoaffective disorders in the WAIST Study 
 Subjective Physical Activity (Modified MAQ) 
 
 
 
 
Independent Variable 
 
 
Total 
Activity 
(METS/day) 
 
Total w/o 
occupational 
activities 
(METS/day) 
Total w/o 
household 
physical activities 
(METS/day) 
Maximal Oxygen Consumption (units) 
   β + SE 
   F-statistics 
   p-value 
   n 
 
15.8 + 37.0 
0.18 
0.67 
103 
 
-8.8 + 28.9 
0.09 
0.76 
105 
 
44.4 + 26.0 
2.92 
0.09 
103 
Objective Physical Activity 
   Activity( counts/day/100) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
 
1.94 + 4.18 
0.22 
0.64 
46 
 
 
-1.75 + 3.63 
0.23 
0.63 
47 
 
 
5.1 + 2.6 
3.77 
0.06 
46 
Activity (counts/min) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
1.12 + 3.97 
0.08 
0.78 
46 
 
-2.0 + 3.4 
0.34 
0.56 
47 
 
3.9 + 2.5 
2.37 
0.13 
46 
Total activity (light, moderate and 
vigorous) (mins/day) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
 
-0.08 + 4.76 
0.00 
0.99 
46 
 
 
-2.9 + 4.1 
0.51 
0.48 
47 
 
 
3.6 + 3.1 
1.37 
0.25 
46 
Total activity (light, moderate and 
vigorous) (% of monitoring time) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
 
-1584.8 + 4585.0 
0.12 
0.73 
46 
 
 
-3786.5 + 3915.4 
0.94 
0.34 
47 
 
 
1907.2 + 2993.9 
0.41 
0.53 
46 
Sedentary (mins/day) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
1.15 + 1.89 
0.37 
0.55 
46 
 
1.25 +1.65 
0.58 
0.45 
47 
 
0.76 + 1.24 
0.38 
0.54 
46 
Sedentary (% of monitoring time) 
      β + SE 
      F-statistics 
      p-value 
      n 
 
1143.8 + 1488.9 
0.59 
0.45 
46 
 
1650.2 + 1342.9 
1.51 
0.23 
47 
 
-330.3 + 752.4 
0.19 
0.66 
46 
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C.1 Reprinted from Mental Health and Physical Activity, 1(1), Janney CA, Richardson CR, 
Holleman RG, Glasheen C, Strath SJ, Conroy MB, Kriska AM, Gender, mental health 
service use and objectively measured physical activity: Data from the National Health and 
Nutrition Examination Survey (NHANES 2003-2004), 9-16, Copyright (2008), with 
permission from Elsevier.  
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C.2  Reprinted from Mental Health and Physical Activity, 3(2), Janney CA, Richardson CR, 
Holleman RG, Glasheen C, Strath SJ, Conroy MB, Kriska AM, Corrigendum to “Gender, mental 
health service use and objectively measured physical activity: Data from the National Health and 
Nutrition Examination Survey (NHANES 2003-2004)” [Mental Health and Physical Activity,1 
(2008) 9-16], 104, Copyright (2010), with permission from Elsevier. 
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C.3  Reprinted from Journal of the American Geriatrics Society (58), Janney CA, Cauley JA, 
Cawthon PM, Kriska AM, Longitudinal physical activity changes in older men in the Osteoporotic 
Fractures in Men Study (Mr.OS), 1128-1133, Copyright (2010), with permission from John Wiley 
and Sons. 
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